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1 ZUSAMMENFASSUNG  
 
KCNE-Hilfsuntereinheiten assoziieren mit Spannungs-abhängigen K+-Kanälen und 
verändern dadurch deren subzelluläre Lokalisation, Regulation sowie deren 
biophysikalische Eigenschaften. Bei heterologer Expression interagiert KCNE3 mit 
mehreren Poren-bildenden K+-Kanal-Hauptuntereinheiten, deren Ströme dadurch stark 
modifiziert werden. Aufgrund dieser in vitro-Experimente wurden verschiedenste 
Funktionen von KCNE3 in den verschiedenen Geweben, wie Gehirn, Herz, Muskel, 
Kolon und Niere, vermutet. Außerdem wurden Variationen im kcne3-Gen mit 
menschlichen Skelettmuskelpathologien in Verbindung gesetzt (Abbott et al. 2001). In 
der gegenwärtigen Literatur wird die physiologische Funktion von KCNE3 eher als 
komplex und heterogen dargestellt. Auch die direkte Beteiligung von KCNE3 an 
Krankheiten ist immer noch spekulativ. 
Zur Untersuchung der physiologischen Funktion von KCNE3 in vivo sowie der 
potentiellen Rolle bei Krankheiten generierten wir ein kcne3-/- Mausmodell. Die 
vorliegende Arbeit unterstützt die kritische Rolle der KCNQ1/KCNE3-Kanäle beim 
Salz- und Flüssigkeitstransport über intestinale und respiratorische Epithelien. 
Insbesondere fanden wir für die KCNQ1/KCNE3-Heteromere eine basolaterale 
Lokalisation in Darm- und Trachea-Epithelzellen, wo sie die transepitheliale Cl--
Sekretion über basolaterales Recycling von K+-Ionen sowie über Erhöhung der 
elektrochemischen Triebkraft für apikalen Cl--Austritt fördern. Da weder 
Veränderungen in der KCNQ1-Expressionsmenge noch in dessen subzellulärer 
Lokalisation festgestellt wurden, ist die durch KCNE3 verursachte Modifikation der 
KCNQ1-Kanaleigenschaften essenziell für die hier beschriebene physiologische Rolle 
im Intestinal- und Trachealtransport. 
Ferner wird von unserer Arbeit die postulierte Funktion von KCNE3-Heteromeren im 
Skelettmuskel, Herz und zentralen Nervensystem nicht unterstützt und erweckt somit 
erhebliche Zweifel über den Beitrag von KCNE3 zu menschlichen Krankheiten, die mit 










2.1 Ion Channels 
An ion channel is a pore-forming protein inserted into the membrane that allows the 
flow of ions through its pore. Ion channels’ functions are basic for several cellular 
processes. Depending on the cell type, the currents generated by the ion flow produce a 
broad spectrum of effects. For instance, cell cycle, muscle contraction, neuronal action 
potential, epithelial ion secretion and reabsorption, nutrient absorption, programmed cell 
death and mucous secretion are processes influenced by ion channel activity. 
Ion channel dysfunctions can lead to dramatic changes in cell physiology causing severe 
pathologies, known as channelopathies (e.g. LQTs, seizures, cystic fibrosis, myotonia 
congenita, Bartter syndrome). According to their ionic permeability, different ion 
channel structures have been described: channels selective for monovalent cations, like 
sodium (Na+) or potassium (K+), divalent cations like calcium (Ca++), or monovalent 
anions like chloride (Cl-).  
Given the essential role of ion channels in many different physiological functions, their 
activity is highly regulated in vivo. Voltage changes, chemical (ATP/GTP increases, 
neurotransmitters, phosphorylations, etc) or mechanical signals (like increases in 
osmotic pressure) regulate channel gating and inactivation. 
 
2.1.1 Resting Membrane Potential and NERNST Equilibrium 
Potential 
All living cells have a plasma membrane, a lipid bilayer that encloses its contents, 
which represents an almost impermeable seal. The internal compartment differs from 
the extracellular space in ionic concentrations, which are generated thanks to energy 
consuming pumps, ion cotransporters and antiporters (table 2.1). Different Na+, K+ and 
Cl- concentrations across the membrane produce an electric potential difference, which 
is known as the “resting potential”. In all living cells, several different ion types, each 
with its own gradient, contribute to this charge separation. Each ion has a determined 




which is calculated according to the following equation: 
 
E= (RT/zF) ln ([ion outside cell]/[ion inside cell]) 
Where: 
R is the universal gas constant: R = 8.314 JK−1mol−1 
T is the absolute temperature  
F is the Faraday constant, the number of coulombs per mole of electrons: F = 9.648×104 
C mol−1 
z is the charge of the ion. 
 
At the Nernst equilibrium potential, there are no net charge fluxes through a channel 
because an electric and chemical equilibrium has been reached. 
Ion channel activity generates rapid ion fluxes driven by chemical concentration and 
electrical charge gradients across the plasma membrane, which modify the cell resting 
membrane potential. Each ion is naturally moved towards its equilibrium potential. In 
the case of K+, which is usually more concentrated intracellularly (140 mM) than in the 
extracellular space (5 mM), its equilibrium potential is more negative (-84 mV) than the 
membrane potential at rest. The opposite is true for Na+, which is more concentrated in 
the extracellular space (140 mM outside and 12 mM inside the cell) and its 
corresponding equilibrium potential is positive (+40 mV). Na+/K+ pumps keep a high 
K+ concentration inside the cell, since they extrude Na+ towards the extracellular space 
and import K+ ions. 
 
Table 2.1 Ionic concentrations inside and outside a mammalian cell. Physiological ionic 
concentrations of the most relevant ions in the mammalian cell (Alberts 2003). 
Ion Intracellular (mM) Extracellular (mM) 
Sodium 5-15 145 
Potassium 140 5 
Magnesium 0.5 1-2 
Calcium 10-4 1-2 
Chloride 5-30 110 
 
These pumps work against chemical concentrations, and therefore consume energy. The 
opening of K+ channels promotes an outward flux that brings the membrane potential to 




exceptions (e.g. KCNQ1/KCNE1 channels in stria vascularis), all K+ channels are 
hyperpolarizing, and they are considered responsible for repolarizing the cell membrane 
after depolarizations. On the other hand, Na+ channels are known to be depolarizing, 
since they allow the entry of Na+ into the cell, bringing the membrane potential towards 
positive values. 
 
2.2 Potassium Channels 
K+ channels are critical for physiological processes that involve rapid responses like 
propagation of electrical signals throughout the nervous system, cardiac, skeletal and 
smooth muscle contraction, transepithelial transport of electrolytes and nutrients, 
maintenance of salt-water absorption in gastrointestinal epithelia. They are as well 
involved in insulin secretion, cell cycle regulation, immune system response, cell 
volume and pH regulation, body balance and hearing. 
Despite the diverse kinetic properties and tissue distribution, K+ channels share a 
common basic architecture. K+ channels are tetrameric structures spanning the plasma 
membrane (MacKinnon 1991), consisting of 4 pore forming subunits, called alpha 
subunits. The subunits are probably assembled as dimer of dimers and symmetrically 
arranged around the pore (Tu and Deutsch 1999). A huge number of K+ channels have 
been described so far (Gutman et al. 2003) and according to their structure and 
biophysical properties, they have been classified into the following subdivisions (Figure 
1.1): six transmembrane domains and one pore loop (6TM/1P), two transmembrane 








Figure 2.1 “KCN” potassium channel families. Phylogenetical relations among 
human K+ channels. The KCN- letter code has been omitted (for instance “E3” stands 
for KCNE3 and “Q1” for KCNQ1). In some cases, also the most common used family 
aliases are highlighted (Adapted from Heitzmann et al 2008). 
 
2.3 Voltage Gated Potassium Channels 
The voltage gated K+ channels (Kv) group includes 40 of the 90 genes of K+ channels 
described so far. According to phylogenetic homology, they are divided into 12 families 
(Kv1 to Kv12) and classified into two main groups. The first group encloses Kv1 to 
Kv9, the second Kv10 to Kv12. 
All Kv channels subunits share the similar 6TM/1P structure and they get activated 
upon membrane voltage changes. Kv channels subunits contain two essential domains: 
the pore domain and the voltage-sensing domain (VSD). Each alpha subunit contains 




pore domain contains a highly conserved amino acid sequence consisting of TVGYG 
(Threonine, Valine, Glycine, Tyrosine, Glycine) that works as a selectivity filter. The 
S4 transmembrane domain is known as VSD because is able to move physically in 
response to changes in membrane potential, due to its positively charged amino acids. 
The VSD transduce electrical potential differences in conformational changes in the 
conduction pore, which open or occlude the ion conduction pathway. 
 
2.4 KCNQ Family 
KCNQ channels are a family of voltage gated K+ channels, also named Kv7 family. 
They have been described and intensely studied in central nervous system (KCNQ2, 3 
and 5), skeletal muscle (KCNQ5), intestine, cochlea, heart (KCNQ1), inner ear 
(KCNQ4), dorsal root ganglia, and recently reported in portal vein (KCNQ4 and 5), 
gastric smooth muscle, and pulmonary artery (KCNQ4 and 5).  
Five members of the family have been described (KCNQ1 to 5). They are all located in 
different chromosomes and share 30% to 65% of homology, mostly in transmembrane 
domains and in the C-terminus. In fact, all KCNQs have a highly conserved KCNQ-
specific domain, the “A-domain” or “subunit interaction (si) domain” in the distal C-
terminal region. This domain contains two double coiled-coil domains TCC1 and TCC2 
(tetramerizing coiled coil 1 and 2), also called A-domain head and tail, that are 
important for subunit recognition, channel assembly and surface expression (Schwake et 
al. 2003). Some of the members of the KCNQ family are able to assemble in functional 
heterotetramers, like KCNQ2 and 3 (Wang et al. 1998), KCNQ3 and 5 (Lerche et al. 
2000; Schroeder et al. 2000), KCNQ3 and 4 (Kubisch et al. 1999). 
KCNQ channel activation promotes outward K+ current that slowly activate under 
depolarizing voltages, being already active close to resting membrane potentials. 
KCNQs are considered hyperpolarizing channels because of their action in repolarizing 
the cell membrane after a strong depolarization. KCNQ channels show very little or no 
inactivation at all.  
The neuronal KCNQ family members show M-current properties (Wang et al. 1998; 
Jentsch 2000), defined by its kinetics and modulation, e.g. they are inhibited by 
acetylcholine-mediated activation of muscarinic receptors.  
Concerning their pharmacological properties, KCNQs are inhibited by Ba++, are 




aminopiridine (a general K+ channel blocker). KCNQs are blocked by linopirdine and 
its more potent analog 10,10-bis(4-pyridinyl-methyl)-9(10H)-anthracenone (XE991). 
Besides, the neuronal forms of KCNQs are also efficiently activated by retigabine. 
Interestingly, KCNQ channels display a diverse sensitivity to tetraethylammonion 
(TEA) according to the following decreasing scale of sensitivity: 
KCNQ2>KCNQ4=KCNQ1>KCNQ5> KCNQ3. This effect indicate differences in 
relevant residues downstream the selectivity filter sequence. 
 
2.5 KCNQ1 
KCNQ1 contains 676 amino acids, and its C-terminal domain is longer than of other 
Kv7, conferring a scaffolding structure for many intracellular signaling proteins. 
Secondary structure studies suggest that the KCNQ1 C-terminal domain possesses four 
conserved alpha helical regions (Yus-Najera et al. 2002). The first two contain protein-
binding domains for channel modulation and the other two form a so called “coiled 
coil” domain, which is important for subunit recognition and channel assembly. It is 
believed that this region is responsible for alpha subunit homo-oligomerization. Unlike 
other KCNQ family members, KCNQ1 channel forms only homotetramers (Howard et 
al. 2007; Wiener et al. 2008).  
The fact that KCNQ1 displays slower activation kinetics compared to the other KCNQs, 
is most probably due to the less charged residues in its S4 voltage sensor domain 
(Panaghie and Abbott 2007). 
KCNQ1 is expressed in epithelia and cardiac tissue (Barhanin et al. 1996; Sanguinetti et 
al. 1996; Lee et al. 2000). More recent reports also claim its expression in skeletal 
muscle (Yang et al. 1997) and brain (Goldman et al. 2009). 
Five KCNQ1 splice variants have been described, with only two of them giving rise to 
functional proteins. In heart, the first isoform was identified by Barhanin and 
Sanguinetti, the second one was described by Wang in 1996 (Wang et al. 1996). 
Expression of a third KCNQ1 isoform has been also reported in heart. When compared 
to the other two functional isoforms, this isoform lacks 127 amino acids in its N-
terminal sequence, and gives rise to a non-functional protein. Interestingly, this third 
isoform seems to inhibit the KCNQ1 wild type currents when heterologously co-
expressed with functional KCNQ1 isoforms. Moreover, this isoform is insensitive to 




KCNQ1 isoform is still not clear, although the fact that it is expressed in specific areas 
of the heart and at different levels might implicate a role in fine-tuning the expression of 
functional KCNQ1 channels. This fine modulation could possibly account for the vast 
heterogeneity of K+ conductances observed in cardiac tissue (Jiang et al. 1997). 
 
2.5.1 Electrophysiological Properties of KCNQ1  
KCNQ1 activation kinetics are slow compared to KCNQ2/KCNQ3 heterotetramers or 
Shaker-type K+ channels, probably due to the less positively charged S4 VSD. 
When KCNQ1 channels are heterologously expressed in Xenopus oocytes or 
mammalian cells, the currents recorded do not resemble any physiologically observed 
current, most probably because KCNQ1 is always part of a heteromeric complex with 
KCNE subunits in vivo.  
In vitro studies of KCNQ1 channels show half maximal activation (V1/2) at voltages that 
range from -12 mV to 36 mV depending on the expression system used (oocytes or 
mammalian cells). The channels activate following an exponential curve within 100 and 
200 milliseconds. In Xenopus oocytes, maximal activation is reached after two seconds 
depolarization pulse and very slow deactivation is usually observed (Barhanin et al. 
1996; Tristani-Firouzi and Sanguinetti 1998) (Figure 2.2).  
KCNQ1 channels display a delayed inactivation process that differs from the classic C-
type inactivation. Tail currents recorded in high K+ concentrations revealed that 
KCNQ1 channels do inactivate (Figure 2.2), being inactivation the third state for the 
channel together with open and closed states (closed < >open < > inactive). Although 
inactivation is difficult to observe in KCNQ1 channels, the transition among inactive 
and closed state is readily seen as a “hook” present in the tail current. This is due to the 
fact that KCNQ1 channels pass from inactive to open state ten times faster than passing 
from open to close state (Pusch et al. 1998). KCNQ1 inactivation does not play a 
relevant physiological role since in vivo it is removed or completely masked by the 






Figure 2.2 Recordings from KCNQ1 
expressing Xenopus oocytes. Slow 
activating KCNQ1 currents were 
recorded under depolarizing voltages 
steps. Pulses were applied in 10 mV 
increments from -70 mv to +40 mV. The 
current tail indicates inactivation (shown 





XE991 inhibits KCNQ1 with an IC50 (concentration necessary to block half of the 
current) of 0.8 µM. However, XE991 IC50 for KCNQ1/KCNE1 is about 11 µM. XE991 
action is however rather unspecific, since it also inhibits other members of the KCNQ 
family in a similar concentration range. The most specific drug which ensures quite 
selective inhibition of KCNQ1 is chromanol 293B (293B, trans-6-cyano-4-(N-
ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethyl-chroman) with a IC50= 27 μM. 
It is important to note that the sensitivity of KCNQ1 to chromanol 293B is increased by 
coassembly with KCNE1 (IC50= 7 μM), and even more with KCNE3 (IC50= 3 μM). At 
much higher concentrations however, chromanol 293B also inhibits CFTR Cl- channel 
(IC50= 19 μM). 
 
2.5.3  Intracellular Modulation of KCNQ1 
KCNQ1 channels probably do not exist in vivo in the homooligomeric form, but they 
are always coexpressed together with KCNE subunits.  In this section, we will describe 
the biochemical mechanisms responsible for the functional regulation of 
KCNQ1/KCNE complexes, which are always part of a major macromolecular signaling 
complex (Marx et al. 2002). 
 
2.5.3.1 cAMP 
High levels of intracellular cAMP activate KCNQ1, KCNQ1/KCNE1 (Yang et al. 
1997), and KCNQ1/KCNE3 (Schroeder et al. 2000). 
Under beta adrenergic signaling in cardiac myocytes, Yotiao, an A-kinase anchoring 




terminus, then recruits cAMP-activated protein kinase A (PKA) which phosphorylates 
KCNQ1 on serine 27 (Marx et al. 2002), and activates the channel. Beta-adrenergic 
stimulation therefore, by promoting KCNQ1 phosphorylation, leads to increase in 
cardiac slowly activating delayed rectifier K+ current (Iks). 
Interestingly, a mutation in the leucine zipper motif (hKCNQ1-G589D), which 
abolishes cAMP-mediated regulation of the KCNQ1 by preventing Yotiao recruiting, 
has been linked to Long QT syndrome (Marx et al. 2002). This cAMP regulation is also 
impaired when KCNE1 C-terminus is mutated (D76N and W87R), mutations which are 
also associated with some forms of long QT syndrome (Kurokawa et al. 2003). 
 
2.5.3.2 Calcium 
Studies addressing the involvement of Ca++ signaling in the regulation KCNQ1-
containing channels yielded to contradictory results (Gamper et al. 2005). It is however 
accepted that calmodulin (a Ca++ binding protein) interacts with KCNQ channels. 
Calmodulin binds to the IQ motif present in the KCNQ1 C-terminal domain, even in the 
absence of Ca++. This interaction is thought to be responsible for “solubilizing” the large 
C-terminal domain, a necessary requirement for the channel to traffick to the plasma 
membrane (Ghosh et al. 2006; Shamgar et al. 2006). Interestingly, a KCNQ1 mutation, 
which abolishes its interaction with calmodulin, resulted in diminished K+ current 




Phosphatidylinositol 4,5-bisphosphate (PIP2) is able to interact directly with the C-
terminal domain of KCNQ1. PIP2 stimulates KCNQ1/KCNE1 complex by increasing 
current amplitude and left shifting its voltage dependence of activation (Loussouarn et 
al. 2003; Kwon et al. 2007). 
 
2.5.3.4 pH 
Extracellular pH has different effects on KCNQ1 homo- and heterocomplexes. Low 
values of extracellular pH strongly decrease the current amplitude of KCNQ1 
homomeric complexes, activate KCNQ1/KCNE2 heteromeric channels (of relevance 




and current amplitude. This latter effect could represent an adaptative mechanism 
during the acidosis associated with cardiac ischemia (Heitzmann et al. 2007). 
 
2.5.3.5 Cell Volume 
Changes in cell volume are also known to regulate KCNQ1 activity. Increases in 
KCNQ1-mediated currents have been reported in rat hepatocytes, myocytes, upper 
airways cells, and MCF-7 epithelial cells, upon swelling (Kubota et al. 2002; Lan et al. 
2005; vanTol et al. 2007). It is believed that the KCNQ1 N-terminus senses the changes 
in cell volume via direct interaction with the cytoskeletal network (Grunnet et al. 2003). 
 
2.6 KCNE Accessory Subunits 
Beta subunits are regulatory or auxiliary proteins that interact with ion channels in order 
to target them to the plasma membrane, to modify the ion channel activity, kinetics and 
sensitivity to certain compounds. 
Several regulatory beta subunits have been described to interact with K+ channels, 
which may be cytosolic, or may span the lipid bilayer with one or several 
transmembrane domains. The KCNE beta subunits contain one transmembrane domain, 
a long extracytoplasmatic N-terminus and an intracellular C-terminus (Takumi et al. 
1988; Abbott and Goldstein 2001). The KCNE family seems to be quite promiscuous 
and in vitro, it is able to interact with multiple members of the voltage gated K+ channel 
family: KCNQ1, KCNQ4, KCNH1, KCNH2 (hERG), KCNC1 (here referred as Kv3.1), 
KCNC4 (here referred as Kv3.4), the KCND3 and KCNB1 (Zhang et al. 2001; Grunnet 
et al. 2003). 
 
2.6.1 KCNE Family Members 
The KCNE family consists of five members (KCNE1-5) which share a high homology 
in their transmembrane and C-terminal domains. They are small (106-177 amino acids) 
single transmembrane-spanning proteins, and their molecular weight ranges from 12 to 
19 kDa, depending on the sugar chains attached at their N-terminal sequences. The long 
and glycosylated N-terminal is extracellular, whilst the intracellular C-terminal length is 
variable and it contains a predicted consensus PKC phosphorylation site (Abbott et al. 




structural motif in the C-terminal domain (e.g. proline 77 in KCNE1) that would bend 
the intracellular structure. This structural scaffold would be important for channel 
modulation (Rocheleau et al. 2006). 
KCNE1 has been the first member of the KCNE family to be cloned (Takumi et al. 
1988), and it had been originally named IsK and later MinK (Minimal K+ channel) 
because of its small size. In fact, KCNE1 was first described as a channel promoting K+ 
currents upon overexpression in Xenopus oocytes, though later it was shown to co-
assemble with endogenous KCNQ1. KCNE2, 3 and 4 were cloned by homology and 
named after MinK as Related Peptides (MiRP) 1, 2 and 3 respectively. Besides, 
KCNE5, which is also known as KCNE1L (KCNE1 like protein), was first discovered 
as a deleted gene in the contiguous gene AMME syndrome (Alport syndrome, Mental 
retardation, Midface hypoplasia and Elliptocytosis) and was named after its high 
homology to KCNE1. Loss of of KCNE5 could be involved in the cardiac and 
neurological abnormalities seen in AMME syndrome (Piccini et al. 1999). 
Several in vitro studies demonstrated that KCNE proteins interact with a subgroup of K+ 
channels, the KCNQ channels, and particularly with KCNQ1 (Schroeder et al. 2000). 
Interactions with other K+ channels (kv3.4, kv2.1, kv3.1 and kv4.3) have been reported 
too. However, in many cases, it is unclear whether these promiscuous interactions are 
indeed occurring in vivo and are physiologically relevant, or they are just artifacts in 
overexpression in vitro systems employed to describe the interaction (Abbott et al. 
2001; McCrossan et al. 2003; Lundby and Olesen 2006).  
Furthermore, some reports have claimed the co-assembly of KCNQ1 with several 
different KCNE subunits in one KCNQ1/KCNE heteromeric complex. These mixed 
complexes would give rise to a greater variety of K+ currents (Morin and Kobertz 2007; 
Manderfield and George 2008). Along these lines, it is important to mention that all 
KCNE transcripts have been indeed found in human cardiac tissue to be co-expressed 
with KCNQ1 (Bendahhou et al. 2005; Lundquist et al. 2005). 
 
2.6.1.1 KCNE1 
KCNE1 mRNA undergoes alternative splicing, which results in two different isoforms: 
KCNE1a, which is ubiquitously expressed, and KCNE1b, which is typically found in 
cardiac tissue (Lundquist et al. 2006). KCNE1 is strongly expressed and plays a 




classical shaker/waltzer behavior (characterized by bidirectional circling, hyperactivity, 
head bobbing, and inability to swim) (Vetter et al. 1996), as well as cardiac arrhythmias 
and increased renal excretion of Na+ and glucose (Arrighi et al. 2001; Vallon et al. 
2001). 
KCNE1 interacts with KCNQ1 in heart and inner ear, where they form an extremely 
slowly activating and deactivating, delayed rectifying complex (Barhanin et al. 1996; 
Sanguinetti et al. 1996) (Figure 2.3). In addition, some reports showed that KCNE1 is 
able to alter Kv4.3 currents in vitro (Radicke et al. 2006), and modify Kv3.1 and Kv3.2 





Figure 2.3 Modification of KCNQ1 currents by KCNE1. KCNQ1 (A 
and B) or KCNQ1/KCNE1 (C and D) currents recorded from Xenopus 
oocytes. Voltage was clamped from -100 to +60 mV in 20 mV 
increments. The corresponding averaged I–V curves are shown in B and 
D. KCNQ1/KCNE1 channel complex elicited extremely slow activating 
and deactivating currents under depolarizing potentials (adapted from 
Grunnet et al. 2002). 
 
2.6.1.2 KCNE2 
Compared to KCNQ1 homomers, co-assembly of KCNE2 with KCNQ1 changes the 
current kinetics, renders the complex voltage independent and strongly reduces its 
currents (Tinel et al. 2000) (Figure 2.4). 
The KCNQ1/KCNE2 complex has been found in stomach, namely in parietal cells, 
being involved in acid gastric secretion (Roepke et al. 2006). Recently the complex has 




biosynthesis (Roepke et al. 2009). Loss of KCNE2 function in mice resulted in a broad 
spectrum of endocrine pathologies like mental retardation, dwarfism and cardiac 
arrhythmia. In addition, kcne2-/- mice show achlorhydria (reduced acid secretion) and 
gastric hyperplasia due to the lack of KCNE2 in parietal cells of the stomach (Roepke et 
al. 2006). Mutant mice also display hypothyroidism, dwarfism, alopecia, goiter, 
impaired maternal milk ejection and cardiac abnormalities. All of this endocrine 
dysfunction are most probably due to the novel role of KCNQ1/KCNE2 as thyrocyte K+ 
channel regulating production of thyroid hormones (Roepke et al. 2009). 
Moreover, in vitro data showed that KCNE2 is able to modulate cardiac Kv4.2 
(modulating Transient Outward K+ currents, Ito) (Zhang et al. 2001), as well as the 
neuronal Kv4.3 together with KChIP2 (Radicke et al. 2006). KCNE2 has also been 
reported to interact with Hyperpolarization-activated, Cyclic Nucleotide-modulated 
(HCN) channels in heart (Decher et al. 2003) and to modulate in vitro kinetic properties 
of Kv3.1 and Kv3.2 (Lewis et al. 2004). KCNE2 has been also shown to co-assemble in 
cardiac tissue with Kv 11 (HERG) channels, thereby producing slowly activating and 






Figure 2.4 Modification of KCNQ1 currents by KCNE2. Compared 
KCNQ1 (A and C) or KCNQ1/KCNE2 (B and D) currents recorded 
from transfected COS-7 cells after 2 s voltage steps from a holding 
potential of –80 mV over the range of –130 to +60 mV in 10 mV 
increments (A) or to +70 mV in 20 mV increments (B). The 
corresponding averaged I–V curves are shown in C and D. 
KCNQ1/KCNE2 channel complex elicited small amplitude voltage 






Co-expression of KCNQ1 with KCNE3 in heterologous systems gives rise to linear, 
voltage independent K+ currents (Schroeder et al. 2000) (Figure 2.5).  
In addition, in vitro KCNE3 is able to interact with many other Kv family members. 
These putative interactions have led to many speculative hypothesis for the function of 





Figure 2.5 Modification of KCNQ1 currents by KCNE3. KCNQ1 (A and 
B) or KCNQ1/KCNE3 (C and D) currents recorded from Xenopus oocytes. 
Voltage was clamped from -100 to +60 mV in 20 mV increments. The 
corresponding averaged I–V curves are shown in B and D. KCNQ1/KCNE3 
channel complex elicited enlarged, linear and voltage independent currents 
(adapted from Grunnet et al 2002). 
 
KCNE3 for example had been speculated to associate with KCNQ1 in colonic crypts 
(Schroeder et al. 2000; Dedek and Waldegger 2001) and to be expressed in human 
skeletal muscle, where it was proposed to associate with Kv3.4 (Abbott et al. 2001). 
Some other reports had claimed KCNE3 expression in the mammalian brain, together 
with Kv2.1 and Kv3.1 (McCrossan et al. 2003) or kv3.4 (Pannaccione et al. 2007). 
KCNE3 expression was also observed in heart, by real-time quantitative RT-PCR and in 
situ hybridization experiments (Bendahhou et al. 2005; Lundquist et al. 2005; Lundquist 
et al. 2006), or in portal vein myocytes (Ohya et al. 2002), where it was proposed to 






The physiological role of the KCNQ1/KCNE4 complex has not yet been clearly 
elucidated. Interestingly however, co-expression studies in heterologous systems have 
shown that KCNQ1/KCNE4 complexes are silent, suggesting that in vivo KCNE4 
would inhibit KCNQ1 currents upon co-assembly (Grunnet et al. 2002) (Figure 2.6). 
These experimental evidences are however still speculative, since specie specific 
differences have been reported between rat and human: the rat KCNE4 protein would 
indeed silence KCNQ1, while the human version would just slow KCNQ1 activation 
kinetics (Teng et al. 2003).  
In addition, KCNE4 has been shown to silence in vitro Kv1.1, Kv1.3 (Grunnet et al. 





Figure 2.6 Modification of KCNQ1 currents by KCNE4. KCNQ1 (A and 
B) or KCNQ1/KCNE4 (C and D) currents recorded from Xenopus oocytes. 
Voltage was clamped from -100 to +60 mV in 20 mV increments. The 
corresponding averaged I–V curves are shown in B and D. Interestingly, 
KCNQ1/KCNE4 channel complex are electrophysiologically silent (adapted 
from Grunnet et al 2002). 
 
2.6.1.5 KCNE5 
Although its physiological function has not been clearly understood, the fact that 
KCNE5 shares its genomic location with several neuronal genes (Lundquist et al. 2006) 
all of which are deleted in the AMME syndrome, prompted the assumption that KCNE5 




Overexpression studies in CHO cells have shown that KCNE5 coassembly with 
KCNQ1 leads to right shifting of its activation voltage (Angelo et al. 2002) (Figure 2.7), 
while a similar effect had not been observed in earlier experiments in Xenopus oocytes 
(Piccini et al. 1999). In vitro KCNE5 has also been reported to assemble with the 




Figure 2.7 Modification of KCNQ1 currents by KCNE5. KCNQ1 
(A) or KCNQ1/KCNE5 (B) currents recorded from Xenopus oocytes. 
Voltage was clamped from -100 to +40 mV in 20 mV steps. 
KCNQ1/KCNE5 channel complex elicited enlarged dependent 
currents. Interestingly, KCNQ1/KCNE5 channel complex behave 
similarly to KCNQ1/KCNE1 (adapted from Angelo et al 2002). 
 
2.6.2 Glycosylation of KCNE Proteins 
KCNE proteins have a single transmembrane domain, with intracellular C-terminus and 
extracellular N-terminus. The N-terminal contains consensus sequences for N-linked 
glycosylation, represented by N - X - T/S sequence motifs (N being an asparagine, X 
any amino acid but proline, and T or S a threonine or serine residue). It has been shown 
by several studies that these consensus sequences are effectively glycosylated in living 
cells (Gage and Kobertz 2004; Chandrasekhar et al. 2006). 
The glycosylation process starts in the rough-ER with the covalent attachment of a 
branched saccharic chain to the peptide, either while it is being synthesized (co-
translational glycosylation) or after the protein has been synthesized (post-translational 
glycosylation). The added oligosaccharide is composed by mannose and N-
acetylglucosamine residues (ManNAc). After correct protein folding, the glycoprotein is 
exported to the Golgi where the glycosylation process is completed by further 
modifications of the sugar chain. N-linked glycoproteins are in fact immature when 
sitting in the ER and acquire complex additional modifications while traveling trough 
medial and trans-Golgi compartments.  
N-glycosylation is important for protein folding, oligomerization and trafficking to the 




glycans are common signals for ER retention. KCNE proteins in particular are also 
retained in the early steps of the secretory pathway until they are coassembled with Kv 
alpha subunits (Chandrasekhar et al. 2006). Assessing the glycosylation state of a 
protein has therefore been extensively used as a marker for its maturational state and to 
determine its “position” along the secretory pathway. In particular, two biomolecular 
tools allow differentiating whether a protein left or not the ER: Endoglycosidase H 
(EndoH), which selectively removes immature glycans; and PNGaseF glycosidase, 
which breaks up all kinds of N-linked oligosaccharides (immature and complex) from 
the peptide backbone (Lemp et al. 1990). The presence of glycans, which are not 
cleaved by the EndoH, but effectively removed by PNGaseF, indicates exit of the 
glycoprotein from the ER compartment. 
 
2.7 KCNQ1/KCNE Complexes 
2.7.1 Intracellular Trafficking of KCNQ1/KCNE Complexes 
When studying KCNQ1 and KCNE partnering in vitro, it is of importance which 
heterologous system is chosen. The fact that some of them, Xenopus oocytes and HEK 
cells for example, already express endogenous KCNQ1, can lead to misinterpretation of 
the results. This is the case of some studies, which had erroneously concluded that 
assembly of KCNQ1 with KCNE1 takes place at the plasma membrane, and not in 
earlier steps of the exocytotic pathway (Romey et al. 1997; Grunnet et al. 2002). A later 
study however, performed in CHO and COS7 cells, which do not express endogenous 
KCNQ1, revealed that KCNE1 and KCNQ1 do not travel independently through the 
secretory pathway but assemble as a channel complex already in the ER (Chandrasekhar 
et al. 2006). 
When overexpressed alone in CHO cells, KCNE1 does not progress past ER and cis-
Golgi, while its co-expression with KCNQ1 leads to a robust KCNQ1/KCNE1 cell 
surface expression. Moreover, a specific mutation on the KCNE1 protein has been 
described which could retain KCNQ1 in the ER, further suggesting that both proteins 
first assemble in this intracellular compartment (Krumerman et al. 2004). Schroeder et 
al had reported a similar finding in 2000, where cotransfection of KCNE3 and KCNQ1, 




plasma membrane in absence of the alpha subunit, but was retained intracellulary in the 
ER compartment. 
 
2.7.2 KCNQ1 and KCNE Assembly and Modulation  
Although in recent years the exact location of the KCNE subunits within the KCNQ1 
channel has been extensively investigated, broad consensus has not yet been reached. 
Early studies suggested that KCNE ancillary subunits are located in the periphery of the 
compact KCNQ1 homotetramer (Wang et al. 1996; Romey et al. 1997) or just across the 
S4 canal (Kurokawa et al. 2001). Other reports suggested KCNE1 subunits to be located 
inside the KCNQ1 pore domain, near the ion pathway (Tai and Goldstein 1998; Chen et 
al. 2003). This hypothesis has been however ruled out by more recent studies based on 
the crystal structure of Kv channels, which showed that the pore region is indeed too 
narrow to harbor a KCNE peptide. Moreover, the fact that KCNQ1/KCNE1 can 
assembly with different stoichiometries, as shown by targeted mutagenesis experiments 
(Wang et al. 1998b), does not support the hypothesis of KCNE subunits being located 
inside the channel pore. 
More recent data have shown that KCNE1 and KCNE3 are able to interact with 
different segments of the KCNQ1 pore-lining S6 domain (Tapper and George 2001; 
Melman et al. 2004; Panaghie et al. 2006) (Figure 2.8), raising the possibility that mixed 
number of KCNE subunits might assemble at the same time within the KCNQ1 
tetramer. Indeed Morin and Kobertz in 2008 described an elegant approach to determine 
the number of beta-subunits in ion channel complexes, and show that there are two 
KCNE subunits in a functioning tetrameric KCNQ1 channel.  
Another study from the same group showed that key residues in the transmembrane 
domain of KCNE3 and KCNE1, called “activation triplet” (Figure 2.8), are able to 
modulate complex assembly and gating by direct interaction with the KCNQ1 pore 
lining region (Gage and Kobertz 2004). In addition to this regulatory mechanism, the 
KCNE C-terminus would be also involved in regulating KCNQ1 kinetics (Takumi et al. 





Figure 2.8 KCNE and KCNQ1 association. Left, Proposed 
association of 2 KCNE beta subunits with the Kv channel alpha 
subunit tetramer (though the stoichiometry and exact localization is 
not conclusively known). Right, KCNE interacting with the p-loop 
neighboring structures, the activation triplet is shown. The positive 
charged amino acids from the S4 voltage sensor domain are 
highlighted. The movement of the S4 under voltage changes (delta 
V) is depicted (adapted from Melman et al. 2002). 
 
Concerning the molecular mechanism by which KCNE subunits could modify KCNQ1 
kinetics, one possibility is that KCNE subunits are able to alter the behavior of the 
KCNQ1 voltage sensing S4 domain. This hypothesis has been directly tested for 
KCNQ1/KCNE1 and KCNQ1/KCNE3 complexes. In the case of the first complex, it 
has been shown that KCNE1 does not alter the behavior of the S4 domain during the 
transition from resting to active state. Therefore it was speculated that the slow 
activation of the KCNQ1/KCNE1 channel complex is probably due to slow opening of 
the intracellular gate (Nakajo and Kubo 2007; Rocheleau and Kobertz 2008). On the 
other hand, KCNE3 has been shown to alter the voltage-sensing domain S4, by 
uncoupling its movements from the intracellular gate opening, thereby facilitating the 
active state of the channel at hyperpolarizing potentials.  
 
2.7.3 Functional Roles of KCNQ1/KCNE1  
2.7.3.1 KCNQ1/KCNE1 in Heart 
The cardiac action potential is comprised of four phases, each one characterized by 
specific ionic currents (Figure 2.9). During the first phase (phase 0) the cell passes from 
the resting membrane potential (close to the equilibrium potential for K+, -84 mV) to a 
depolarized membrane potential due to the activation of fast Na+ channels (SCN5A) 






Figure 2.9 Electrocardiogram and cardiac action potential. Left, 
electrocardiogram showing the P wave (atrial depolarization), the 
QRS complex (reflects one heartbeat and corresponds to the 
depolarization of the right and left ventricles), the T wave is the 
repolarization of the ventricles, and the QT interval (measured from 
the beginning of the QRS complex to the end of the T wave). Right, 
cardiac action potential composed of 5 phases from 0 to 4 (a detailed 
description in the main text). 
 
The next phase (phase 1) starts when Na+ channels inactivate and outward K+ currents, 
promoted by Kv4.2/4.3, get activated (Ito). During phase 2 there is a plateau, 
representing an ionic equilibrium between the inward movement of Ca++ (Ica) through 
L-type Ca++ channels and outward movement of K+ ions (slowly activating delayed 
rectifier K+ current, Iks) through the slow delayed rectifier KCNQ1/KCNE1 channel 
complex. In this phase also Na+/Ca++ exchanger current, INa,Ca and the Na
+/K+ pump 
current, (INa,K) are involved. In phase 3, there is a rapid membrane repolarization 
because L-type Ca++ channels close while delayed rectifier KCNQ1/KCNE1 channel 
complex is still open, thereby it hyperpolarizes the cell membrane and activates rapid 
delayed rectifier hERG channels, probably co-assembled with KCNE2, and inward 
rectifying Kir2.1/2.2/2.3 channels (Ik1).  
 
KCNQ1/KCNE1 channels close when the membrane potential is back to resting 
conditions (-80 mV). The Kir 2.1/2.2/2.3 are major players in phase 4, where resting 
conditions are maintained till the next stimulus comes and activates Na+ channels, 
thereby reinitiating the cycle. 
Both KCNQ1 and KCNE1 subunits are almost exclusively localized in atrial and 
ventricular myocytes, where they were shown to co-assemble into functional 
heteromeric complexes. The KCNQ1/KCNE1 function is essential to get the cell ready 
for the next stimulus, repolarizing the cell to its resting membrane potential values slow 




homotetramers could not perform this function alone since this complex would open 
and close too fast, thereby being unable to maintain the appropriate repolarization of 
cardiac myocytes. The modulatory role of the beta subunit KCNE1 is therefore essential 
for the physiological role of the complex.  
Mutations that impair or modify KCNQ1/KCNE1 kinetics provoque a dramatic effect 
on cardiac activity, causing arrhythmias (irregular beat rhythmicity). Mutations on 
either KCNE1 or KCNQ1 extend the cardiac action potential, lengthening the so called 
“Q to T” interval (which represents the time in an electrocardiogram (ECG) recording 
for both ventricular depolarization and repolarization to occur, Figure 2.9), causing the 
„Long QT Syndrome” in humans (Wang et al. 1996). These mutations can be dominant 
or recessive, causing Romano-Ward Syndrome (RWS) (Chouabe et al. 1997; Wollnik et 
al. 1997), or Jervell-Lange Nielsen Syndrome (JLNS), respectively. KCNQ1 or KCNE1 
recessive mutations in homozygosis provoque a total loss of the channel function. In 
this case, cardiac arrhythmia is also associated with congenital deafness (Vetter et al. 
1996; Splawski et al. 1997). 
 
2.7.3.2 KCNQ1/KCNE1 in Inner Ear 
The cochlea contains the sensory organ of hearing, the organ of Corti. The 
KCNQ1/KCNE1 complex was identified in apical surfaces of marginal cells in the stria 
vascularis, a layer of epithelial cells on the outer wall of the cochlear duct (Neyroud et 
al. 1997). The stria vascularis maintains the special ionic composition of the 
endolymph, the liquid that fills the scala media, one of the three fluid-filled 
compartments of the cochlea. The high K+ concentration present in the endolymph 
bathes the hair cells, the sensory receptors present on the basilar membrane in the organ 
of Corti. Under stimulation, K+ and not Na+, enters into the hair cell creating a 
depolarizing current called mechano-electric transduction current.  
The KCNQ1/KCNE1 complex is involved in maintaining the elevated K+ 
concentrations in the endolymph (Nicolas et al. 2001). Remarkably, KCNQ1 homomers 
alone are not able to perform this function, since the channel is inactivated and none 
conducting at the membrane potential of the marginal cells of the stria. Mutations on 
either KCNQ1 or KCNE1 produce severe deafness. KO mice models for either one the 
proteins show inner ear defects, resembling those observed in Jervell and Lange–




2.7.3.3 KCNQ1/KCNE1 in Kidney 
The nephron is the basic structural and functional unit of the kidney. Each nephron is 
composed of an initial filtering component (the glomerulus) and a tubule specialized for 
reabsorption and secretion (the renal tubule). The renal tubule itself is subdivided into 
several functional and structural parts, the proximal tubule being one of these 
components. Across the luminal membranes of proximal tubules electrogenic Na+ 
coupled transport of substrates, such amino acids and glucose, depolarizes the 
membrane. In order to repolarize the membrane, slow conductance K+ channels activate 
under depolarization (Lang et al. 1986; Lang and Rehwald 1992). Then, repolarization 
of the cell membrane is essential to maintain the negative voltages necessary for the Na+ 
reabsorption. 
Given the fact that KCNQ1 and KCNE1 are expressed in proximal tubules of the kidney 
(Sugimoto et al. 1990; Vallon et al. 2001) and that the channel complex is voltage 
dependent, led to the speculation that both proteins might be involved in proximal 
tubule membrane repolarization (Arrighi et al. 2001; Demolombe et al. 2001). 
Accordingly, mice lacking the KCNE1 protein suffer from increased renal excretion of 
Na+ and glucose (Vallon et al. 2001; Warth et al. 2002a). However, kcnq1-/- animals do 
not show any impairment in renal transport under basal conditions, but only under 
substrate overloading (Vallon et al. 2005). 
 
2.7.3.4 KCNQ1/KCNE1 in Pancreas 
The pancreas is a gland organ in the digestive and endocrine system of vertebrates. It 
assolves both endocrine and exocrine functions, being responsible for producing several 
important hormones (including insulin, glucagon, and somatostatin), as well as secreting 
digestive enzymes into the small intestine. KCNQ1/KCNE1 complex is expressed in 
exocrine pancreas, where it regulates Cl- secretion, contributing to enzymatic granules 
release (Demolombe et al. 2001; Thevenod 2002). KCNQ1 seems to be also involved in 
regulating the membrane potential of insulin secreting cells (endocrine pancreas), since 






2.7.4 Functional Roles of KCNQ1/KCNE2 
2.7.4.1 KCNQ1/KCNE2 in Stomach 
The adult human body produces 2-3 liters of gastric juice per day. Gastric juice is 
strongly acidic liquid (pH around 1-2), whose major components HCl, KCl, NaCl and 
digestive enzymes. Gastric glands produce the gastric acid, while surface epithelial cells 
secrete alkaline mucus to protect the tissue from the acidic gastric juice. Deep in the 
gastric gland, three major cell types have been described: parietal, chief, and 
enterochromaffin-like cells. (Figure 2.10) 
Upon food stimulus, parietal cells start to secrete H+ and Cl- into the lumen of the 
gastric gland. Chief cells release pepsin protease precursors and are located at the base 
of the gland, while enterochromaffin-like cells have paracrine and endocrine roles and 
play important regulatory roles for the gastric secretory function. 
The biophysical properties of KCNQ1/KCNE2 channel complex together with the 
pharmacological inhibition of acid gastric production by C293B, led to the hypothesis 
that KCNQ1/KCNE2 complexes are involved in gastric acid secretion (Grahammer et 
al. 2001a). KCNQ1 and KCNE2 form a functional complex characterized by voltage-
insensitive background currents activated up on cAMP, PIP2 or acidic pH stimulation 
(Tinel et al. 2000; Heitzmann et al. 2007). 
 
 
Figure 2.10 Histology of the stomach. On the left, gross stomach anatomy showing muscle layers, 
esophagus and the pyloric sphincter, as well as the lumen. On the right, a three-dimensional view of 
layers of the stomach. The stomach wall is composed of four layers: mucosa, submucosa, muscularis 
and serosal. The gastric glands are located in the mucosa and the gastric pits face the lumen of the 




In the model described by Heitzmann et al., acid secreting parietal cells harbor two 
different populations of vesicles containing either H+/K+ ATPase or KCNQ1/KCNE2. 
Upon stimulus, both types of vesicles fuse to the large canaliculi, deep invaginations of 
the plasma membrane. H+/K+ ATPase import K+ in, and pump H+ out of the cell, whilst 
KCNQ1/KCNE2 lowers the intracellular K+ concentration, building up luminal K+, an 
absolute requirement for H+ extrusion. In support of their functional involvement in 
gastric physiology, KCNQ1, KCNE2 or H+/K+ ATPase KO mice show gastric 
hyperplasia, as well as achlorhydria (Scarff et al. 1999; Lee et al. 2000; Roepke et al. 
2006). 
 
2.7.4.2 KCNQ1/KCNE2 in Thyroid 
The thyroid gland secretes thyroxin (T4) and triiodothyronine (T3) hormones, which 
play a major role in the regulation of metabolism. These hormones (T4 is converted into 
the active form T3 in target tissues) are involved in diverse processes from bone growth, 
neuronal maturation to protein synthesis and acceleration of basal metabolism. 
The synthesis of T4 hormones involves the attachment of iodine atoms (4 in T4) to the 
thyroglobulin, for this purpose iodide ions are actively loaded into the thyrocyte by the 
basolateral Na+/iodide symporter NIS. This cotransport requires the Na+/K+ ATPase Na+ 
efflux and probably KCNQ1/KCNE2 channel complex in the basolateral membrane, to 
recycle the K+ back to the extracellular space (Roepke et al. 2009). Indeed, it has been 
recently reported that kcne2-/- animals suffer from hypothyroidism, dwarfism, alopecia 
and cardiac abnormalities due to the inability to produce T4/T3 hormones. These 
phenotypes were alleviated by complementing the diet with T3/T4 hormones. 
 
2.7.4.3 KCNQ1/KCNE2 in Heart 
KCNE2 has been reported to be expressed in heart and to interact with HERG (Abbott 
et al. 1999) and with KCNQ1 channels. Its malfunction has been associated with cardiac 
arrhythmias and atrial fibrillations (Yang et al. 2004). Moreover, kcne2-/- mice suffer 
from cardiac hypertrophy. It is however important to mention that the cardiac 
pathologies linked to KCNE2 deficiencies could be due to primary electrical defects in 





2.8 Putative Functional Roles of KCNE3 
2.8.1 KCNE3 in Intestinal Tract 
The small intestine is the organ where most of the digestion and absorption of nutrients 
takes place, and it is subdivided into duodenum, jejunum and ileum (Figure 2.11). The 
latter is followed by caecum and colon (Figure 2.12). The first literally refers to the 
“dead-end” structure connecting the ileum with the colon, which is found in herbivores 
and is needed to digest vegetal material, such as cellulose. In most carnivores, however 
a vermiform appendix replaces this structure. The final water and salt absorption takes 
place in the colon, where stools are dehydrated and finally expelled out of the intestinal 
tract.  
At the microscopic level, a small intestine transversal section reveals a highly 
invaginated epithelia consisting of villi and crypts (Figure 2.11).  
 
 
Figure 2.11 Anatomy of the small intestine. The upper picture 
displays a cross section of the small intestine lumen showing the 
tongue shaped structure called villi. The lower picture is a higher 
magnification of an intestinal crypt, showing the different cell 
population, the blood supply, and lymphatic system vessels (lacteal) 





The function of the villi and enterocyte microvilli is to increase the surface available for 
nutrients absorption. On the other hand, the colon is devoid of villi and instead presents 
large intestinal crypts (Figure 2.12). 
Glucose and amino acid uptake is performed by the villi and it is coupled to Na+ 
reabsorption. Basolateral K+ channels, like KCNQ1, actively contribute to maintain the 
cell membrane potential at its resting value, thereby helping in substrate loading. 
Although being mainly an adsorptive tissue, the intestine has also secretory properties, 
with Cl- and HCO3
- secretion taking place at intestinal crypts. Cl- is basolaterally 
imported into the cell through the 1 Na+, 2 Cl- and 1 K+ cotransporter NKCC1. Cl- 
leaves the cell apically by passing through the cAMP activated CFTR channel.  
 
 
Figure 2.12 Histology of the colon. Three-dimensional view of layers of 
the colon. The Colon is composed of several layers: mucosa, muscularis 
mucosae, submucosa, two muscle layers, and the serosa. Note that in the 
colon the openings of the colon crypts face directly to the lumen of the 
colon (adapted from Encyclopedia Britannica). 
 
The cAMP signaling cascade is activated by multiple stimuli: prostaglandin E2, 
serotonin, vasoactive intestinal polypeptide (VIP), pituitary adenylate cyclase- 
activating polypeptide (PACAP), and by bacterial toxins, e.g., cholera toxin. 
Remarkably, the effect of cholera toxin is not only on the enterocyte cAMP cascade, but 
it includes also increase in blood supply, immune system activation and enteric nervous 
system alterations (Nocerino et al. 1995; Farthing et al. 2004). These multiple 
synergistic effects are responsible for the overwhelming intestinal Cl- secretion and the 




It is important to mention that, since mucosal cells, lymphatic system, neurons, smooth 
muscle, blood vessels, immune system cells, and endocrine cells coordinate with the 
enterocytes to facilitate nutrient absorption and electrolyte secretion, it is not an easy 
task to study intestinal physiology, since in vitro and even ex vivo preparations will 
always lack one or several modulatory factors. 
Basolateral activation of K+ channels not only recycles K+ to the extracellular space to 
fuel NKCC1 and Na+/K+ ATPase, but also hyperpolarizes the cell membrane. Both 
actions increase the driving force for apical Cl- exit (Schroeder et al. 2000; Dedek and 
Waldegger 2001; Kunzelmann et al. 2001; Matos et al. 2007). Interestingly, in 
duodenum another cAMP stimulated K+ conductance has been observed, which differs 
from KCNQ1/KCNE3 channel complex in its large single channel conductance 
(McNicholas et al. 1994). This would explain why cAMP stimulated Cl- secretion is 
only partially abolished (50% of control levels) in KCNQ1-deficient small intestine 
(Vallon et al. 2005). In addition, Ca++ activated KCNN4 K+ channels are expressed in 
basolateral membranes of enterocytes in small intestine and colonic epithelia, and Ca++ 
activated Cl- channels have been identified in goblet cells but not in enterocytes. 
KCNN4 would extrude K+ upon intracellular Ca++ increases, hyperpolarizing the cell 
membrane and thus helping Cl- leaving the apical membrane through CFTR. 
Intracellular Ca++ waves would stimulate mucous secretion by goblet cells, as well as 
Cl- and water flush from basal crypt cells. Therefore, KCNN4 could possibly 
compensate for the loss of functional KCNQ1/KCNE3 complex in this tissue. 
 
2.8.2 KCNE3 in Heart 
Several reports have claimed that KCNE3 might play an essential role in cardiac 
physiology by assembling with diverse K+ channels like KCNQ1, HERG, and Kv4.3. 
(Mazhari et al. 2002; Ohya et al. 2002; Lundby and Olesen 2006), although the precise 
function and kinetics remained unclear. In addition, several sequence variations in the 
KCNE3 gene have been linked to diverse cardiac pathologies like Long QT syndrome 
(Ohno et al. 2009), Brugada syndrome (Delpon et al. 2008) or atrial fibrillation (Lundby 
et al. 2008). 
Ohno and coworkers in 2009 conducted a genetic screening in 485 Long QT syndrome 
(LQTS) probands and identified KCNE3 T4A, P39R, R99H sequence variations. This 




activated currents and the voltage dependence towards faster activation and voltage 
independency. The authors speculated that the lack of the KCNE3 subunit would reduce 
repolarizing K+ currents in the myocardium. No direct evidence was provided to support 
this hypothetic function of KCNQ1/KCNE3 complexes in cardiac muscle, and it is still 
unclear how this complex would work in conjunction with KCNQ1/KCNE2 and 
KCNQ1/KCNE1 heterooligomers, which are also present in these cells. 
To date only two single reports detected relatively low KCNE3 transcripts in human 
cardiac tissue by real time PCR experiments (Bendahhou et al. 2005) or in situ 
hybridization (Lundquist et al. 2005). Unfortunately, these studies lack of appropriate 
controls (e.g. KCNE3 deficient tissues and specific antibodies) and do not demonstrate 
the presence of KCNE3 protein in murine and human cardiac tissue. 
 
2.8.3 KCNE3 in Airways 
The pulmonary airway belongs to the respiratory system, conceptually beginning at the 
nose and mouth, and terminating in the alveoli. At the cellular level, the airway surface 
is populated by columnar ciliated, fluid secreting cells, non-ciliated cells, mucous 
secreting goblet cells, basal and Clara cells. Basal cells work as scaffold for the 
columnar cells (Shebani et al. 2005). Clara cells secrete multiple substances to protect 
airway epithelium and detoxify inhalated substances. Ciliated cells create a fluid layer 
(known as Airway Surface Liquid (ASL)) on top of the cilia, which helps the mucous to 
move upwards. CFTR channel localized primarily at the apical surfaces of epithelial 
cells lining the airway and in submucosal glands (Engelhardt et al. 1992; Kalin et al. 
1999).  
The ciliated cells carry out two important physiological functions: Cl- secretion and Na+ 
absorption (Welsh 1987). Cl secretion provides the osmotic driving force for epithelial 
water secretion, since paracellular water movement accompanies Cl- secretion. Cl- may 
exit the apical membrane of ciliated cells through cAMP-activated channels (CFTR) or 
Ca++ activated Cl- channels (CaCC) (Blouquit et al. 2006). In order for Cl- to be 
extruded from the cell, there must be an electrochemical gradient across the membrane, 
which drives its movement. Activation of basolateral K+ channels, cAMP (KCNQ1) or 
Ca++ activated (KCNN4), hyperpolarizes the cell membrane, counteracting the 
depolarizing effect of Cl- efflux, thus increases electrochemical driving force for apical 




exchange intracelluar Na+ for K+ and, the NKCC1 that cotransports 1 Na+, 2 Cl- and 1 
K+ ions simultaneously into the cell. In conclusion, basolateral K+ channels are needed 
to recycle K+ back to the extracellular space to avoid intracellular K+ overloading. 
Hence, apical Cl- secretion is coupled to basolateral K+ outward currents (McCann and 
Welsh 1990; Quinton 1990). 
 
Figure 2.13 Anatomy of the 
upper airways. On the left, 
gross anatomy of the airways 
showing the larynx, trachea 
and main primary bronchi. On 
the right, cross section of the 
trachea showing a detailed 
histology, where the ciliated 
and columnar epithelium can 




Regarding the molecular identity of basolateral K+ channels, KCNQ1 has been detected 
in trachea and has been described as the dominant K+ conductance in basolateral 
membranes of ciliated cells (MacVinish et al 1998, Mall et al 2000, Grahammer et al 
2001). The fact that KCNE3 mRNA was detected in trachea led to the speculation that 
KCNQ1/KCNE3 complexes would be directly involved in cAMP-stimulated Cl- 
secretion. Besides, also KCNN4 was reported to play a role in tracheal basolateral K+ 
transport (Devor et al. 1996; Ishii et al. 1997; Grahammer et al. 2001b). 
CFTR mutations, which are the cause of cystic fibrosis in humans, lead to excessive Na+ 
absorption and lack of Cl-, bicarbonate and water secretion from respiratory tissues. 
This chain of events leads to dehydrated mucous, acidic ASL, and consequently 
compromised mucociliary clearance and lung defense. Because of the severe 
impairment in respiratory tissue physiology, Cystic Fibrosis causes progressive 




In mice however, CFTR deletion did not result in any obvious respiratory complication. 
This is probably due to, first, the different anatomy of the airways, and second, to the 
fact that murine upper airways do not only express CFTR as apical Cl-  conductance, but 
also a Ca++ activated Cl- channel (CaCC), which might compensate for the loss of CFTR 
(Clarke et al. 1994; Grubb et al. 1994).  
 
2.8.4 KCNE3 in Central Nervous System 
KCNE3 has been reported to be broadly expressed in brain together with Kv2.1 and 
Kv3.1 to alter neuronal excitability (McCrossan et al. 2003). KCNE3 would slow Kv3.1 
gating, broading the action potential and lowering the maximal firing frequency in 
selected neuronal subpopulations. Besides, in hippocampus and other regions, KCNE3 
would downregulate the Kv2.1 delayed rectifier currents and slow its deactivation, 
producing a delayed repolarization. 
Alzheimer disease is the most common of dementia in humans. This disease has been 
associated with apoptotic neuronal cell death triggered by deposits of amyloid peptide in 
the brain of affected patients. Pannaccione et al. in 2007 reported that expression of the 
Kv3.4/KCNE3 complex is upregulated by the amyloid peptide. Kv3.4 is expressed in 
neurons of the adult dentate gyrus and in the mossy fibers terminals of the 
hippocampus, where it regulates action potential length and membrane repolarization in 
axons and pre-synaptic terminals (Heinemann et al. 1996; Rudy et al. 1999). According 
to the hypothesis of Pannaccione and collaborators, beta amyloid peptide would 
upregulate Kv3.4/KCNE3 expression in plasma membrane, leading to increased K+ 
outward currents, which would then lower K+ intracellular concentrations and directly 
promote cell death (Pannaccione et al. 2005; Pannaccione et al. 2007).  
 
2.8.5 KCNE3 in Skeletal Muscle 
Myocytes, the cellular units of skeletal muscle fibers, are excitable cells that transduce 
the chemical signal of neuromuscular synapses into electrical membrane potential 
depolarizations and mechanical contraction. 
Kv3.4/KCNE3 heteromeric K+ channels have been suggested to set the resting 
membrane potential of skeletal myocytes (Abbott et al. 2001; Abbott et al. 2006). 
Abbott et al reported a prominent KCNE3 expression in human muscle tissue, and 




channel on voltage and intracellular pH, accelerate its recovery from inactivation, and 
increase its single channel conductance.  
Moreover, a sequence variant on KCNE3 gene (R83H) was reported to decrease K+ 
currents upon co-expression in heterologous cells in a dominant negative manner 
(Abbott et al. 2001). Importantly, the R83H sequence abnormality was found in patients 
from two families with periodic paralysis and was absent in 120 unaffected individuals, 
leading to the conclusion that mutations in kcne3 might underlie some forms of this 
genetically heterogeneous human disease. Periodic paralysis is an hereditary disease 
that leads to frequent muscle feebleness, debility and even paralysis after exercise, 
fasting, high carbohydrate intake or emotional stress. Three distinct types of periodic 
paralysis have been classified according to the conditions under which  muscle cell 
irresponsiveness becomes manifest: the hypokalemic-type, where muscular deficit is 
promoted by low blood levels of K+; the hyperkalemic-type, by high blood levels of K+; 
the paramyotonia congenital-type, where muscle contractures are present either in low 
or high levels of K+ in the bloodstream. KCNE3 R83H would provoke an abnormal 
positive skeletal muscle membrane potential, causing irresponsiveness of the muscular 
cell to the contracting stimulus. These data have been however heavily disputed, since 
several other groups have found KCNE3 R83H in healthy humans suggesting that it is a 
benign polymorphism (Sternberg et al. 2003; Jurkat-Rott and Lehmann-Horn 2004). 
 
2.9 Aim of the Study  
When overexpressed in heterologous systems, KCNE3 is able to interact with several 
pore-forming K+ channel alpha subunits greatly modifying their currents. Based on 
these in vitro evidences, KCNE3 has been proposed to serve different roles in multiple 
tissues, including brain, heart, muscle, colon and kidney (McCrossan and Abbott 2004). 
Additional reports have also linked sequence variations in the KCNE3 gene to cardiac 
(Delpon et al. 2008; Lundby et al. 2008; Ohno et al. 2009) and skeletal muscle 
pathologies in human (Abbott et al. 2001). Based on the literature, the overall picture of 
KCNE3 physiological function is rather complex and heterogeneous, and its direct 
involvement in pathologies is still speculative and far from being conclusively proven. 
In order to study the physiological role of KCNE3 in vivo and to address its potential 
pathological implications, we generated kcne3-/- mice. Although this approach has been 




KO approach, is an invaluable tool to define or clarify the in vivo function of the protein 
of interest. In addition, tissues from KO animals, which are completely devoid of the 
protein of interest, provide the most specific and valuable controls to study protein 
localization by conventional biochemical and immunohistochemical techniques. For 
these reasons, we undertook a genetic approach to study KCNE3 expression pattern and 





3.1 Chemicals and Enzymes  
Unless otherwise specified, standard chemicals companies BioRad (Hercules, USA), 
Boehringer (Mannheim), Fluka (Neu-Ulm), Merck (Darmstadt), Roth (Karlsruhe), 
Riedel de Haen (Seelze), Serva (Heidelberg) and Sigma ( Munich, Germany). 
Restriction enzymes were purchased from New England Biolabs (Schwalbach / 
Taunus), Invitrogen (Eggenstein) and Fermentas (St. Leon-Rot). The oligonucleotides 
were synthesized by the company Biomer (Ulm).  
 
3.2 Buffers and Solutions  
DEPC water 
900μl diethylpyrocarbonate in 450ml H2O. Incubate 
stiring overnight at 37 ° C, and autoclave 
Dextran solution  
Add some Dextran granules in H2O;take 250μl and add 
to 15ml of 100% EtOH  
DNA loading buffer (10x)  
0.25% (w / v) bromophenol blue, 0.25% (w / v) 
Xylencyanol, 30% (w / v) glycerol  
Fixation buffer  4% PFA in PBS  
Homogenization buffer 
(Membrane prep)  
140mM NaCl, 20 mM Tris, pH 7.4, 5 mM EDTA; 
1xComplete (Roche).  
IF pre treatment trachea 0.05% trypsin in 0.1% CaCl2, 0.05 M Tris, pH 7.8 
IF block solution  
2% normal goat serum (NGS), 1% bovine serum 
albumin (BSA), 0.05% Tween, and 0.2% Triton X100 
in PBS  
Ketamine-Rompun mixture  120μl Ketamin10; 80μl 2% Rompun; 800μl PBS  
Lysis buffer (mem.prep) 
50 mM Tris pH 6.8, 5mM EDTA, 2% SDS and 
Complete® protease inhibitor (Roche) 




Lysis buffer (tail cuts)  
50 mM Tris, 100 mM EDTA, 100 mM NaCl, 1% SDS, 
 pH8, 0.5 mg / ml proteinase K  
Low-TE buffer  
10 mM Tris pH 7.5, 0.1 M EDTA pH 8, pH 7.1 with 
HCl  
Na+-phosphate buffer 
Na-phosphate buffer (50 mM, pH 7.4), 1% NP40 and 
PNGase F 0.5 U/25 µg of total protein (Roche) 
PBS  
137mM NaCl, 7.4 mM Na 2 HPO 4, 2.7 mM KCl, 1.5 
mM KH 2 PO 4, pH 7.4  
Ponceau Red (10x)  
2 g Ponceau S, 30 g trichloroacetic acid, sulfosalicylic 
30g; to 100ml water  
Protein Transfer Buffer  
25mM Tris, 200mM glycine, pH 8.3 with HCl, 20% 
methanol  
RNase buffer  
0.5 M NaCl, 0.01 M Tris pH 7, 1 mM EDTA, 0.02 mg / 
ml RnaseA  
SB-hybridization buffer  
 (Speed-hybrid 2)  
7% SDS, 10% polyethylene glycol, 1.5 x SSPE  
SB-Wash buffer A  0.5% SDS, 2% SSC  
SB-Wash buffer B  0,1% SDS; 0,2% SSC 0.1% SDS, 0.2% SSC  
Separating gel buffer  1.5 M Tris, 0.4% SDS, pH 8.8 with HCl  
SDS (10%)  
Heat 100 g SDS in 900 ml of H 2 O at 68 ° C, adjusted 
to pH 7.2 with HCl, to replenish 1L with H 2 O  
SDS-PAGE running buffer 
(10x)  
250mM Tris, 2M glycine, 1% SDS  
SDS-PAGE sample buffer 
(5x)  
250mM Tris, 10% SDS, 0.5% bromophenol blue, 50% 
glycerol solution, at 50 ° C (+5% β-mercaptoethanol for 
reducing conditions)  
Sequencing buffer  5 mM MgCl 2, 200mM Tris, pH 9  
SSC (20x)  3M NaCl, 0.3 M sodium citrate, pH 7  
SSPE (20x)  3M NaCl, 0.2 M NaH 2 PO 4, 20 mM EDTA, pH 7.4  
Stacking gel buffer (4x)  0.5 M Tris, 0.4% SDS, pH 6.8 
TAE buffer (50x)  0.2 M Tris-acetate, 10 mM EDTA pH 7.4  





Toluidine Blue Stock  Toluidine blue O (Sigma) 1 g ;70% alcohol 100 ml 
Toluidine Blue working  
Toluidine blue stock solution 5 ml; 1% Sodium 
chloride, pH 2.3 45 ml 
Trypsin / EDTA  0.25% trypsin, 0.02% EDTA in PBS  
WB-block buffer  5% skimmed milk powder, 0.1% NP-40 in TBS  
WB-wash buffer  0.1% NP40 in 1xTBS  
 
3.3 Bacterial Culture  
3.3.1 Media  
LB medium  0.5% NaCl, 0.5% yeast extract, 0.1% glucose, pH 7  
LB-amp medium  100μg/ml ampicillin in LB medium  
LB-amp plates  15g Agar in 1000 ml LB-Amp medium  
LB agar  LB medium with 1.5% agar  
LB-Amp agar  LB agar with 100μg/ml ampicillin  
Top Agar  LB medium with 0.7% agarose  
 
3.4 Cell Culture of Embryonic Stem Cells  
R1 ES cells  Murine embryonic stem cell line (Nagy et al., 1993)  
 
3.4.1 Media and Solutions  
DMEM (+ Glutamax)  Gibco # 61965026  
Fetal calf serum (FCS)  Gibco # 10270106  
MEM amino acid cocktail Gibco # 11140035  
Penicillin / streptomycin  Gibco # 15070022  
DMEM  Gibco # 42430025  
Glutamine  Gibco # 25030024  
Sodium pyruvate  Gibco # 11360039  
2-mercaptoethanol  Gibco # 31350010  
Geniticin (G418, Neomyzin)  Gibco # 10131019  




Trypsin / EDTA  
(for ES cells)  
Gibco # 25200056  
PBS  Gibco # 18912014  
Oil  Sigma # M-8410  
0.1% gelatin  Sigma # G-1890  
Mitomycin C  Sigma # M-0503  
MEF medium  
DMEM + Glutamax, 9% FCS, 1x MEM, 1x Pen 
/ Strep  
ES medium  
DMEM, 15% FCS, 2 mM glutamine, 1x MEM, 
1x Pen / Strep, 1x Nukleosidmix, 1x sodium 
pyruvate, 0.1 mM 2-mercaptoethanol, 1000 U / 
ml LIF  
ES-selection medium  ES-medium, 200-300 µg / ml G418  
Electroporation buffer  
20 mM Hepes, 137 mM NaCl, 5 mM KCl, 0.7 
mM Na 2 HPO 4, 6 mM glucose, pH 7.5  
ES-freezing  50% FCS, 40% ES medium, 10% DMSO  
 
3.5 Plasmids 
pBluescript SK +  
From Stratagene, the vector contains an f (1) - and a ColE1-
origin of replication (ORI), ampicillin resistance, a bacterial lacZ 
gene, and a multiple cloning site  
pcDNA3 
Mammalian plasmid from Invitrogen, contains a CMV promoter, 
a f (1) - and a ColE1-origin of replication (ORI), ampicillin 
resistance, and a multiple cloning site  
 
3.6 Oligonucleotides  










Southern blot 3’probe  
 CAAAGAAGGAGGAAAAGGAA/ 
ATAAAGGGCTGGCTCTGAAA 
Northern KCNE3 probe 
CACATTCCAGCTCTTCCCATACC/ 
CACATCAGATCATAGACACACGG 




3.7 Antibodies  
3.7.1 Primary Antibodies  
Antibodies  Species  Dilution  Company  
Actin  Rabbits polyclonal  1:1000 (WB)  Sigma  
H+/K+ ATPase beta Mouse 1:500 Dianova 







All compounds (carbachol, ATP, 3-Isobutyl-1-Methylxanthine (IBMX), forskolin, 
amiloride, indomethacin were of highest available grade of purity and were from Sigma 
(Taufkirchen, Germany). 293B was gifts from Aventis Pharma (Frankfurt,Germany). 
3.8.2 Solutions 
Ice cold buffer 
solution 1 
(in mM) NaCl 145, KH2PO4 0.4, K2HPO4 1.6, d-glucose 6, 
MgCl2 1, Ca-gluconate 1.3, pH 7.4 
Ice cold colon 
solution 
(in mM) NaCl 127; KCl 5; Na-pyruvate 5; D-glucose 5; 
HEPES 10; MgCl2 1; CaCl2 1.25, pH 7.4. 
Ca++ free solution 
(in mM) NaCl 127; KCl 5; Na-pyruvate 5; D-glucose 5; 
HEPES 10; MgCl2 1; EDTA 5, pH 7.4 
Pipette solution 
(in mM): K-gluconate 95; KCl 30; NaH2PO4 1.2; Na2HPO4 
4.8; CaCl2 0.73; MgCl2 2.38; EGTA 1; D-glucose 5; ATP 3. 
Bath solution 
(in mM): NaCl 145; K2HPO4 1.6; KH2PO4 0.4; CaCl2 1.3; 










4.1 Microbiological Methods 
4.1.1 Electroporation of Plasmid DNA into Competent Bacteria  
A 50 μl aliquot of freshly thawed electrocompetent cells was mixed with an appropriate 
amount of DNA (1 µl of ligation reaction or 1 µl of 1/1000 dilution of a plasmid 
preparation) and poured into a chilled electroporation cuvette. Electroporation was 
conducted using a Gene Pulser (BioRad) at 2.5 kV. Then, 0.9 ml LB medium were 
added immediately to the cuvette, the mixture was transferred in a new tube and 
allowed to recover for 1 hour, at 37°C in a shaking hot plate. After recovery, the cells 
were carefully centrifuged and the pellet resuspended in 100 µl of LB-medium and 
plated on selection agar plates. 
 
4.2 Molecular Biological Methods 
4.2.1 DNA Plasmid “Mini” Preparation 
This method from Holmes et al. (1981) is used for the quick analysis of clones after 
transformation to determine the success of transfer of the plasmid DNA into the 
bacterial cells, e.g. after ligation. Single colonies were chosen and incubated over night 
at 37°C in 2 ml selection tubes. The DNA of this culture was purified using the EZNA 
plasmid Miniprep Kit I (Peqlab Biotechnology) according to the manufacturer 
handbook. 
 
4.2.2 Preparation of Plasmid DNA from 50 ml Cultures (Midiprep)  
Preparations from 100 to 200 µg plasmid DNA from 50 ml cultures were done using the 
Jet Star plasmid purification system (Genomed). The process was carried out as 





4.2.3 Isolation of Genomic DNA from ES Cells  
Confluently grown ES cells were washed twice with PBS. Then 100 μl of lysis buffer 
was added and were incubated overnight at 55 °C in a moist chamber. Subsequently, 10 
μl LiCl (8 M) and 100 μl isopropanol were added and incubated over night in a shaking 
moist chamber. Afterwards, the plates were centrifuged 30 minutes at 3800 rpm. The 
DNA pellet was washed twice with 70% ethanol, dried at 37 °C and resuspended in 100 
μl low TE. 
 
4.2.4 Genomic DNA Isolation from Mouse Tail Samples 
Quick isolation of genomic DNA from mouse-tails was performed using either the 
Invisorb kits (Invitek) according to the manufacturer’s guidelines or by phenol 
chloroform precipitation (DNA for Southern blots).  
For the phenol-chloroform precipitation the tissue was lysed with 0,5 ml tail biopsy 
lysis buffer in a shaking hot plate set at 55 °C overnight. Subsequently, 500 μl of 
25:24:1 phenol-chloroform-isoamyl alcohol were added and the mixture was incubated 
45 minutes at RT in a shaking overhead. After 30 minutes centrifugation at 14000 rpm, 
the upper phase was transferred into a new tube and the DNA was precipitated by 500 
μl lithium chloride / isopropanol addition. Light shaking of the tubes evidenced the 
genomic DNA as a white filamentous precipitate. The DNA was then pelleted by 30 
minutes centrifugation at 14000 rpm. The supernatant was removed and the pellet 
washed with 400 μl 70% ethanol. After 30 minutes centrifugation at 14000 rpm, the 
supernatant was again removed and the pellet air-dried. The dry pellet was resuspended 
in 100 μl low TE buffer and stored at 4 ° C.  
 
4.2.5 Digestion of DNA by Restriction Endonucleases  
Restriction enzymes were purchased together with the appropriate 10 x concentrated 
buffer for optimal reaction conditions. Restriction digests of plasmid DNA were 
performed by incubating restriction reaction mixtures for 1.5 to 2 hours at the enzyme 






Preparative Restriction Mix 
Plasmid DNA                                1-2 µg 
Restriction Buffer 10x                    10 µl 
Restriction Enzyme                       1.5 µl 
(BSA 10x)                                       10 µl 
To 100 µl final volume with water 
 
4.2.6 DNA Agarose Gel Electrophoresis 
Agarose gel electrophoresis was used to separate, identify and purify negatively charged 
DNA fragments based on their size. DNA bands were made visible with ethidium 
bromide, and could be photographed in UV-Light (254 or 314 nm). Usually 0.7 to 2% 
gels were used. Agarose was dissolved by heating in 100 ml of the required 1x TAE 
buffer, and 0.5 mg/ml Ethidium Bromide was added. Samples were mixed with 10x 
DNA loading buffer to a final 1x concentration, and loaded into the wells. DNA 
fragments are separated at constant voltage (80-120 V) in TAE running buffer. 
 
4.2.7 Isolation of DNA Fragments from Agarose Gels 
Single electrophoretic DNA bands can be excised from the gel and the containing DNA 
can be eluted and used for further applications. For this purpose, the High Pure PCR 
Product Purification Kit (Roche) was used. The protocol, outlined in the handbook for 
purifying PCR fragments, was provided by the producers. 
 
4.2.8 DNA Sequencing 
The DNA sequence analysis was performed by chain termination method by Sanger 
(Sanger and Brownlee 1970). The 20 μl PCR mixture for sequencing contained 0.5-1 µg 
DNA, 4 μl ABI premix (ABI Prism Dye Terminator Cycle Sequencing Ready Reaction 
Kit, Applied Biosystems), 4 μl Sequecing buffer and 1 μl primer. The PCR program 
used consisted of a first step of 3 minutes at 96 °C, followed by 28 cycles comprised of 
15 seconds at 96 °C, 20 seconds at 60 °C and 4 minutes at 60 °C, and terminated by a 
last step of 7 minutes 60 °C. To precipitate the DNA produced, 90 μl of sodium acetate 




into a new tube, to improve the visibility of the pellets dextran blue was added After 
repeated inversion, the DNA was pelleted by 15 minutes centrifugation at 14000 rpm. 
The pellet was washed with 70% ethanol, dried and resuspended in 20 μl Template 
Suppressor Reagent (Applied Biosystems). The resuspended DNA was sequenced in an 
ABI Prism 310 Genetic Analyzer (Perkin Elmer). The analysis of the sequences was 
carried out with the bioinformatics program DNASTAR.  
 
4.2.9 Measuring DNA Concentrations  
Nucleic acids concentration was determined by Gene Quant II photometer (Pharmacia). 
Briefly, 1 OD measured at 260 nm corresponds to 50 µg/ml double-stranded DNA, 40 
µg/ml single-stranded DNA or RNA and 33 µg/ml oligonucleotides. As an indicator of 
sample purity the ratio of the OD at 260 nm and the OD at 280 nm was given, being 1.8 
for pure nucleic acid solutions. 
 
4.2.10 Polymerase Chain Reaction (PCR) 
In vitro enzymatic DNA amplification is achieved via PCR (Mullis et al., 1992). The 
PCR reaction mix included double-strand template DNA, single-strand primers, 




50 ng of cDNA template 
1 µl 5’ Primer (10 pmol) 
1 µl 3’ Primer (10 pmol) 
1 µl dNTP-Mix (2.5 mM each) 
5 µl 10x Polymerase Buffer 
2 µl MgCl2 25 (mM) 
1 U Taq Polymerase (Invitrogen) 





Basic PCR cycling parameters were as follows: 
Step 1: 95°C for 5 minutes 
Step 2: 95°C for 30 seconds 
Step 3: Annealing temperature for 30 seconds 
Step 4: 72 °C for extension time (30-40 cycles from step 2) 
Step 5: 72°C for 10 minutes 
 
4.2.10.1  Genotyping PCR 
KCNE3 genotyping was performed on mouse genomic DNA by separate amplification 
of wild-type and knock-out alleles. The wild-type and knock-out alleles were amplified 
with primers listed in materials. Amplification conditions used were identical for both 
amplifications, detailed above. 
 
4.2.11 RNA Preparation  
The RNA was extracted from WT and KO animals, in order to compare gene expression 
in both genotypes. The mice were killed by cervical dislocation, and the desired tissues 
were removed and weighed. All tissues but stomach and intestine were immediately 
frozen in liquid nitrogen. Colon, small intestine and stomach were cut open lengthwise 
to clean all contents before freezing. The frozen tissues were crushed in a nitrogen-filled 
mortar with a pestle. Then, 1 ml of Trizol per 70 mg of starting tissue was added to the 
powder and the mixture was homogenized using a glass douncer. 200 μl of chloroform 
per 1 ml Trizol were added and shaken vigorously for 15 seconds. After 5 minutes 
incubation at RT the mixture was centrifuged at 10,000 rpm (4 °C) for 15 minutes. The 
upper phase was transferred into a fresh reaction vessel, mixed with 500 μl of 
isopropanol per 1 ml Trizol, vortexed and incubated for 10 min at RT. A further 10 min 
centrifugation at 10,000 rpm (4 ° C) served to pellet the RNA. The pellet was washed 
first with 1.5 ml ice-cold 70% ethanol and then centrifuged 5 minutes at 7500 rpm. 
Afterwards, 1.5 ml of ice-cold 80% ethanol and further 5 minutes centrifugation at 
14,000 rpm (4 ° C). Finally, the supernatant was removed and the pellet dried. The dry 




4.2.12 Purification of RNA  
Freshly isolated and DNase digested RNA samples were filled with DEPC water to 100 
μl and purified according to the manufacturer's instructions using RNeasy columns 
(Qiagen). The RNA was eluted with 35 μl DEPC water from the columns and then the 
concentration determined photometrically.  
 
4.2.13 cDNA Synthesis  
After measuring the purified RNA concentration and verify their integrity by agarose 
gel electrophoresis, 1 to 5 µg of RNA were used for cDNA synthesis. First, the RNA 
was filled up with DEPC water to 9 μl, 1 μl oligo dT primer (500 µg/ml) (Roche) was 
added and the mixture was incubated for 10 min at 65 °C. The samples were briefly 
chilled in ice, and the following ingredients were added: 4 μl of 5x first-strand-reaction 
buffer (Superscript II kit, Invitrogen), 2 μl DTT (0.1 M), 2 μl dNTP mix (10 mM) and 1 
μl RNase inhibitor (RNaseOUT 40 U/µL, Invitrogen). The mixture was gently mixed 
and incubated for 2 min at 42 °C before 1 μl Superscript II RT (200 U/µL) (Invitrogen) 
was added. The negative control "- RT " samples instead received 1 μl DEPC water. 
The synthesis reaction was terminated after a 60 minutes at 42 ° C by a heating step of 
15 minutes at 70 °C. 
 
4.2.14 Southern Blot  
Digested genomic DNA (~ 10 µg) was separated on an agarose gel at 4 V/cm. 10 min 
incubation with HCl (0.25 M) was necessary to depurinate and cleave the DNA in the 
agarose gel, as an indicator the bromophenol blue turned yellow/green. Subsequently, 
the gel was washed briefly with ddH2O and incubated for 30 minutes with NaOH (0.4 
M) at RT, in order to denature the DNA present in the gel. The transfer to a positively 
charged nylon membrane (Hybond N +, Amersham Biosciences) was performed by 
capillarity in a NaOH (0.4 M) bath for at least 12 hours. The membrane was moistened 
before use with ddH2O and equilibrated 15 minutes in transfer buffer (0.4 M NaOH). 
For the transfer, the gel was placed on three layers of Whatman 3 MM paper 
equilibrated with transfer buffer, both extremes soaked also in transfer buffer. On top of 
the gel, the nylon membrane, several layers of Whatman 3 MM paper equilibrated in 




the membrane was washed with 2 x SSC and dried. The nylon membranes were backed 
for 2 hours at 80°C in order to permanently link the DNA to the membrane. 
 
4.2.15 Northern Blot  
Total RNA was prepared from various mouse organs using Trizol reagent (Gibco-
Invitrogene, Karlsruhe, Germany) according to the manufacturer’s instructions, as 
described above. MOPS, formamide and formaldehyde were added to 30 µg of total 
RNA. The samples were load into denaturing formaldehyde agarose gel with MOPS 
running buffer. The transfer to a positively charged nylon membrane (Hybond N +, 
Amersham Biosciences) was performed by capillarity using 20×SSC buffer. After 
transfer, the RNA was covalently link to the membrane by UV irradiation. All the 
solutions were done with DEPC-H2O. 
 
4.2.16 Radioactive Labeling of DNA Samples  
cDNA probes were labeled with 32P by random priming with the RediprimeII kit 
(Amersham Biosciences). 25 ng of DNA denatured for 5 minutes at 100 °C and rapidly 
cooled in water ice, to prevent rehybridization of the individual strands. The denatured 
DNA was added to the reaction mix provided by RediprimeII kit and well mixed before 
adding 50 mCi 32P-dCTP. The final mixture was incubated 30 minutes at 37 °C. The 
purification of the radiolabelled DNA was carried out with Quick Spin Columns 
(Roche) according to the manufacturer's specifications. 
 
4.2.17 Hybridization of Genomic DNA  
After capillary transfer, Northern blot membranes were incubated with Ultrahyb buffer 
(Ambion) in a glass tube in a rotating oven set at 42°C for 30 minutes. While Southern 
blot membranes were incubated at 65°C with 20 ml Speed Hybrid II and 200 µg/ml 
denatured herring sperm DNA for 1 hour. Afterwards the buffer was discarded and new 
hybridization buffer added. Subsequently, the radioactive cDNA probe was added to the 
hybrization solution and left overnight in the rotating oven set at 42°C (Northern 
blotting) or 65°C (Southern blotting). After hybridization, the membrane was wash in 




repetitively washed till the radioactivity was only slightly above normal background 
activity. The membrane was then wrapped in a moist plastic film (Saran paper) and 
exposed for 1 to 12 hours on imaging plates (Fuji Imaging Plate). Afterwards, signals 
were detected using a PhosphoImager Bas-1500 (Fuji, USA). 
 
4.3 Protein Biochemical Methods 
4.3.1 Membrane Preparation 
Mice were perfused transcardially with PBS to remove blood. Organs were dissected, 
snap-frozen in liquid N2, minced in a mortar, transferred into ice-cold homogenization 
buffer (140 mM NaCl, 20 mM Tris pH 7.4, 5 mM EDTA and protease inhibitor 
(Complete®; Roche)) and homogenized in a glass douncer. Membranes were pelleted 
from post-nuclear supernatants (~100.000 x g for 30 minutes at 4°C) and resuspended in 
lysis buffer (50 mM Tris pH 6.8, 5mM EDTA, 2% SDS and Complete® protease 
inhibitor (Roche)).  
 
4.3.2 Lysates of Transfected Cells 
COS7 transfected with an expression plasmid (pcDNA3 from invitrogen) containing the 
human KCNE3 cDNA downstream of an HA-tag fused in frame. Were harvested after 
~40 hours of expression, cells were detached mechanically in Ca++-free phosphate 
buffered saline (PBS) and cell membranes were prepared as described above for tissue 
membrane preparation.  
 
4.3.3 Deglycosylation of Membrane Bound Proteins 
For deglycosylation, membrane preparations (described above) were denatured for 10 
minutes at 95°C, diluted in Na+-phosphate buffer (50 mM, pH 7.4), 1% NP40 and 
PNGase F 0.5 U/25 µg of total protein (Roche). After incubation for 2 hours at 37°C, 





4.3.4 Determination of Protein Concentrations 
The determination of protein concentrations was carried out using the BCA protocol, 
and following the instructions provided by Protein Assay from Uptima-Interchim. This 
assay is based on Cu+2 reduction and the selective colorimetric detection of the cuprous 
cation (Cu1+) by Bicinchoninic acid. 
 
4.3.5 Sodium-Dodecyl-Sulfate-Polyacrylamide Gel Electrophresis 
(SDS-PAGE)  
In SDS polyacrylamide gel electrophoresis, proteins are separated based on their 
molecular size as they migrate in an electrical field through pores in the gel matrix 
towards the anode. Pore sizes decrease with increasing acrylamide concentrations.  
 
4.3.6 SDS-PAGE gel Composition 
 
 Separation Gel (for 2 gels) Stacking Gel (for 2 gels) 
Acrylamide  X ml (for desired gel %) 0.4 ml 
Buffer 2.5 ml 0.75 ml 
H2O 10 ml 1.85 ml 
10% APS 60 µl 60 µl 
TEMED 6 µl 6 µl 
 
4.3.7 Preparation of SDS-PAGE Gels 
After pouring the separation gel, the surface was covered with isopropanol to obtain a 
smooth surface of the gel. After polymerization of the gel, the isopropanol was removed 
and the remaining volume above the gel was filled with stacking gel solution and the 
comb was inserted. After the gel was polymerized, the protein samples were mixed with 
SDS sample buffer and warmed at 55°C for 12 minutes before loading on the 15% gel. 
As molecular weight marker, the stained Protein Standard Benchmark (Invitrogen) was 
used. The gel chamber was filled with SDS running buffer and the electrophoresis was 




4.3.8 Western Blotting 
Western Blotting (or immunoblotting) is used to identify specific antigens on proteins 
separated by SDS-PAGE and transferred to nitrocellulose membranes. The 
identification relies on the specificity of antibody-antigen reactions. Proteins were first 
separated by SDS-PAGE, and the antigens were electrophoretically transferred at 250 
mA for 2 hours, or overnight at 40 mA, to a nitrocellulose membrane. The process was 
subsequently monitored by reversible Ponceau staining. The transferred proteins bound 
to the surface of the membrane, providing access to reactions with immunodetection 
reagents.  
 
4.3.9 Immunostaining of Blots and Visualisation  
For immunoblotting, a primary antibody was used which recognizes a specific epitope 
on the protein of interest. Unspecific binding was inhibited additionally by the use of 
blocking solution containing either protein or detergent blocking agents. To detect the 
antigen-antibody reaction, a horseradish peroxidase (HRP)-labeled secondary antibody 
was used, which binds to the first unlabelled antibody (indirect staining method). The 
active components of the ECL system are luminol and H2O2. The peroxidase reduces 
the hydrogen peroxide, and the resulting oxygen oxidizes the luminol, which releases 
light. Western Lightning Chemiluminescence Reagent (Perkin Elmer) was used for the 
detection. The chemiluminescence is then enhanced through appropriate enhancers and 
visualized using a Peqlab dark chamber connected to LVDS camera and the Chemi-
Capt 5000 software from Viber Lourmat.  
 
Number of washes Buffer Time (min) 
1 Blocking Buffer 30 (or overnight at 4°C) 
1 Blocking Buffer and 1° Ab 60 (or overnight at 4°C) 
4 Blocking Buffer 5 
1 Blocking Buffer and 2° Ab 60 
3 Blocking Buffer 5 
3 Washing Buffer 5 




The above incubations were done at room temperature under moderate shaking. 
Occasionally, blocking or incubation with primary antibody were performed overnight 
at 4°C. After the last washing step of the above protocol, the membrane was placed on a 
glass plate and ECL signal development was performed according to the manufacturer's 
instructions. A clean transparency was placed on top of the membrane and the 
membrane was visualizedo using a Peqlab dark chamber connected to LVDS camera 
and the Chemi-Capt 5000 software from Viber Lourmat  
 
4.4 Cell Biological Methods  
The ES cell culture was carried out in the Transgenic Mouse Facility of the ZMNH with 
the help of Dr Irm Hermans-Borgmeyer.  
 
4.4.1 Culture of Murine Embryonic Fibroblasts  
Murine embryonic fibroblasts (MEF) cells are required to support embryonic stem cells 
growth, since they work as feeder cells. MEF cells were cultured at 37 °C in 7.5% CO2 
humidified air (Heraeus incubators). Media and solutions were warmed at 37 °C before 
use.  
 
4.4.2 Trypsinization of Embryonic Fibroblasts  
The medium from a 150 mm plate with MEF cells was removed; the fibroblasts were 
washed twice with PBS and then incubated with 3 ml trypsin/EDTA for 3-5 minutes at 
37 °C Addtion of MEF medium stopped the reaction and the fibroblasts were isolated 
with a Pasteur pipette. Afterwards, the trypsinized cells were seeded in the desired 
density and the medium changed after 6-8 hours.  
 
4.4.3 Inactivation of Embryonic Fibroblasts  
The MEF cells were inactivated with mitomycin (MMC, Sigma) before using them as a 
substrate for embryonic stem cells. MMC cross-linked the DNA strand, therefore 
blocked further cell cycle and stopped the MEF cells from further dividing. Confluent 




and MMC (10 µg/ml final concentration) addition. Subsequently, the medium was 
aspirated, the cells washed twice with PBS and trypsinized (see above). The inactivated 
fibroblasts were seeded on gelatinized cell culture dishes at the desired density (5 x 104 
cell/cm2). The plates were used for embryonic stem cells (ES cells) culture after 12-24 
hours. 
 
4.4.4 Culture of Murine Embryonic Stem Cells  
Murine embryonic stem cells were cultured on gelatinized (0.1% gelatin) MEF-coated 
cell culture dishes at 37 °C in 7.5% CO2 humidified air (Heraeus incubators). The ES 
cell medium was changed every 24 hours. In order to identify recombinant clones, 
copies of these cell colonies were grown for DNA extraction on gelatinized plates 
without MEF cells. All media and solutions were pre warmed at 37 ° C before use. 
 
4.4.5 Trypsinization of Embryonic Stem Cells  
ES medium was removed; the cells were washed twice with PBS and then incubated 
with 3 ml trypsin/EDTA for 3-5 minutes at 37°C. Addition of ES medium stopped the 
reaction and the ES cells were isolated with a Pasteur pipette. Trypsinized ES cells were 
seeded in the desired density on gelatinized (0.1% gelatin) MEF-coated cell culture 
dishes.  
 
4.4.6 Freezing Embryonic Stem Cells  
a) Freezing cells in cryovials 
Embryonic stem cells grown in 24 - and 6-well plates were washed, trypsinized, isolated 
and frozen in cold cryovials (NUNC) at -80 °C. After several days, the tubes were 
transferred into a liquid nitrogen tank.  
b) Freezing the cells in 96-well  
For temporary storage of frozen isolated ES cell clones 96-well plates were frozen. 
Consequently, the ES cells grown in the 96-well plates were first washed with 
PBS/EDTA, then trypsinized with 40 μl 0.25% trypsin and resuspended in 60μl ES 




carefully, finally a drop of mineral oil was put on top of the mixture. The storage was 
for a maximum of 4 weeks at -80 °C.  
 
4.5 Generation of Transgenic Mice  
4.5.1 Electroporation of Embryonic Stem Cells  
800 μl electroporationbuffer containing 1 x 107 embryonic stem cells (R1) were placed 
in a 0.4 cm gap electroporation cuvette (suitable for Biorad Electroporator). 25-50 μg of 
the linearized target vector DNA were added to the electroporation mixture. Two 
consecutive short pulses of 800 V and 3µF, and 240 V and 500µF were applied. After 
electroporation, the cells were plated into several 10 cm cell culture dishes in varying 
densities and incubated at 37 ° C. The cell culture dishes were previously coated with 
gelatin and contained inactivated embryonic fibroblasts, which serve to support ES cells 
growth.  
 
4.5.2 Selection and Isolation of ES Cell Clones  
In order to positively select the recombinant cells, the ES-cell medium was enriched 
with Genicitin (150-300 g / ml, G418, mixed Gibco) 2 days after transfection and until 
the isolation of individual colonies. Every 24 hours the ES cell medium was changed 
After 6-8 days of in vitro culture, colonies that were round but not flat and sharply 
defined with a smooth surface were lifted with yellow pipette tips and transferred from 
the cell culture dish to a 96-well with round bottoms containing 40 μl of trypsin. Once 
2-3 rows of the 96-well plate were filled with colonies, the plate was incubated 3 min at 
37 °C, after carefully pipetting up and down 100 μl ES medium were added. These ES 
cell clones were afterwards transferred in gelatinized 96-Well with flats bottoms 
containing inactivated MEF cells, again the medium was changed every 24 h. After 2-3 
days, the ES cells were trypsinized again in order to get multiple copies of individual 
clones. Therefore, the ES medium was removed, the colonies washed with 200 μl 
PBS/EDTA and incubated with 40 μl trypsin in PBS at 37 °C for 3 min. Cells were 
resuspended with 80 μl medium and splitted (1:4 ratio) in 4 different 96-well plates, 2 




(without MEF cell monolayer) were digested to isolate genomic DNA. Southern blot 
was performed to genotype the DNA of the cell clones. 
 
4.5.3 Blastocyst Injection  
For blastocyst injection positive ES cell clones were carefully thawed at 37 °C and 
mixed with 200 μl ES medium. In order to expand clones, they were transferred from 
the initial 96-well MEF plates to 24-well MEF plates and then to 6-well MEF plates. It 
is important that the culture never reach confluence, otherwise the ES cells would start 
to differentiate. The ES medium was changed 2 h before the injection. For the injection, 
the cells were washed with PBS, trypsinized, resuspended into 3-5 ml of ES medium 
and centrifuged for 4 min at 1000 rpm, after that the pellet was taken up in 500 μl ES 
medium. The injection into blastocysts, was carried out by the facility. The blastocysts 
(C57BL/6J line) were taken 2.5 days after fertilization. 10-16 ES cells were injected in 
each blastocyst using a micromanipulator (Eppendorf). Afterwards the injected 
blastocysts were implanted in the uterus of pregnant foster mothers.  
 
4.6 Histological Methods 
4.6.1 Mice Perfusion 
For histological and immunohistochemical studies, mice were transcardially perfused 
first with PBS to washout red cells and then with the fixative PFA to better preserve 
tissue structures. The mice were anesthetized by injecting a ketamine-Rompun mixture 
(100 μl /10 g body weight) before its chest was cut opened. The heart was exposed and 
a cannula introduced into the left ventricle and a small incisure was performed in the 
vena cava. First, 0.01% heparin in PBS (pH 7.4) were pumped into the heart at a 
constant pressure of 180 mmHg for 1-3 min pumped in order to prevent clotting of 
blood and flush the blood out of the body (through the cut vena cava). Then 4% PFA in 
PBS (pH 7.4) was pumped in the heart and fixate the body tissues. After perfusion, the 





4.6.2 Paraffin Sections  
The organs were removed after perfusion and passed through an ascending Isopropanol 
row (2 h 60%, 3 h 75%, 3 h 90%, 4 h 100%), then incubated for 12 h at 63 ° C in an 
isopropanol/paraffin mixture (1:1) and then left in pure paraffin for at least 6 hours. 
Tissues were embedded with liquid paraffin in small metallic containers and placed at 
4°C O/N. Afterwards the paraffin block was hard enough to be removed from its 
container. The block was then sectioned in 6-micron thick slices using a microtome. 
The paraffin sections floating in a 50 °C warm water bath were mounted on microscope 
slides and dried. They were stored at room temperature until further processing.  
 
4.6.3 Hematoxylin-Eosin (HE) Staining  
Using this staining, nuclei appear blue-violet by hematoxylin and cytoplasms are stained 
pink by eosin. Paraffin sections were first deparaffinized in 10 min Histoclear (or 
xylene) following short incubations in descending ethanol series. The sections were then 
incubated for 10 min in hematoxylin solution and then washed with running tap water. 
In order to remove the excess of staining the section were briefly rinsed with 70% 
EtOH/1% HCl. Staining with 0.3% eosin solution (with a few drops of acetic acid) was 
then perfomed. Short incubations in ascending ethanol row (50%, 70%, 100%) removed 
the excess of staining and prepared the section for the final dehydration step 6 min in 
xylene (Histoclear) and the mounting in DPX (Histokitt).  
 
4.6.4 PAS (Periodic Acid Schiff) Staining 
The staining was used to detect excess of glycogen and mucin in mucous secreting 
tissues such as small intestine and airways. The glycogen and mucin will be stained 
pink-purple. Paraffin-embedded tissue sections were first deparaffinized in 10 min 
Histoclear (or xylene) following short incubations in descending ethanol series and then 
hydrated to water. The sections were oxidize in 0.5% periodic acid solution for 5 
minutes, rinsed in distilled water, and incubated for 15 minutes in Schiff reagent 
(sections become light pink color during this step). Wash in lukewarm tap water for 5 
minutes (immediately sections turn dark pink color). Afterwards, short incubations in 
ascending ethanol row (50%, 70%, 100%) prepared the section for the final dehydration 




4.6.5 Toluidine Blue Staining 
Mast cells play a key role in inflammatory process, defense against pathogens and, 
wound healing. Therefore they were used as a marker of tissue integrity.. They are 
found in the connective tissue and their cytoplasm contains granules (metachromatic) 
composed of heparin and histamine. Toluidine blue stained mast cells red-purple and 
the background blue (orthochromatic staining). 
Paraffin-embedded tissue sections were first deparaffinized in 10 min Histoclear (or 
xylene) following short incubations in descending ethanol series and then hydrated to 
water. The sections were then stained with toluidine blue working solution for 2-3 
minutes, washed 3 times with distilled water and quickly dehydrated through 95% and 2 
changes of 100% ethanol (these changes in alcohol were fast enough to avoid stain to 
diffuse away). Sections were then incubated twice in xylene for 3 minutes each, and 
then mounted in DPX (Histokitt).  
 
4.6.6 Immunofluorescence 
Paraffin embedded sections of stomach; small intestine and colon were boiled for 10 
minutes in a microwave in 10 mM citrate buffer (tracheal sections only 3 minutes). The 
sections were cooled down slowly and washed twice with PBS and then incubated in 
PBS, 1% SDS for 15 minutes. Tracheal sections were incubated at room temperature 
with trypsin solution for 10 minutes. After 1 hour in blocking solution, sections were 
incubated with primary antibodies (diluted in blocking solution) overnight at 4°C. The 
rabbit antibody against KCNE3 was used at 1:1000 dilution, and the KCNQ1 antibody 
at 1:500 dilution. Sections were then incubated with goat-anti-rabbit IgG coupled to 
Alexa Fluor 488 (absorbance maximum approx. 495 nm, emission maximum 519 
nm;Molecular Probes, Mo Bi Tec, Göttingen, Germany) and the nuclear stain Topro-3 
1:5000 (absorbance maximum approx. 642 nm, emission maximum 661; Invitrogen). 
Analysis was by confocal microscopy (Zeiss LSM 510 META, Germany) using 





4.7 Animal Experiments 
4.7.1 KCNE3 Antibody Generation 
Dr. M. Beyermann (FMP) synthesized a peptide representing the entire cytoplasmic C-
terminus of mouse KCNE3 (RSRKVDKRSDPYHVYIKNRVSMI) that was coupled via 
maleimidobenzoic acid-N-hydroxysuccinimide ester to keyhole limpet hemocyanine 
using a cysteine residue added to its N-terminus. Antisera were obtained from rabbits 
injected 6 times within 90 days (Pineda Antikörper-Service, Berlin) with the carrier-
coupled peptide and were purified by affinity against the peptide. One of the purified 
antisera showed specificity in Western blots of transfected COS-7 cells and WT/KO 
colon membrane preparations and recognized KCNE3 (at 1:1000 dilution) in 
immunofluorescence in intestinal and tracheal tissue sections. Staining was specific as 
revealed by the absence of signals in KO tissues. 
 
4.7.2 Serum, Feces and Urine Analysis  
Blood was drawn from the heart of WT and KO mice under isoflurane anesthesia and 
and stored until the clot at 4 ° C. The cellular components were pelleted by 
Centrifugation at 14,000 rpm (4 ° C) for 10 min and the serum stored until analysis at -
80 ° C. Mice were kept in metabolic cages (Phymep, Paris, France) for 6 days. Weight, 
food and water intake were controlled daily. Urine and feces were collected daily. Feces 
were dried at 95°C for 3 hours, weighed, and dissolved in 0.75 M HNO3 at room 
temperature overnight. After homogenization in a glass douncer and centrifugation to 
remove insoluble material, the electrolyte composition of the supernatant was analyzed 
by flame photometry (IL 943 Flame Photometer, Instrumentation Laboratory). 
Concentrations of creatinine, glucose, proteins or and urine electrolytes were 
determined by Dr. D. Becker (Institut für Labormedizin, Helios Klinikum Berlin-Buch). 
 
4.7.3 Measurement of Intestinal Fluid Secretion in vivo 
Wild type or KCNE3 knockout mice (body weight 20-22 g) were deprived of food 24 h 
prior to prior to the experiment. Briefly, animals were placed in an anesthetic chamber 
and exposed to isoflurane using the Univentor 400 anesthesia unit (airflow rate 400 - 
500 mL/min, 4% isoflurane). Afterwards, anesthetized mice were placed in the modifies 




anaesthetized by exposure to 2% isoflurane using a mask and a constant flow rate (150 - 
250 ml/min). A small abdominal incision was made to expose the small intestine. Ileal 
tissue proximal to the caecum was exteriorized and isolated, and 2-3 loops (~20 mm 
each) were tide up. The closed loops were then injected with 100 μl of PBS alone or 100 
μl PBS containing 0.5 μg CTX (Gentaur). The wound was sutured and mice were 
allowed to recover. After 6 h, mice were sacrificed, intestinal loops removed, weighed 
with and without fluid contents, and their length measured. 
 
4.7.4 Rotarod Performance 
Ability to maintain balance and movement agility on a rotating rod apparatus (TSE 
accelerating rotarod) was assessed for each genotype and condition in adult mice. 8 WT 
and 8 KO animals were first kept for 15 days under hypokalemic diet, in the control 
group 8 WT and 8 KO animals were kept under standard diet. Animals from both 
groups were randomly observed several times a day, no signs of periodic paralysis were 
observed during these 15 days in WT neither in KO mice. On day 16th, animals were 
accustomed to the rotating rod apparatus (TSE Systems, Inc. Chesterfield, MO, USA 
accelerating rotarod) by placing them on the rod at the lowest speed (4 rpm) for 3 
minutes. After some rest (5 minutes) the animals were test in an accelerating mode 
rotarod (4 to 40 rpm); the average time to fall (latency) was measured from three trials 
and analyzed. 
 
4.7.5 Measurement of Mucociliary Clearance  
Dr. Rainer Schreiber carried out these experiments in the lab of Prof. Kunzelmann. 
Dept. of Physiology at the University of Regensburg 
Tracheas were mounted with insect needles onto an extra thick blot paper (Bio-Rad, 
Germany) and transferred into a humid chamber at 37°C. The filter paper was perfused 
with buffer solution at a rate of 1 ml/min and at 37°C. Polystyrene black dyed 
microspheres (diameter 6.51 ± 0.58 µm, Polybead®, Polyscience Inc., Warrington, PA, 
USA) were washed with buffer solution (± ATP 10 µM), twice. Particle solution (10 µl 
with around 0.5% Latex) was added onto the surface of the trachea, without and 
subsequently with ATP (10 µM). Carbachol (100 µM) was applied from the basolateral 




the Zeiss stereo microskope Discovery.V12 with PlanS objective (1.0x, FWD 81 mm), 
Zeiss digital camera AxioCam ICc1 and the software AxioVision (Release 4.6.3, Zeiss, 
Göttingen, Germany). 5 to 8 moving particles of different regions of the trachea were 
selected and the transport was calculated by measuring the distance per time (µm/min) 
using the AxioVision Software (Release 4.6.3, Zeiss, Göttingen, Germany). 
 
4.8 Electrophysiological Experiments 
4.8.1 Ussing Chamber: Colonic Epithelia 
Experiments done under Dr. Dorothee Guenzel supervision in Prof. Fromm’s lab (Dept 
of clinical Physiology at the Charité Berlin). 
The Ussing chamber was invented by Hans Ussing in the 1950s to measure the net ion 
transport taking place across an epithelium clamped between two reservoirs are filled 
with symmetrical solutions. The equal charges in both sites of the epithelia result in an 
initial equilibrium at the set up potential of 0 mV. Ions that move through paracellular 
pathways, tight junctions or across the cell generate a voltage difference among 
chambers. Addition of specific drugs will promote or inhibit channel activity and 
modify the ionic conductances, thereby changing the voltage. The amount of current 
injected to clamp the voltage to 0 mV is called short circuit current (Isc) and is the 
measure of net ion transport across the epithelium.  
Briefly, in our set up the current was applied by two silver/silver chloride (Ag/AgCh) 
electrodes (one for each tank,) placed in a vessel filled with KCl. Agar bridges (filled 
with KCl) connected the electrode vessel with the Ussing chamber and allow 
homogeneous current distribution. They were placed at the same distance of the 
epithelium in each of the two halves of the Ussing-chamber. Similarly, electrodes 
placed in KCl filled vessels, also connected to the Ussing chamber by KCl filled agar 
bridges, measured the transepithelial voltage. 
This method very valuable to measure ionic permeability (conductance or resistance) 





Mice were anesthetized and killed by inhalation of 100% CO2 . Late distal colon was 
dissected, cut open along the mesenteric insertion and partially stripped, where, the 
lamina muscularis propria was removed. The partial 'stripping' allows assessment of the 
epithelium contribution by removal of all subepithelial elements. The epithelium 
(lamina propria mucosae) was then clamped in the Ussing chamber. The epithelium was 
stretched over a silicon ring of 0.05 cm2, fixed with a tissue adhesive to a plastic 
container and then placed into the chamber. The two reservoirs were filled with 10 ml 
ringer solution warmed up by a closed water circuit (at 37°C) and gassed with carbogen 
(95% O2, 5% CO2, to maintain pH 7.4). This bubble lift facilitated the continuous 
chamber perfusion, and proper mix of the solution. Addition of 50 mg/l Piperacillin 
(Hexal AG, Holzkirchen, Germany) and 10 mg/l Zienam (MSD Sharp & Dohme GmbH 
Haar, Germany) effectively inhibited bacterial growth. TTX (serosal, 1 µM), 
indomethacin (mucosal and serosal, 10 µM) and amiloride (mucosal, 10 µM) were 
applied to inhibit neuronal activity, prevent prostaglandin release, and block apical Na+ 
channels (ENaC), respectively. 
Prior to each experiment, the resistance of the bath solution between the voltage-sensing 
electrodes was determined and taken into account. 
 
4.8.1.2 Measurement of Voltage, Resistance and Short Circuit Current 
The transepithelial resistance was calculated following the Ohm's Law taking the 
transepithelial potential differences (V1 and V2) and the current injected by the pulse 
generator (I1-I2). Rte = (V1-V2)/(I1-I2). For the correct calculation of transepithelial 
resistance, the area of the tissue being studied (A=0,05 cm2) and the resistance of the 
empty removable disk or of the blank filter, were taken into account The short circuit 
current was calculated as the ratio between voltage and resistance, where the 
transepithelial resistance is known and the transepithhelial voltage is directly measured. 





4.8.2 Ussing Chamber: Tracheal Epithelia 
Dr. Ousingsawat carried out these experiments in the lab of Prof. Kunzelmann. Dept. of 
Physiology at the University of Regensburg  
Tracheas were dissected, opened longitudinally on the opposite side of the cartilage free 
zone and were transferred immediately into an ice cold buffer solution 1 containing 
amiloride (10 µM). Stripped colon was put into ice-cold buffer containing amiloride (10 
µM) and indomethacin (10 µM). Tissues were mounted into a micro-perfused Ussing 
chamber with a circular aperture of 0.785 mm2. Luminal and basolateral sides of the 
epithelium were perfused continuously at a rate of 5 ml/min. Bath solutions were heated 
to 37 °C, using a water jacket. Experiments were carried out under open circuit 
conditions. Data were collected continuously using PowerLab (AD-Instruments, 
Australia).  
Values for transepithelial voltages (Vte) were referred to the serosal side of the 
epithelium. Transepithelial resistance (Rte) was determined by applying short (1s) 
current pulses (I = 0.5 µA). Rte and equivalent short circuit currents (ISC) were 
calculated according to Ohm’s law (Rte = Vte/I, ISC = Vte/Rte).  
 
4.8.3 Patch Clamp of Mouse Colonic Crypt Cells 
Experiments done in collaboration with Prof. Warth. Dept. of Physiology at the 
University of Regensburg 
In this technique, the membrane potential is held constant (“clamped”) while the current 
flowing through the membrane is measured. Technically, a patch pipette with a tip 
diameter of approximately is placed in contact with the plasma membrane. When little 
negative pressure is applied from the interior of the pipette, a very high resistance seal 
(Giga-seal – resistance typically 50 GΩ) develops between the membrane patch and the 
glass of the pipette (“on-cell” configuration). Rupture of the membrane patch 
underlying the electrode surface (whole-cell configuration) allows direct 
communication between the interior of the electrode (filled with so called “internal 
solution”) and the intracellular space. Voltage-clamp of the cell, which consists in 
maintaining membrane voltage at a constant fixed value, is then achieved using a 





Mice were killed by cervical dislocation. A 3 cm piece of mouse distal colon was 
everted and rinsed with ice-cold “colon” solution. Both ends were tied to obtain a sac 
preparation. This sac was filled with a “Ca2+-free” solution and then incubated in 
“Ca2+-free” solution for 11 min at 37° C. Isolated crypts were obtained by shaking these 
sacs in “colon” solution. 
For patch clamp experiments, crypts were transferred into a bath chamber mounted on 
the stage of an inverted microscope. The crypt under study was held by a suction 
pipette. All experiments were performed at 37° C. Individual cells were approached on 
the basal cell pole (crypt base and crypt middle cells) by patch pipettes with a mean 
resistance of 6-10 MΩ. The patch pipettes solution and bath solution compositions are 
detailed in electrophysiology materials. The recordings reported here were obtained in 





5.1 Generation of kcne3-/- Mouse 
In order to investigate the function of the KCNE3 subunit, we generated the kcne3-/- 
mouse by homologous recombination in mouse embryonic stem (ES) cells.  
Figure 6.1A depicts the targeting vector that contained a DNA sequence of the initial 
intronic sequence and the first 3 exons of the KCNE3 gene, which are part of the 
5’untranslated region (UTR), and exon 4, which contains the entire coding region for 
KCNE3 (Lundquist et al. 2006). Exon 4 was flanked with LoxP sites in order to allow 
its selective removal by using the Cre/LoxP-recombinase system (see below). 
In addition, three selectable genes have been introduced in the targeting construct in 
order to select for the desired recombination product (Figure 5.1A): the neomycin 
resistance (neo) gene for positive selection, which allows cells to survive in the presence 
of the antibiotic neomycin, the diphtheria toxin (dta) gene and the herpes simplex virus 
type 1 Thymidine Kinase gene (tk). Dta and tk genes are used for “positive-negative” 
selection in case of random integration of the targeting vector in the murine genome. 
Those cells in which random integration has occurred retain the dta or the tk gene and 
thus will be specifically eliminated by expression of the dta protein or by the antiviral 
agent ganciclovir. 
As seen in figure 5.1A, both the dta and the tk genes were placed outside the 
homologous region (5’ of the short arm and 3’ of the long arm of the vector, 
respectively). In this configuration, if homologous recombination occurs between the 
targeting construct and the native KCNE3 gene, both the dta and the tk genes will be 
excluded. 
To exclude possible undesired effects due to the insertion of the neomycin cassette into 
the mouse genome, the neomycin resistance cassette was also flanked by 2 loxP sites to 
allow its removal by the Cre-recombinase. 
ES cell clones that incorporated the recombined allele in the desired fashion were 
expected to be resistant to neomycin. To further test the specificity of the clones which 
survived positive selection, we employed a Southern blotting analysis of genomic DNA. 
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Figure 5.1. Generation of kcne3-/- mice. A, strategy for disruption of the KCNE3 gene. Top, 
wild type allele showing exons 1-3 (UTR), 4 (CDS, Exon 4 contains the entire coding region) 
depicted as boxes and unique 12 kb Bgl1 restriction fragment. Middle upper, targeting vector. The 
neomycin cassette (neo) inserted for positive selection, introduced a new Bgl1 restriction site. 
Diphteria toxin (dta) and Thymidine Kinase (tk) gene located outside the homologous region were 
used for negative selection. The neomycin cassette was flanked by loxP sites (◄). A third loxP 
site was inserted after exon 4. Middle lower, recombined allele after successful homologous 
recombination, Bgl1 enzymatic digestion produces a 6 and 8 Kb restriction fragments, detected in 
Southern blot analysis by the probes indicated as bold bars labeled as 5’ (detected 6 kb Bgl1 
restriction fragment) or 3’ (detected 8 kb Bgl1 restriction fragment). Bottom, KO allele after Cre 
excision. The neocassette and exon 4 (CDS) were removed by cre recombinase leaving instead 1 
loxP sites (◄). The 9,5 Kb BglI restriction fragment was detected with either 5’ or 3’ probe (bold 
bars) by Southern blot (see C). B, Southern blot analysis of embryonic stem cells showing the 
wild type band (12 kb) and the successfully recombined band detected with probe 3’ (8 kb). The 
positive clone was afterwards injected into a blastocoele. C, Southern blot analysis of tail DNA 
from WT (12 kb) and KO (9.5 kb) mice. D, PCR for routine genotyping showing the wild type 
and kcne3-/- bands . 
 
or 3’ probes. As shown in figure 5.1B, the wild type allele was identified by a sharp 
band about 12 kb, whilst the recombinant allele band was about 6 kb for the 5’ probe or 
8 kb for the 3’ probe.  
Positive clones were injected into the blastocoele cavity of C57BL/6 embryos and 




chimerism were bred to C57BL/6 females. Successful germ line transmission and hence 
transfer of the modified ES cell genome to their offspring, was determined by Southern 
blotting. Subsequently, the selected offspring was crossed with Cre-deleter mice 
(Schwenk et al. 1995) (in C57BL/6J background) to excise the neomycin selection 
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Figure 5.2. Modified KCNE3 gene region sequence. The modified KCNE3 
gene fragment was first amplified by PCR from the kcne3-/- mouse genome and 
then subjected to sequencing. The nucleotide sequence with the respective color 
codes are shown, corresponding to the 334 bp covering KCNE3 exon 3 
downstream the 3’ end of the KCNE3 gene. As expected, in the kcne3-/- mouse, 
exon 4 (containing the whole coding region for KCNE3) has been removed, 
leaving instead a single loxP sequence (the 34 bp loxP sequence is highlighted). 
Moreover, also neomycin cassette has been deleted from the recombined allele. 
 
Cre-deleter mice ubiquitously express high levels of cre-recombinase, an enzyme that 
catalyzes site-specific recombination of floxed DNA segments, meaning that fragments 
between loxP sites in the same orientation will be deleted.  
As a result, KCNE3 gene was permanently modified in the knock-out (KO) allele, 
leading to a constitutive deletion of kcne3 expression. As shown by Southern blotting 
analysis performed from homozygous offspring, KO allele was identified by a specific 
9,5 kb after BgII digestion (Figure 5.1C). Afterwards, the presence of the KO allele was 
routinely checked by genotyping PCR (Figure 5.1D).  
Further sequencing of the kcne3-/- genomic DNA confirmed that the Cre-recombinase 
excised both the neocassette and exon 4 (Figure 5.2), leaving instead a unique loxP site 




Kcne3-/- mice resulting from interbreeding heterozygous animals were obtained at the 
predicted Mendelian frequency, were viable, superficially indistinguishable from their 
wild type littermates and showed no obvious phenotypic changes in the cage 
environment.  
 
5.2 Analysis of KCNE3 Expression Pattern in Murine Organs 
The expression profile of the KCNE3 protein has been studied in recent years by several 
groups. However, given the lack of the kcne3-/- tissues, which would serve as the most 
ideal and specific control to reliably study the expression pattern of the gene, these 
studies have been source of many controversies. A number of contradictory datasets has 
accumulated, which report KCNE3 expression in brain, skeletal muscle, kidney and 
heart, besides epithelial secretory tissues like trachea and intestine.  
To address KCNE3 tissue distribution and better understand its physiological role, we 
performed an extensive analysis of KCNE3 expression at the mRNA and protein level 
in several wild type tissues. Northern blotting analysis was employed to study mRNA 
expression pattern, while Western blots and immunohistochemistry were used to 
analyze protein distribution and subcellular localization. Most importantly, our data in 
wild type animals have been routinely validated by employing KCNE3 deficient tissues 
from kcne3-/- littermates as negative controls.  
 
5.2.1 Analysis of KCNE3 mRNA Distribution 
Northern blot analysis was carried out to investigate KCNE3 mRNA expression pattern 
in murine organs. Total RNA (30 g) was extracted from skeletal muscle, lung, heart, 
brain, kidney, caecum, colon, ileum, jejunum, duodenum and stomach. Small aliquots of 
these samples were pre-run in a standard agarose gel containing ethidium bromide, 
ribosomal 28S and 18S RNA were clearly visible assuring the quality and integrity of 
the total RNA extracted.  
As shown in figure 5.3B, a strong KCNE3 band at 1.5 kb was detected all along the 
gastrointestinal tract of wild type mice. KCNE3 transcript signals were found in wild 
type stomach, duodenum, jejunum, ileum, caecum and colon (Figure 5.3A and B). 
Northern blot analysis revealed prominent KCNE3 expression in colon. No KCNE3 




probe and providing additional confirmation for the disruption of the KCNE3 gene in 
kcne3-/- animals (Figure 5.3A). KCNE3 transcripts were not detectable in brain, heart, 
kidney, lung and skeletal muscle (Figure 5.3A).  
 
 
Figure 5.3. KCNE3 mRNA expression. A, Northern blot analysis of total RNA (30 µg per 
lane) from wild type (+) and kcne3-/- (-) tissues. KCNE3 probe (354 bp) contained the coding 
region (part of exon 4) as described in Experimental Procedures. A KCNE3 specific band was 
detected at ~1-1.5 Kb in wild type caecum, colon, ileum and jejunum. This signal was absent 
from kcne3-/- tissues. KCNE3 mRNA was not detected in muscle, lung, heart, brain and in 
kidney total RNA. Beta actin was used as RNA loading control (band runs at 2 kb). Note that 
muscle and heart present different beta actin mobilities. 1.6 kb and 1.4 kb respectively (Zhang et 
al. 2006). B, Northern blot analysis of total RNA (30 µg / lane) from upper gastrointestinal tract 
of wild type animals. KCNE3 mRNA is present in stomach, duodenum, jejunum and ileum. The 
hybridization probe (354 bp) contained the coding region (part of exon 4). Beta actin was used as 
RNA loading control. 
 
In addition to mRNA, total RNA also contains ribosomal and transfer RNA, in a 
proportion that is tissue specific. Therefore, although the same amount of total RNA 
was loaded in all wells, relative mRNA levels might change depending on the specific 
organ of origin. Hence, an internal standard was needed to prove that uniform amounts 
of mRNA were present in each lane.  
Beta actin is a housekeeping gene commonly used as a control, and has been 
extensively evaluated throughout the years (Zhang et al 2006). Beta actin is a highly 
conserved isoform of actin, which carries on cytoskeletal functions in all tissues, and it 
is constitutively expressed with several transcribed but not translated pseudo-genes 
(Vaarala et al. 2001; Bas et al. 2004).  
When probed for beta-actin, the tissues analyzed displayed a 2 kb band corresponding to 
beta actin (Figure 5.3A and B). Heart and skeletal muscle displayed bands lower than 2 
kb, 1.4 kb and 1.6 kb respectively (Zhang et al. 2006; Vaarala et al. 2001). In 
conclusion, mRNA levels were indeed in a similar range within all wild type and kcne3-




Altogether, our analysis on the expression pattern of KCNE3 mRNA revealed that 
KCNE3 is expressed in gastrointestinal tissues. Although KCNE3 had been previously 
reported to be expressed in skeletal muscle, heart, kidney and brain, we did not observe 
any detectable signal in these tissues. Furthermore, compared to the studies which have 
been published previously, our data on the expression pattern of KCNE3 in wild type 
tissues included an additional level of specificity, provided by the use of kcne3-/- tissues 
from control littermates. Our data are therefore extremely useful to clarify the 
contradictory expression patterns reported in the recent years (Abbott et al. 2001; 
McCrossan et al. 2003; Lundquist et al. 2006)  
 
5.2.2 Anti-KCNE3 Antibody Generation 
In order to study KCNE3 expression at the protein level, and given the current lack of a 
reliable and specific anti-KCNE3 antibody, a novel anti-KCNE3 antibody was 
generated. Anti-KCNE3 antisera was raised in rabbits, against a 23 residues peptide 
corresponding to the KCNE3 cytoplasmic carboxy-terminus (Figure 5.4A) (see methods 
for further details).  
To assess the specificity of the immunopurified antibody, HA-tagged KCNE3 cDNA 
was heterologously expressed in COS7 cells. As shown in figure 5.4B, Western blot 
analyis of KCNE3-transfected cells shows that anti-KCNE3 and anti-HA antibodies 
specifically detected several bands between 19 and 25 kDa (Figure 5.4B and D). These 
multiple bands, which appear around the expected molecular weight of the KCNE3 
protein, have been previously suggested to represent differentially glycosylated KCNE3 














































Figure 5.4. Specificity of the newly generated anti-KCNE3 antibody. A, the 103 amino acid 
sequence of the KCNE3 protein is depicted. The anti-KCNE3 antibody was raised against a 23 
amino acid peptide representing the whole C-terminal domain of KCNE3 (depicted as filled green 
box).  The N-terminal presents 3 putative N-glycosylation sites indicated by blue diamonds and the 
transmembrane domain is shown by the filled grey box. B, Western blot analysis from lysates of 
COS-7 cells overexpressing N-terminally HA-tagged version of KCNE3. The anti-HA antibody 
detected a 3 band pattern (between 19 and 25 kDa, filled arrowhead) (lane T), which were absent 
from the non-transfected COS-7 cells (lane NT). C, a faint but similar band pattern was detected in 
a membrane fraction preparation of wild type colonic tissue, and it was absent from kcne3-/- tissues. 
Asterisk indicates a KCNE3-immunoreactive, high-molecular weight band, which might represent 
SDS-resistant KCNE aggregates. D, after deglycosylation by PNGase, the newly generated KCNE3 
antibody recognized a single band (~14 kDa arrowhead) in membrane preparation of wild type 
colon (WT lane). No specific signal was detected in kcne3-/- tissue (KO lane). As a positive control, 
total lysate of COS-7 cells overexpressing HA-KCNE3 was used (T lane), where different 
glycosylation states of HA-KCNE3 were still observed. The presence of several bands in the latter 
lane might be owed to incomplete deglycosylation caused by the N-terminal HA tag. Please note 
that when blot with anti-KCNE3 antibody, independently of the genotype an unspecific band at 30 
kDa was homogenously labeled in all tissues and cell lysates. 
 
As it has been previously reported, KCNE3 undergoes posttranslational modifications 
and contains three putative glycosylation sites on its N-terminal (Gage and Kobertz 
2004). To test whether the posttranslational added sugar chains accounted for the 
migration shifts and the multiple band pattern observed in our Western blot in figure 
5.4B-D, lysates from transfected cells were treated with Peptide N-glycosidase F 
(PNGaseF) prior to loading. Under these conditions, only three specific prominent 
bands at approx. 14, 17, and 19 kDa were detected with anti-KCNE3 antibody (Figure 
5.4D last lane). These bands correspond to the expected molecular weight of non-
glycosylated HA-tagged KCNE3 (14 kDa) and to incomplete glycosylated forms 
(aprox. 17 and 19 kDa). Interestingly, these last incompletely deglycosylated bands 




the untagged KCNE3 protein was probed in native tissue after PNGaseF treatment 
(Figure 5.4D, first lane; Figure 5.5). Chandrasekhar et al in 2006 have also reported a 
very similar incomplete PNGaseF-mediated deglycosylation of HA-tagged KCNE1. I 
therefore assume that the N-terminal position of the HA tag of KCNE3 might have 
provided steric interference with the PNGaseF mediated deglycosylation reaction, 
thereby preventing efficient removal of one of its sugar chains. 
As it was shown in figure 5.3, KCNE3 mRNA was abundant in the gastrointestinal 
tract, particularly in colon. To further characterize the specificity of our anti-KCNE3 
antibody in native tissue, we prepared membrane-bound protein fractions from wild 
type and kcne3-/- colon. Similar to what it was previously observed in Western blot 
analysis of HA-tagged KCNE3 transfected cells (Figure 5.4B and D), lysates from wild 
type colon which were not treated with the deglycosylating enzyme PNGaseF also 
exhibited a similar band pattern between 19-25 kDa (Figure 5.4C). Besides, in these 
samples an additional KCNE3-immunoreactive band was detected around 40 kDa 
(marked with asterisk (*) in Figure 5.4C). This additional band observed in wild type 
colon lysates might represent SDS-resistant KCNE3 aggregates that run at higher 
molecular weights, a common phenomenon that had been previously reported for 
several other membrane-associated proteins (Sagne et al. 1996). However, 
Chandrasekhar et al in 2006 when blotting against KCNE1 protein also described the 
same additional band at 40 kDa, and claimed that it was instead due to posttranslational 
KCNE modifications.  
On the other hand, PNGaseF treatment resulted in a shift of the apparent molecular 
mass of the glycosylated species, which migrated now as a single visible band at 14 kDa 
(Figure 5.4D, first lane).  
Taken together, these data lead us to conclude that first, KCNE3 undergoes N-linked 
glycosylation in heterologous expression and in native tissue. As expected, the presence 
of complex oligosaccharides increased the molecular weight of the KCNE3 protein, 
producing several KCNE3 immunoreactive bands in Western blot analysis. Similar to 
KCNE1 (Chandrasekhar et al. 2006), deglycosylation with PNGaseF was necessary to 
detect a single KCNE3-specific band at the expected molecular weight of 14 kDa in 
wild type tissues, which was absent in kcne3-/- controls (Figure 5.4D). In particular, our 
newly generated anti-KCNE3 antibody was able to recognize both glycosylated and 




native tissues, thereby proving an extremely useful tool for further investigations 
(Figure 5.4C and D). 
 
5.2.3 Analysis of KCNE3 Protein Distribution 
In order to study more extensively the tissue distribution of KCNE3 at the protein level, 
we performed a Western blot analysis from a wide number of wild type tissues, using 
KCNE3 deficient tissues as controls for the specificity of the assay. Membrane-bound 
protein fractions from wild type and kcne3-/- tissues were deglycosylated and probed for 
KCNE3 (Figure 5.5).  
Clear specific bands at the expected KCNE3 molecular weight (14 kDa) were detected 
in wild-type jejunum, ileum, caecum, and colon (Figure 5.5A and C). A KCNE3 
specific band in stomach and trachea was only visible after longer exposures of the blots 
(Figure 5.5D). KCNE3 immunoreactive bands were absent in kcne3-/- tissues, 
confirming the specificity of our newly generated antibody (Figure 5.5A-D). 
Consistent with our data on KCNE3 mRNA expression (Figure 5.3), our Western blot 
analysis also confirmed the presence of the KCNE3 protein in intestine, while no 
KCNE3 specific signals were observed in brain, kidney, heart and skeletal muscle 
(Figure 5.5). Our results are in accordance with previously published data on KCNE3 
expression in gastrointestinal epithelia (Schroeder et al. 2000). Altogether, our data 
show KCNE3 expression to be restricted to the secretory epithelia, namely 
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Figure 5.5. KCNE3 protein distribution in wild type tissues. A-D, Western blot 
analysis of KCNE3 expression in wild type and kcne3-/- tissues. After 
deglycosylation by PNGase, a single KCNE3-immunoreactive band (~14kDa) was 
specifically detected in wild type membrane fractions from jejunum, ileum and 
colon (A) and caecum (C). This band was not detected in wild type brain, heart, 
muscle (B) and kidney (C). KCNE3 band was absent in all kcne3-/- samples (A-D). 
D, Western Blots showing KCNE3 band in wild type trachea and stomach after 
long exposure. Kcne3-/- samples were devoid of KCNE3 signal (~14kDa). Beta 
actin (~ 42 kDa) was used as a loading control. 
 
5.2.4 Subcellular Localization Studies of KCNQ1 and KCNE3 
5.2.4.1 Immunolocalization of KCNE3 and KCNQ1 in Stomach 
Since our Northern blot analysis revealed moderate KCNE3 transcript levels in the 
stomach (Figure 5.3), we analyzed in more detail the KCNE3 localization at the 
subcellular level in this tissue.  
For this aim, we first compared the general morphology and integrity of the gastric 
epithelia in wild type and kcne3-/- littermates by standard histological techniques. No 
significant changes in gastric tissue organization were observed in kcne3-/- mice 
compared to controls (Figure 5.6). This is in contrast to the disruption of kcne2 or kcnq1 
genes, which lead to gastric glandular hyperplasia (Roepke et al. 2006, Lee et al. 2000) 
and impaired acid secretion. This dramatic phenotype relies on the presence of 
KCNQ1/KCNE2 heteromeric channels in parietal cells (Lee et al. 2000; Dedek and 
Waldegger 2001; Heitzmann et al. 2004). We can therefore conclude that KCNE3 








Figure 5.6. Stomach morpholo gy. 
Histological analysis of 
Hematoxylin/eosin (H/E) stained sto-
mach sections from 1 year-old wild 
type and kcne3-/- mice. Scale bars 
denote same lengths for kcne3-/- and 
wild type. No obvious morphological 
diffe-rences were observed between 
tissues from the two genotypes. 
 
 
Next, we performed an immunohistochemical analysis on wild type and kcne3-/- 
stomach. As shown in figure 5.7A, C and D, kcne3-/- controlled staining showed that 
KCNE3 was present in basolateral membranes of epithelial cells at the bottom of gastric 
glands. Interestingly, anti-KCNQ1 antibody yielded a similar basolateral staining 
pattern at these positions both in wild type or kcne3-/- stomach sections (Figure 5.7G-I). 
Additionally however, anti-KCNQ1 antibody strongly labeled cell bodies of other cells 
located closer to the opening of the gland (Figure 5.7G). As described previously 
(Grahammer et al. 2001a; Heitzmann et al. 2004), KCNQ1 co-localized in these latter 
cells with the H+/K+ ATPase (Figure 5.7H and I), identifying them as parietal cells.  
Parietal cells are acid-secreting cells, that express KCNE2 as well as KCNQ1 and H+/K+ 
ATPase (Dedek and Waldegger 2001; Grahammer et al. 2001a; Heitzmann et al. 2004).   
Our data show that cells stained for KCNE3 were not positive for the H+/K+ ATPase 
(Figure 5.7A-D). Sections of wild type stomach showed basolateral KCNE3 staining of 
cells restricted to the lowest segment of the gastric gland. In particular, KCNE3 was 
present only in basolateral membranes of chief cells and other epithelial cells found 
deep down the gastric gland in the proliferative zone (Figure 5.7A, C and D). This 
staining was completely absent in kcne3-/- tissues (Figure 5.7E and F), providing further 
confirmation for the specificity of the signal. 
Altogether our results indicate that, although KCNE2 is coexpressed in the gastric tissue 






Figure 5.7. Immunolocalization of KCNE3 in stomach. A-D, immunolocalization of 
KCNE3 (green) and H+/K+ ATPase (B-D; red) in stomach. KCNE3 expression was 
restricted to the basal region of the gastric glands which are devoid of the H+/K+ 
ATPase. KCNE3 is expressed both in regions with a prominent presence of H+/K+ 
ATPase-expressing parietal cells (A-C), and in regions lacking those cells (D). E – F, 
kcne3-/- controls for specificity of KCNE3 staining in areas lacking (E) or expressing 
(F) the H+/K+ ATPase. G-I. Immunolocalization of KCNQ1 (green) and H+/K+ ATPase 
(red) in regions lacking (G) or expressing (H, I) the ATPase. KCNQ1 and the ATPase 
co-localize in parietal cells in a staining pattern broadly covering the cytoplasm. 
KCNQ1 is additionally present at the bottom of gastric glands in basolateral membranes 
of cells lacking H+/K+ ATPase (G). These cells express KCNE3 (A-D). KCNQ1 
staining was similar in kcne3-/- stomach. Counterstaining by Topro-3 (blue) was 
performed to identify cell nuclei. Inset scale bar in (D), which shows higher 
magnification of marked area, is 5 μm. Lower right scale bar in (D) represents 50 μm 
and also applies to (E, F). 
 
While KCNE2 is expressed in H+/K+ ATPase-positive parietal cells located apically in 
the gastric gland axis (Heitzmann et al. 2004, Roepke et al. 2006), we found KCNE3 to 
be present in more basal gastric gland cells (Figure 5.7A,C and D). This in an important 
piece of evidence that suggests possible differential functional roles of the two KCNE 




5.2.4.2 Immunolocalization of KCNE3 and KCNQ1 in Small Intestine 
Next, we focused on the small intestine and analyzed its morphology in the kcne3-/- 
mouse. Hematoxilin-eosin stained sections of kcne3-/- small intestine did not show any 
sign of morphological abnormality and appeared indistinguishable from control wild 
type tissues (Figure 5.8). Transversally and longitudinally cut villi appeared normal in 
kcne3-/- sections, they were not overgrown or damaged, and crypts were tightly packed 





Figure 5.8. Small intestine morpho 
logy. Hematoxylin/eosin (H/E) 
stained small intestine sections from 
1 year-old wild type and kcne3-/- 
mice. Scale bars denote same lengths 
for kcne3-/- and wild type. No 
obvious morphological differences 
were observed between tissues from 
the two genotypes. 
 
In small intestine, we also analyzed in more detail the subcellular localisation of the 
KCNE3 protein by immunohistochemical methods. The anti-KCNE3 antibody labeled 
only intestinal crypts cells, whith no signal being observed in apical surface or villi 
(Figure 5.9A). On the other hand, kcne3-/- sections of the same organ from control 
littermates did not show any signal (Figure 5.9B). 
Resembling KCNE3 staining and consistent with previous work (Schroeder et al. 2000; 
Warth et al. 2002a), we also detected KCNQ1 in wild type intestinal crypts with our 
anti-KCNQ1 antibody (Figure 5.9C). Similar to what we have previously shown in the 
stomach (Figure 5.7), kcne3-/- sections of small intestine also exhibited typical KCNQ1 
expression and localization (Figure 5.9D) indistinguishable from control tissues. 
Taken together, our data indicate that in wild type small intestine, KCNE3 is selectively 
expressed in basolateral membranes of intestinal crypts cells. Furthermore, like in the 
stomach (Figure 5.7), in KCNE3-deficient small intestine the localization of the 





Figure 5.9. Immunolocalization of KCNE3 
in small intestine. A, in small intestine, 
KCNE3 expression (green) was restricted to 
the basolateral membrane of crypt cells. B, 
KCNE3 staining in kcne3-/- intestine shows 
complete absence of specific immunoreactive 
signal. C and D, immunolocalization of 
KCNQ1 (green) in wild type (C) and kcne3-/- 
(D) small intestine. Basolateral KCNQ1 
distribution was not altered in the kcne3-/- 
intestinal tissue. Nuclei are shown by Topro 
staining (blue). Insets show higher 
magnifications of regions shown in frames, 
except for the lower left inset of (A) that is 
from a different section and highlights 
KCNE3 expression in basolateral membranes 
Scale bars are 50 µm. Inset bar is 5 µm. 
 
5.2.4.3 Immunolocalization of KCNE3 and KCNQ1 in Colon 
Both our Northern blot (Figure 5.3) and Western blot analysis (Figure 5.5) revealed that 
KCNE3 expression is highest in colonic tissue. We therefore extensively investigated 
the general morphology of this organ in kcne3-/- animals (Figure 5.10). H-E stained 
colonic sections from kcne3-/- animals were indistinguishable from wild type control 
littermates (Figure 5.10A and B). Close examination did not reveal any aberration, 
obstruction or tissue damage in kcne3-/- colonic tissue. In addition, Periodic Acid 
Staining (PAS), which is conventionally used for staining structures containing a high 
proportion of carbohydrate macromolecules, showed that mucous density and 
accumulation were similar in both genotypes (Figure 5.10C and D). Toluiden blue 
staining, which selectively stains mast cells commonly found in connective tissue, did 
not detect infiltration of immune cells or other signs of inflammation in the kcne3-/- 
colon (Figure 5.10E and F). 
Altogether, these data indicate that overall morphology and general function of colonic 
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Figure 5.10. Colon morphology. Colonic sections 
from 1 year-old wild type and kcne3-/- mice stained 
with hematoxylin/eosin (H/E) (A-B), periodic acid 
staining (PAS) (C-D) and toluiden blue (E-F). Scale 
bars denote same lengths for kcne3-/- and wild type. 
No obvious morphological differences were 
observed between tissues from the two genotypes. 
No abnormal mucous accumulation neither 
excessive mast cell infiltration nor inflammation 
were detected in the kcne3-/- tissue. 
 
Next, we analyzed the localization of KCNE3 in wild type colon. Immunohistochemical 
analysis revealed a prominent KCNE3 staining in the middle lower part of colonic 
crypts (Figure 5.11A). Consistent with other published studies focusing on KCNE3 
localization in rat and guinea pig colon (Liao et al. 2005), our anti-KCNE3 antibody 
labeled basolateral membranes of murine colonic crypt cells. KCNE3 antibody failed to 
detect any protein in the kcne3-/- sections, confirming again the specificity of our signals 
(Figure 5.11B). 
Our data therefore indicate that KCNE3 is selectively expressed in secretory regions of 
the colonic tissue (the crypts) all along the proximal and distal colon (Figure 5.11A). In 
those areas we could also identify KCNQ1 protein (Figure 5.11C and D). Anti-KCNQ1 
antibody stained basolateral membranes of colonic crypts cells, overlapping perfectly to 
the KCNE3 localization (Figure 5.11A and C). As we have described above for kcne3-/- 
stomach (Figure 5.7G-I) and kcne3-/- small intestine (Figure 5.9C and D), also in kcne3-/- 





Figure 5.11. Immunolocalization of 
KCNE3 in colonic epithelia. A and 
B, KCNE3 localization (green) in the 
basolateral membrane of wild type 
colonic crypt cells (A), and absence 
of specific immunoreactive signal in 
kcne3-/- colonic tissue (B). C and D, 
immunolocalization of KCNQ1 
(green) in wild type (C) and kcne3-/- 
(D) colonic tissue. Basolateral 
KCNQ1 distribution was not altered 
in the kcne3-/- tissue. Nuclei are 
shown by Topro staining (blue). 
Insets show higher magnifications of 
regions shown in frames. Scale bars 
are 50 µm. Inset bar is 5 µm. 
 
5.2.4.4 Immunolocalization of KCNE3 and KCNQ1 in Trachea 
Since RT-PCR experiments had previously reported KCNE3 mRNA expression in 
trachea, together with KCNQ1, KCNN4 and CFTR (Grahammer et al. 2001b; Cowley 
and Linsdell 2002) we next focused our analysis on tracheal tissue, by first analyzing 
the morphology of tracheal tissue in kcne3-/- animals (Figure 5.12). H/E staining 
revealed that the general morphology was preserved in KCNE3-deficient tracheas 
(Figure 5.12A-D). In addition, PAS staining of tracheal sections showed that overall 
physiology was conserved, since no abnormal mucous density or altered mucosal gland 
distribution could be observed (Figure 5.12E and F). 
Next, in order to examine in more detail tracheal KCNE3 expression, we performed 
Western blot and immunohistochemical analysis. After long exposure of the blot, our 
Western blotting revealed KCNE3 expression in wild type tracheal epithelium, (Figure 
5.5D), indicating that KCNE3 protein is indeed present in upper airways tissue as it was 
suggested previously (Grahammer et al. 2001b; Cowley and Linsdell 2002).  
Furthermore, by immunohistochemical approach we were able to pin down KCNE3 
localization to the lining epithelial layer in wild type trachea. As shown in Figure 5.13, 
KCNE3 was clearly localized at the membranes of the epithelial cells found in tracheal 
epithelium. Specificity of KCNE3 localization pattern was confirmed by absence of 












Figure 5.12. Trachea mor 
phology. Histological analy 
sis of tracheal tissue from 1 
year-old wild-type and kcne3-
/- mice. A-D hematoxylin/eo 
sin (H/E) stained tracheal 
sections shown at 2 different 
magnification levels, from 
wild type (A and C) and 
kcne3-/- (B and D) mice. 
Periodic acid staining from 
wild type (E) and kcne3-/- (F) 
mice. Scale bars denote same 
lengths for kcne3-/- and wild 
type. At higher magnificati 
on, no obvious morphologi 
cal differences in the tracheal 
lining epithelium are evident, 
while the lower magnifica 
tion shows unaltered general 
morphology of tracheal tissue 
in kcne3-/- mouse. 
 
 
Interestingly, KCNQ1 had been previously shown to localize in basolateral membranes 
of the epithelial airway (Grahammer et al. 2001b), the same compartments where we 
have observed KCNE3 expression (Figure 5.13A). These data provide the first 
indication for a possible interaction of KCNE3 and KCNQ1 outside the gastrointestinal 
tract. 
In conclusion, our data indicate that KCNE3 is expressed in basolateral membrane 
compartment of epithelial cells in tracheal tissue. Together with the previously reported 
localization of KCNQ1 in the same compartments, these data suggest a possible role of 
the KCNQ1/KCNE3 complex to sustain cAMP stimulated Cl- secretion through CFTR 





Figure 5.13. Immunolocali 
zation of KCNE3 in upper 
Airways. A, KCNE3 locali 
zation (green) in the basolate ral 
compartment of the lining 
epithelia of wild type tra chea. 
Inset shows a magnifi cation of 
the indicated area. B, complete 
absence of KCNE3 immunoreac 
tive signal in kcne3-/- tracheal 
sections. Nuclei are shown by 
Topro staining (blue). Scale bars 
are 50 µm. Inset bar is 5 µm. 
 
5.3 KCNQ1 is not Altered in the kcne3-/- Mouse 
In vitro studies have shown that KCNE3 needs KCNQ1 to be efficiently transported to 
the plasma membrane (Schroeder et al. 2000). To test if the KCNE3 deletion resulted in 
altered KCNQ1 localization, we performed immunohistochemistry analysis on wild 
type and kcne3-/- stomach (Figure 5.7), small intestine (Figure 5.9) and colon (Figure 
5.11). As discussed in previous sections, the KCNQ1 protein was expressed properly 




















Figure 5.14. KCNQ1 is not altered in 
kcne3-/- tissues. Western blot from 
colonic membrane preparations shows no 
difference in KCNQ1 protein amount 
between wild type and kcne3-/- mice. 
Colonic membranes from 3 different wild 
type and kcne3-/- littermates are shown. 
Equal amounts of proteins (~50 μg) were 
loaded and α-actin served as loading 
control. 
 
Furthermore, we tested if KCNQ1 expression levels were changed upon KCNE3 
deletion in kcne3-/- mice. For this reason, we prepared membrane-bound protein 
fractions from colon of three wild type and three kcne3-/- animals, and analyzed them by 
Western blotting for the presence of KCNQ1. As shown in Figure 5.14, wild type and 
kcne3-/- fractions did not exhibit any compensatory change in KCNQ1 expression levels.  
Taken together, these results indicate that KCNE3 deletion did not result in any 
compensatory change in expression levels of the alpha-subunits. Furthermore, the 





5.4 Analysis of Metabolic Parameters in kcne3-/- Mouse 
Our data indicate that KCNE3 is expressed in several epithelial tissues with absorptive 
and secretory function. In order to investigate in more detail the physiological 
implications of KCNE3 deletion, kcne3-/- and control mice were subjected to metabolic 
cage experiment.  
 
62.4 ± 3.571.3 ± 0.8ALP IU/L
14.9  ± 1.516.4 ± 1.7Glucose (mM)
3.1 ± 0.13.6 ± 0.3Phosphorus (mM)
3.9 ± 0.13.8 ± 0.2Protein (g/dL)
1.3 ± 0.11.3 ± 0.1Mg (mM)
2.1 ± 0.11.9 ± 0.1Ca (mM)
93.4 ± 2.796.8 ± 3.8Cl (mM)
126.7 ± 2.3131.2 ± 5.6Na (mM)(n= 8 per genotype)
6.3 ± 17.2 ± 0.8K (mM)Serum
81.9 ± 25.7137.6 ± 32.2K µmol/ gr dry
28 ± 8.540.7 ± 10.2Na µmol/ gr dry
Feces
(n=4 per genotype)
28.5 ± 2.229.6 ± 2.7Protein/creatinine (mg/mg)
14 ± 1.714.8 ± 2.1Pi/creatinine (mmol/mmol)
7.7 ± 1.28.6 ± 0.6Mg/creatinine (mmol/mmol)
1.2 ± 0.60.8 ± 0.1Ca/creatinine (mmol/mmol)
68.8 ± 2.975.6 ± 3.8Cl/creatinine (mmol/mmol)
37.6 ± 2.539 ± 1.7Na/creatinine (mmol/mmol)
104.3 ± 6.1112.2 ± 5.7 K/creatinine (mmol/mmol)
3.1 ± 0.312.6 ± 0.5Creatinine mM
Urine 
(n=6 per genotype) 
KCNE3 -/-KCNE3 +/+
 
Table 5.1. Urine, feces, and serum parameters from wild type and kcne3-/- mice. Urine, electrolyte 
and protein levels were normalized to the creatinine values. Feces, Na+ and K+ concentrations assessed in 
fecal water were normalized to their dried weight. Serum, electrolytes and protein content are indicated as 
mM concentrations. No statistically significant difference was observed between wild type and kcne3-/- 
mice in any of the measured parameter in urine, feces and serum. Each urine and feces sample consisted 
of 1 day of recollection from N animals (6 recollection days in total). The number of animals is indicated 
in brackets. Data are shown as mean ± SEM. 
 
This approach allows monitoring of mice under standardized conditions, collecting 
urine and feces as well as tracking of food and water intake to analyze general ion 
homeostasis and renal function. Animal weight, food and water intake were monitored 
every 24 hours in kcne3-/- mice and their wild type control littermates. The biochemical 
analysis of serum, urine and feces did not reveal any statistically significant difference 




These results conclude that kcne3 disruption in the gastrointestinal system did not 
impair Na+ absorption or K+ secretion. Although KCNE3 had been previously reported 
be expressed in human kidney (Schroeder et al. 2000), we did not detect KCNE3 
mRNA nor protein in the murine kidney samples analyzed (Figure 5.3A and 5.5C). 
Moreover, all the metabolic parameters measured from urine samples of kcne3-/- animals 
were within the normal range, further indicating that kidney function in the kcne3-/- 
mouse was not altered.  
 
5.5 Analysis of the Secretory Function in kcne3-/- Intestinal 
Epithelia  
Hans Ussing invented the Ussing chamber in the 1950s to measure the net ion transport 
taking place across an epithelium clamped between two chambers that are filled with 
Ringer solution. Ions that move through paracellular pathways, tight junctions or across 
the cell generate a voltage difference among chambers. Addition of specific drugs will 
promote or inhibit channel activity and modify the ionic conductances, thereby 
changing the voltage. The amount of injected current (called short circuit current, Isc) 
necessary to clamp the voltage to 0 mV is the measure of net ion transport taking place 
across the epithelium.  
To study the secretory functions of kcne3-/- colonic epithelia, we performed Ussing 
chamber experiments from colonic tissue preparations. 
 
5.5.1 Role of KCNQ1/KCNE3 K+ Channels in Colonic Chloride 
Secretion 
Based on the biophysical and pharmacological properties of KCNQ1/KCNE3 
heteromers, it has been previously postulated that KCNQ1/KCNE3 channels might be 
involved in increasing the driving force for apical Cl- exit by hyperpolarizing the apical 
membrane and recycling basolateral K+ (Greger et al. 1997; Schroeder et al. 2000). 
To determine whether cAMP-stimulated Cl- secretion was impaired in the kcne3-/- 
intestine, colonic samples were mounted in Ussing chambers, and both basal and drug 





To avoid stimulation of colonic transport by prostaglandins that may be generated and 
liberated from submucosal tissue and to inhibit action potentials of attached neurons, 
indomethacin (10 μM) and tetrodotoxin (1 μM), respectively, were present throughout 
these experiments. For better isolation of Cl- currents, apical ENaC Na+ channels were 
inhibited by 10 μM amiloride (Figure 5.15). 
First, we investigated the effects of forskolin addition (10 µM) on net ion flux in colonic 
tissues from kcne3-/- and wild type littermates. Forskolin is a natural medicinal 
component, produced by the plant Coleus forskohlii, which activates adenylate cyclase 
thereby stimulating cAMP production. Forskolin application leads to CFTR and 
KCNQ1/KCNE3 activation. 
The addition of 10 μM forskolin, evoked a large and sustained anion secretion (Isc 156.8 
± 21.7 µA/cm2, n=7) seen by a peak in the recorded Isc in wild type colonic tissue 
(Figure 5.15A and C). In addition, this current component could be efficiently inhibited 
by 10 μM chromanol 293B, a K+ channel inhibitor that preferentially inhibits KCNQ1-
containing channels (Figure 5.15A and C) with an IC50~1-10 µM. In wild type samples, 
the remaining current after chromanol 293B application was 51.3 ± 11.5 µA/cm2. In 
contrast to wild type, forskolin-stimulated current was almost abolished in kcne3-/- colon 
(Isc = 34.1 ± 5.4 µA/cm
2, n=6) and the application of chromanol 293B had no effect 
(Figure 5.15B). 
Additionally, carbachol was used to stimulate muscarinic Ca++ dependent Cl- secretion, 
and led to increases in Isc that were on average indistinguishable between wild type and 
kcne3-/- tissue (Figure 5.15A-C; Isc WT 95.7 ±16.6 µA/cm







Figure 5.15. Transepithelial transport across intestinal epithelia of wild type and kcne3-/- mice.  
A and B, representative traces of short-circuit current (Isc) recordings performed with Ussing 
Chamber from wild type (A) and kcne3-/- (B) distal colon clamped to 0 mV. Luminal amiloride 
(10µM), serosal forskolin (FSK; 10 µM), serosal chromanol 293B (C293B, 10 μM), and serosal 
carbachol (CCH, 100 μM) applications are shown above the traces. C. Bar graph summarizing the 
mean of ΔIsc under different conditions (WT, n = 7; KO, n = 6). Data are means ± SEM.  (*) 
Indicates the level of significance of p<0.0005. The resistance of the colonic tissues was 66.8 ± 5.2 
(WT) and 68.4 ± 5.0 (KO) Ω cm2, . The resistance of the fluid amounted to 19 - 25 Ω cm2. 
 
Carbachol binds to muscarinic acetylcholine receptors, activating a G-protein (Gq/11) 
cascade that stimulates phospholipase C that in turn hydrolyzes phophatidyilinositol 
(PIP2) to diacyl glycerol (DAG) and inositol triphosphate (IP3). The latter will release 
the Ca++ from the endoplasmatic reticulum (ER), by acting on IP3 receptors bound to the 
ER membrane.  
Increases in cytosolic Ca++ promote a K+ efflux at the basolateral membrane due to 
KCNN4 activation. Simultaneous increase of intracellular cAMP and Ca++ will promote 
a synergistic acute effect on anion secretion, as seen in figure 5.15A-C for both 
genotypes. Since the recorded carbachol stimulated Isc were within the normal range 
(Strabel and Diener 1995; Warth et al. 1999b) for both genotypes, carbachol was a 
suitable test for tissue viability, and was used at the end of every experiment. 
Similar results were obtained with tissue samples taken from the proximal, middle and 




Taken together, these results clearly demonstrate the dependence of the cAMP-
stimulated Cl- secretion pathway on the KCNE3 subunit. Membrane hyperpolarization 
and K+ recycling via the KCNQ1/KCNE3 is therefore a key pathway to sustain cAMP-
activated Cl- secretion all along the colonic tissue. Interestingly, the response to 
carbachol was not affected in kcne3-/- tissues (Figure 5.15B and C), indicating that 
cAMP and Ca++ stimulated Cl- secretion do not crosstalk and function independently 
one from the other in the murine colon. 
 
5.5.2 Whole Cell Recordings of Colonic Crypt Cells 
The results obtained with the Ussing chamber technique, were further supported by 
electrophysiological data of whole cell recordings from intact murine colonic crypts 
(please see material and methods for additional details).  
 
 
Figure 5.16. Colonic crypt. Picture showing a 
colonic crypt under the electrophysiological 
recording configuration. The holding pipette 
stabilizes the crypt, while the recording patch-
pipette is approaching. One cell per colonic crypt 
was patched. All the recorded cells were from the 
lower part of the colonic crypt. 
 
Colonic crypt cell patching is a challenging technique where cells from the mid-basal 
crypt are patched while the upper part of the crypt is smoothly sucked by holding 
pipette (Figure 5.16). Patches lasted from 5 to 10 minutes, long enough to apply a 
voltage step protocol ranging from -95 mV to +25 mV under the 3 following solutions: 
(1) control, (2) control + forskolin, and (3) control + forskolin + chromanol 293B. As 
described in the previous section, forskolin will raise intracellular cAMP and 
consequently Cl- will be secreted apically through CFTR, thus increasing the total 
currents. 
Addition of chromanol 293B, will specifically inhibit KCNQ1/KCNE3 currents (IC50 = 
1-10 µM), affecting the driving force for Cl- and its secretion. There has not been yet 




chromanol 293B sensitive whole cell current component had been reported for rat 
colonic crypts (Diener et al. 1996; Schroeder et al. 2000). 
Our experiments demonstrated that also murine wild type colonic crypt cells exhibited a 
K+ conductance sensitive to chromanol 293B (Figure 5.17E and F), that was absent in 
kcne3-/- colonic cells.  
Under control conditions both, wild type and kcne3-/- colonic crypt cells displayed 
whole-cell currents that depended almost linearly on voltage (Figure 5.17A, B and D). 
Consistent with a reduced K+ conductance, currents from kcne3-/- cells were about 30% 
smaller than those from wild type cells and reversed at a slightly more positive voltage. 
In the presence of forskolin (Figure 5.17B, C and D), currents from both wild type and 
kcne3-/- crypt cells reversed at more positive potential (WT control is -75 mV and WT 
FSK -45 mV; KO control is -70 mV and KO FSK is -35 mV), compatible with a 
prominent Cl- current component carried by CFTR in cells from both genotypes. Under 
our ionic conditions, the Cl- reversal potential is calculated to -37 mV. Again, currents 
of kcne3-/- cells showed a more positive reversal potential that is compatible with a 
partial loss of a K+ conductance.  
Surprisingly, even though cAMP should increase total currents through CFTR and 
KCNQ1/KCNE3 (Figure 5.17B, C and D), the whole cell conductance was not 
increased by forskolin (at 25 mV: WT control 131.7 ± 13.7 pF/pA, WT FSK: 112.5 ± 
21.5 pA/pF, and KO control 91.9 ±15.1 pF/pA, KO FSK: 61.9 ± 4.5 pA/pF, n= 9). It is 
worth to mention that another group obtained similar results in similar an experimental 







Figure 5.17. Whole-cell recordings from wild type and kcne3-/- colonic crypt cells. A and C, 
current/voltage relationship of WT (♦) and KO (□) colonic crypt cells under control conditions (A) and 
after addition of 10 μM forskolin (C). Number of cells: (A), 10 WT, 9 KO; (C) 10 WT, 7 KO. E, 
C293B-inhibitable current component of wild type (♦) and kcne3-/- (□) colonic crypt cells obtained by 
subtracting currents recorded in the presence of FSK from those in the presence of both FSK and 
C293B (10 WT and 7 KO) cells). B and D, representative current traces recorded from wild type (B) 
and kcne3-/- (D) colonic crypts during superfusion with control- (left), FSK- (middle) and FSK + 293B-
containing solutions (right). From a holding potential of -95 mV, the voltage was clamped for 2 s to 
values between -95 and +25 mV (voltage-step protocol shown as inset in figure D). F, representative 
traces of 293B-sensitive currents recorded from wild type and kcne3-/- crypt cells. Recorded cells were 
located at the lower third of an isolated crypt. Voltage-step protocol is shown in the inset. Mean values 
± SEM are shown.*, p<0.05. **, p<0.005. 
 
This result can be explained either by a concomitant downregulation of apical Na+ 
absorption (by ENaC), or by a deactivation of K+ outward currents, e.g. carried out by 
KCNN4. Increases of cytosolic cAMP may switch off the Ca++ activated K+ 




Nonetheless, kcne3-/- cells exhibit lower whole cell currents under forskolin compared 
to wild type cells (Figure 5.17C), probably due to the lack of the basolateral 
hyperpolarizing KCNQ1/KCNE3 K+ channel complex, which lowered the driving force 
for Cl- to exit apically the cell. 
We next evaluated the chromanol 293B-sensitive current after stimulation by forskolin 
(Figure 5.17E). This current was obtained by subtracting the chromanol 293B remaining 
currents from the forskolin induced currents (WT chromanol 293B sensitive 22.9 ± 4.6 
pA/pF, n = 10; kcne3-/- chromanol 293B sensitive 4.3 ± 1.7 pA/pF, n = 7; p-
value=0.003). The chromanol 293B sensitive current component, which accounts for 
about 20% of whole cell current under our experimental conditions, was totally 
abolished in kcne3-/- crypt cells (Figure 5.17 E and F).  
The reversal potential of the inhibited current is about -75 mV, which is close to the K+ 
reversal potential (-86.2 mV with 140 mM in the pipette and 5.6 mM in the bathing 
solution). Wild type cells clearly showed a K+ current, which was absent in kcne3-/- cells 
(Figure 5.17E and F). 
As a conclusion, these results show that first, whole cell currents from kcne3-/- crypt 
cells were 30% smaller compared to wild type controls, corresponding to a partial loss 
of the K+ conductance. Second, consistent with the lack of a basolateral hyperpolarizing 
K+ channel, forskolin stimulated currents from kcne3-/- cells reversed at more positive 
potentials. Third, kcne3-/- cells show a nearly totally abolished chromanol 293B 
sensitive current, indicating that KCNQ1/KCNE3 mediates the bulk of chromanol 293B 
sensitive current. 
 
5.5.3 Analysis of Cholera Toxin Mediated Intestinal Fluid Secretion in 
vivo 
At the molecular level, we have shown that KCNE3 and KCNQ1 were both expressed 
(Figure 5.5 and 5.14) in basolateral membranes of gastrointestinal tissues (Figure 5.7, 
5.9 and 5.11). At the functional level, we demonstrated that ex vivo colonic tissues from 
kcne3-/- animals were unable to secrete Cl- in response to an increase in intracellular 
cAMP levels (Figure 5.15). Next, we decided to test in vivo the effect of cholera toxin 




























Figure 5.18. Kcne3-/- mice show no 
difference from wild type in CTx-
mediated small intestine fluid 
secretion. A and B, representative 
ileal loops 5 h after luminal 
injection of PBS alone (left ligated 
loop) and PBS + cholera toxin 
(CTx; 0.5 μg per loop) (right ligated 
loop) in wild  type (A) and kcne3-/- 
mice (B). C, bar graphs showing 
averaged loop mass/length from 
wild type and kcne3-/- mice 5 h after 
PBS (white bar) and PBS + CTx 
(grey bar) injections. Data are 
shown as mean ± SEM, n=3 each. 
There are no statistically significant 
differences between the two 
genotypes. 
 
Injection of cholera toxin into intestinal closed-loops induces an acute luminal fluid 
accumulation, due to a dramatic Cl- secretion in the intestinal lumen (Richardson et al. 
1984). Consequently, net increase in gut weight (weight of maximally stimulated minus 
weight of unstimulated loops) can be taken as an estimate for the cholera toxin effect on 
fluid secretion (Banwell et al. 1970).  
In our experiments (Figure 5.18), examination of the averaged gut mass/length indicated 
that kcne3-/- mice were able to secrete fluid as efficiently as their wild type littermates 
(CTx KO 0.23±0.04; PBS KO 0.084±0.012; CTx WT 0.213±0.013; PBS WT 
0.111±0.02). 
In kcne3-/- mice we could not observe the expected reduction in intestinal fluid loss after 
in vivo cholera toxin injection. Cholera toxin promoted an acute and dramatic Cl- 
secretion also in the kcne3-/- gastrointestinal tissue (Figure 5.18).  
 
5.6 Analysis of the Secretory Function in kcne3-/- Airway Epithelia 
In ciliated cells of the airways lining epithelia there are two main ion fluxes: Cl- 
secretion (through CFTR and Ca++-activated Cl- channel CaCC) and Na+ absorption 
through ENaC.  
In human airways CFTR is the main player for Cl- secretion, as mutations in CFTR lead 




the airway surface liquid (ASL). In murine airways however, there seem to be at least 
an equal contribution from CaCC and CFTR, since cftr-/- mice did not suffer of any kind 
of airway complication. Although, it is important to notice that the different tracheal 
morphology might also account for the discrepancies between human and murine 
studies. 
To study the secretory functions of kcne3-/- tracheal epithelia, we performed Ussing 
chamber experiments from tracheal tissue preparations. In addition, to study the impact 
of the KCNE3 deletion on tracheal tissue function, we performed mucociliay clearance 
experiments. 
 
5.6.1 Role of KCNQ1/KCNE3 in Tracheal Chloride Secretion 
Since KCNE3 is expressed in trachea (Figure 5.13), we studied short-circuit currents 
(Isc) of tracheal preparations in Ussing chamber experiments to assess the contribution 
of KCNE3 to epithelial transport in upper airways.  
Consistent with the notion that KCNQ1/E3 support Cl- secretion but not Na+ absorption 
in epithelial cells, basal and amiloride-sensitive currents (Figure 5.19A and C) showed 
no significant difference between wild type and kcne3-/- tissues (WT amiloride -48.37 ± 






Figure 5.19. Effect of secretagogues on ion transport by tracheal epithelia from wild type and 
kcne3-/- mice measured under current-clamp conditions. A and B, original continuous Ussing-
chamber recording of transepithelial voltage (Vte) for wild type (left) and kcne3-/- (right) tracheas. The 
upper line shows Vte, the length of the voltage pulses reflects the transepithelial resistance (Rte). 
Luminal amiloride (20 µM), serosal forskolin (FSK; 2 µM), serosal IBMX (100 µM), serosal 
chromanol 293B (C293B; 10µM) and luminal ATP (100µM) applications are shown above the traces. 
Luminal application of amiloride or FSK, and C293B in the presence of FSK are shown in A. Luminal 
application of ATP (B) caused a biphasic response in wild type tracheas (left): a rapid transient increase 
(“peak”) of Vte was followed by a steady state lumen-negative Vte. Both deflections were drastically 
reduced in kcne3-/- tissues. C, bar graph summary of the mean calculated short circuit current (Isc) from 
wild type and kcne3-/- tracheas under control and luminal application of amiloride (10 µM) (WT, n = 
12; KO, n=11). D, bar graphs summarizing differential currents (ΔIsc) by serosal application of 
forskolin (FSK; 2µM) plus IBMX (100 µM) (left bars), and calculated C293B-sensitive component of 
forskolin–stimulated current (right bars) of wild type and kcne3-/- tracheas. Kcne3-/- tissues showed a 
drastic reduction in current response to serosal application of FSK and IBMX as well as almost 
complete absence of C293B-sensitive currents (C293B 10µM). E, maximal (peak) and steady-state 
(plateau) differential currents ΔIsc induced by 100 μM ATP showing a significant lower ATP peak and 
plateau for the kcne3-/- trachea (WT, n = 12; KO, n = 10). Data are means ± SEM. * p<0.05 ** p<0.005. 
The resistance of the tracheal tissue samples was 42.2 ± 2.6  and 46.1 ± 2.6 Ω cm2. The resistance of 
the fluid in the Ussing chamber was 3.4 ± 2.1 Ω cm2. 
 
In a first set of experiments, we analyzed cAMP-stimulated Cl- secretion in kcne3-/- 
tracheas by monitoring Isc after forskolin application. Compared to wild type controls, 
kcne3-/- tracheas exhibited lower levels of luminal Cl- secretion induced by application 
of forskolin plus IBMX (that prevents cAMP from being degraded) (Figure 5.19A and 
D; WT IBMX+FSK -86.73 ± 14.95 µA/cm2 n=11 ; KO IBMX+FSK -13.5 ± 7.09 
µA/cm2 n=8).  
The addition of the specific KCNQ1 inhibitor chromanol 293B (IC50= 1-10 µM), 




5.19A and D; Figure 5.20). Chromanol 293B had no effect on kcne3-/- trachea (WT 
chromanol 293B 92.41 ± 15.16 µA/cm2 n= 11; KO C293 4.11 ± 1.48 µA/cm2 n=8). 
In a second set of experiments, we used carbachol application to monitor Ca++ 
dependent Cl- secretion from kcne3-/- and wild type tracheal tissues (Figure 5.20). In 
wild type trachea, carbachol application led to a massive increase in Isc that was reduced 
in kcne3-/- trachea (Figure 5.20).  
In a subsequent set of experiments, Cl- secretion from kcne3-/- and wild type tracheas 
was induced by ATP application (100 µM) (Figure 5.19B and E; Figure 5.20). ATP 
binds to luminal P2Y receptors and raise both intracellular cAMP and Ca++ levels 
(Kottgen et al. 2003; Mounkaila et al. 2005), thereby activating apical Cl- secretion via 
CFTR and CaCC.  
Upon ATP application, wild type trachea Isc was increased approximately 4-fold at its 
peak and then declined to a plateau value that was about twice as large as control. This 
effect of ATP was drastically reduced in kcne3-/- trachea (Figure 5.19B and E; Figure 
5.20; wild type ATP -293.62 ± 80.54 µA/cm2 n= 12 ; KO ATP -58.10 ± 17.41 µA/cm2 
n=10). These results indicate that basolateral K+ secretion through KCNQ1/KCNE3 is 
also needed under parallel activation of cAMP and Ca++ intracellular pathways.  
Note that compared to forskolin/IBMX (Figure 5.19A and D), the increase in wild type 
Isc was larger when we applied ATP (Figure 5.19B and E), which raised both 
intracellular cAMP and Ca++ levels, leading to a synergistic potentiation of Cl- efflux.  
In addition, a new set of experiments was done in the presence of the ENaC channel 
inhibitor amiloride (10 µM) (Figure 5.20) in order to better isolate Cl- currents, and to 
assess the contribution of Na+ absorption to the recorded Isc. Also in the presence of 
amiloride, ATP, forskolin/IBMX and carbachol stimulated currents were decreased in 







Figure 5.20. Effect of secretagogues on ion transport by tracheal epithelia in the presence 
of 20 μM amiloride to abolish Na+- transport. A, original recordings showing effects of 
luminal ATP (100 μM), FSK (2 μM) + IBMX (100 μM), and carbachol (100 μM) on wild type 
and kcne3-/- tracheas. B, mean differential currents (ΔIsc) induced by 100 μM ATP, 2 μM FSK + 
100 μM IBMX, or 100 μM carbachol, always in the presence of 20 μM amiloride. Number of 
measurements (animals): WT, 7; KO, 7. *, p<0.05. **, p<0.005. The resistance of the tracheal 
tissue samples was 42.2 ± 2.6 and 46.1 ± 2.6 Ω cm2. The resistance of the fluid in the Ussing 
chamber was 3.4 ± 2.1 Ω cm2. 
 
Altogether, our results indicate that KCNE3 containing K+ channels, probably by 
increasing the driving force for apical Cl- exit, are involved in both cAMP- and Ca++-
activated apical Cl- secretion in tracheal tissues. 
 
5.6.2 Analysis of Mucociliary Clearance 
The mucociliary clearance is the mechanism to maintain the airways clear from any 
inhalated pollutants by transporting a viscous film of mucous upwards (Knowles and 
Boucher 2002). Mucociliary dysfunction is a common feature of chronic airway 
diseases in humans suffering from cystic fibrosis, asthma, and chronic bronchitis. 
However, the mechanisms that lead to deficient mucous clearance are still poorly 
understood. It is suggested that purines control the clearance by regulating the water 
transport and electrolyte secretion (Tarran et al. 2002; Hayashi et al. 2005).  
In order to address the impact of KCNE3 deletion on mucociliary clearance, we 
measured ex vivo the ciliary transport of small (6 μm) polystyrene microspheres in 
isolated tracheas from kcne3-/- and wild type animals. Under control conditions, basal 
transport was similar in wild type and kcne3-/- tissues (Figure 5.21). Addition of ATP 




µm/min, n=10; KO ATP 261.59 ± 51.58 µm/min, n=9). Interestingly, while in kcne3-/- 
tracheas MCC in the presence of ATP did not statistically differ from the control 
conditions, in wild type controls a significant increase was observed (Figure 5.21; WT 
control 191.48 ± 34.33 µm/min, n=10; KO control 206.43 ± 36.63 µm/min, n=9). ATP 
application had no effect in kcne3-/- tracheas, since the effect was not significantly 
different from the control solution. However, there was no significant difference 
between wild type and kcne3-/- particle movement after ATP stimulation. These results 
indicate that kcne3-/- tracheas do not display any impairment in mucociliary clearance, 
although they show a tendency to transport particles less efficiently that wild type 
control under ATP stimulation, which would indicate that they might secrete less fluid 
under these conditions. 
 
 
Figure 5.21. Summarized effects of mucoci 
liary clearance. MCC was determined by 
measurement of the transport of polystyrene 
microspheres (diameter 6 ± 0.58 μm) in 
isolated wild type and kcne3-/- tracheas after 
apical application of ATP (10 μM) or CCHO 
(100µM). Kcne3-/- tracheas showed a 
decreased ATP induced MCC compared to 
wild type (WT, n = 10; KO, n = 9) Data are 




Compared to control conditions the lack of increased MCC upon ATP observed in the 
kcne3-/- epithelia correlates with the decreased ATP stimulated Cl- secretion observed 
Ussing chamber experiments of kcne3-/- tracheal rings.  
Additionally, kcne3-/- and wild type tracheas displayed a very similar degree of particle 
movement under carbachol stimulation, that was significantly different form control and 
ATP stimulated MCC (Figure 5.21; WT CCOH 523 ± 82.02 µm/min, n=10; KO CCOH 
674.52 ± 112.86 µm/min, n=10).  
Altogether, these preliminary results suggest that, despite the fact that there is no 
statistically significant difference among particle movements in wild type and kcne3-/- 
tracheas under ATP stimulation, there is a tendency in kcne3-/- tracheas to transport 




5.7 Role of KCNE3 in Skeletal Muscle 
In agreement with our experimental data, which failed to detect KCNE3 mRNA (Figure 
5.3A) and protein (Figure 5.5B) in skeletal muscle, we never observed spontaneous 
paralysis nor myotonia or uncoordinated movements in kcne3-/- mice. Kcne3-/- mice 
behaved normally in rotarod assays, which examine motor coordination.  
In addition, histological analysis of skeletal muscle did not reveal any morphological 
abnormalities (Figure 5.22A-D), contrasting with the vacuoles and tubular aggregates 
observed in muscle biopsies from some of the patients affected by  periodic paralysis, 
carrying the R83H in the KCNE3 gene (Abbott et al. 2001; Abbott. et al 2006). In these 
patients, as described by Abbott et al. attacks often occur after exercise or when having 
low K+ blood levels. In order to mimic these conditions and to test more stringently the 
effect of KCNE3 deletion under low K+ blood levels, we also put kcne3-/- and their 
littermates on K+-depleted diet for two weeks and tested them for motor performance on 
rotarod test. 
Although this diet decreased serum K+ level from 6.5 to 3.5 mM in both genotypes, no 
attacks of paralysis were observed. Rotarod tests did not reveal any differences between 
the genotypes, either. The time mice were able to stay on the turning and slowly 
accelerating rods were 4.02 ± 0.42 min (WT) versus 4.24 ± 0.8 min (KO) under normal 
diet, and 4.23 ± 029 min (WT) vs.  4.36 ± 0.45 min (KO) under K+-depleted diet (n=6) 





Figure 5.22. Muscle morphology and motor 
performance. A-D, Hematoxylin/eosin (H/E) 
stained muscle sections from 1 year-old wild 
type and kcne3-/- mice. Transversal (A-B) and 
longitudinal (C-D) sections of hind limb 
skeletal muscle from wild type (A and C) and 
kcne3-/- (B and D) mice. Scale bars denote 
same lengths for kcne3-/- and wild type. No 
obvious morphological differences were 
observed between tissues from the two 
genotypes. To note that no degeneration 
neither vacuoles nor aggregates were observed 
in kcne3-/- skeletal muscle. E, rotarod 
performance averaged times from wild type 
and kcne3-/- mice under control or 
hypokalemic diet. No significant differences 
were observed between genotypes. All 
performance times are within the normal 
range. 
 
We can therefore conclude that KCNE3 does not play a crucial role in muscle 
physiology. These data on kcne3-/- animals strongly reinforce the doubts (Sternberg et 
al. 2003; Jurkat-Rott and Lehmann-Horn 2004) on the assertion that KCNE3 mutations 
can underlie periodic paralysis in humans (Abbott et al. 2001; Abbott et al. 2006).  
 
5.8 Role of KCNE3 in Central Nervous System 
Whereas KCNE3 levels in brain were below the detection limit in our studies (Figure 
5.3A, 5B) others (McCrossan et al. 2003; Lewis et al. 2004) have reported that KCNE3 






Figure 5.23. brain morphology A-D 
Hematoxylin/eosin (H/E) stained brain 
sections from 1 year-old wild type and 
kcne3-/- mice. H/E stained brain sections 
showing hippocampus of wild type (A) 
and kcne3-/- mice (B) and cerebellum of 
wild type (C) and kcne3-/- (D) mice. Scale 
bars denote same lengths for kcne3-/- and 
wild type. No obvious morphological 
differences were observed between tissues 
from the two genotypes. To note that no 
degeneration neither apoptotic regions 
were observed in the kcne3-/- brain. 
 
 
Therefore, we further investigated the kcne3-/- brain morphology. We neither detected 
morphological brain abnormalities (Figure 5.23), nor in hippocampal neither in 
cerebellar region. Besides, no obvious neurological defects, balance problems or 










6.1 Expression Pattern of KCNE3 
In recent years, the expression pattern of KCNE3 has been matter of debate (Abbott et 
al. 2001;Pannaccione et al. 2007; Sternberg et al. 2003; Jurkat-Rott and Lehmann-Horn 
2004; Jurkat-Rott and Lehmann-Horn 2007; Lundquist et al. 2005 and 2006). Part of 
these controversies might have arisen from the current absence of reliable tools to 
investigate KCNE3 expression pattern, namely a specific and reliable anti-KCNE3 
antibody and kcne3-/- mice. Kcne3-/- tissues from KO animals represent the optimal and 
most specific control to test and validate expression data. In the absence of KOs, 
controls by omission of primary antibodies, replacement with non-immune 
immunoglobulins, preadsorption with antigens, or staining with 2 different antibodies 
that recognized non-overlapping epitopes of the same protein, have been widely used to 
achieve some level of specificity in conventional biochemical and 
immunohistochemical techniques. These controls however do not provide definitive 
information about the specificity of the reactions (Fritschy 2008). 
The generation of a new, specific antibody tested against wild type and kcne3-/- tissues 
was necessary. Our anti-KCNE3 antibody proved to be specific in Western blot (Figure 
5.4 and 5.5) and immunohistochemistry (Figure 5.7, 5.9, 5.11 and 5.13), to perform a 
systematic analysis on KCNE3 expression in murine tissues by employing kcne3-/- 
samples as controls. By these means, KCNE3 expression has been restricted to 
gastrointestinal tissue and upper airways. Moreover, we addressed the subcellular 
localization of the KCNQ1/KCNE3 in these tissues.  
 
6.1.1 KCNE3 Subunits can be Detected only in Secreting Epithelia 
The kcne3 gene contains 4 exons, of which only exon 4 codes for the entire KCNE3 
protein. Exons 1 to 3 form part of the 5´UTR and undergo alternative splicing. This long 
UTR region might serve to tightly regulate KCNE3 gene expression at the translational 
level in different tissues. 
Most of the published work on KCNE3 expression has been performed at the mRNA 





of reliable anti-KCNE3 antibodies. Besides, given that KCNE3 exons 1-3 undergo 
extensive splicing, it is not possible to design appropriate intron-spanning primers (that 
produce only one PCR product) for real-time quantitative PCR (RT-PCR) reactions. 
Intron-spanning primers are generally used in RT-PCR analysis to avoid co-
amplification of contaminating genomic DNA. The RT-PCR is a very sensitive method, 
where careful experimental design, application and validation are needed to avoid 
amplification of nonspecific PCR products that cause false-positive signals. We 
therefore believe that the majority of the KCNE3 expression studies reported by other 
groups, which were performed only at the mRNA level, should be further validated by 
using other complementary approaches to detect the KCNE3 protein as well. Therefore, 
our analysis on the expression pattern of KCNE3 was performed at both mRNA and 
protein level, by employing biochemical (e.g. Western and Northern Blotting) and 
immunohistochemical techniques (Preston et al. 2010). 
At the mRNA level, KCNE3 expression was observed in the entire gastrointestinal tract 
(stomach, duodenum, jejunum, ileum, caecum and colon; Figure 5.3), while a number of 
other tissues (brain, kidney, heart and skeletal muscle) were not positive for kcne3 
expression. Similarly, also at the protein level KCNE3 was found to be highly expressed 
in gastrointestinal tissues. Outside of the gastrointestinal tract, we observed KCNE3 
expression only in trachea, while kidney, skeletal muscle, heart, and brain were devoid 
of specific signals (Figure 5.5).  
In order to get additional evidence for the absence of KCNE3 in the above mentioned 
tissues, we performed immunohistochemical experiments. These experiments also failed 
to report KCNE3-specific signals (data not shown). In particular, multiple tests were 
performed aiming at improving the immunoreaction by varying methods of tissue 
fixation, tissue processing and stringency of the binding reaction. In none of the 
conditions tested we were able to observe specific signals above background levels 
(data not shown).  
 
Altogether, these data strongly support the absence of significant KCNE3 expression 
outside of the gastrointestinal tract, with the exception of tracheal tissue. These results 
are quite surprising, in view of recent works that reported KCNE3 expression and 
possible physiological role in murine and human brain (McCrossan et al. 2003; 
Pannaccione et al. 2005; Pannaccione et al. 2007); rat and human skeletal muscle 




Bendahhou et al. 2005; Lundquist et al. 2005; Lundquist et al. 2006); human kidney 
(Schroeder et al. 2000; Duranton et al. 2010). 
The discrepancies between the expression pattern of KCNE3 observed in human tissues 
and their murine counterparts (e.g. in heart, kidney and skeletal muscle) might be a 
consequence on species-specific differences. We however believe that the studies 
mentioned above suffer from major limitations, given the lack of appropriate controls 
(kcne3-/- tissues) which are necessary to perform a reliable study of KCNE3 expression 
pattern. Our data on the other hand provide a more direct and clear evidence for the 
presence or absence of KCNE3 in the analyzed tissues (Figure 5.3 and 5.5). 
Interestingly, although we (Figure 5.5D) and others (Grahammer et al. 2001b) have 
shown expression of KCNE3 in trachea, we did not observe expression in lung tissue 
neither by Northern blot (Figure 5.3) nor by immunohistochemical techniques (data not 
shown). Although upper airways and lungs are part of the same functional system and 
share many common properties, they seem to differ in respect to the rates of mucus 
secretion. In contrast to lungs, upper airways can in fact produce higher amounts of 
mucus (Van der Schans 2007), which aids in the protection of the lungs by trapping 
foreign particles (e.g. dust, particulate pollutants, allergens, infectious agents, bacteria) 
that enter in the respiratory system during breathing (Mall 2008). Given this major 
functional difference, it is therefore conceivable to believe that trachea and lungs 
express a different subset of ion channels, which in turn might account for their 
differential secretory properties. In this regard, by being expressed only in trachea and 
not in lungs (Figure 5.3, 5.5 and 5.13), KCNE3 would be part of this molecular and 
functional heterogeneity. 
Nonetheless, it should be mention that very low KCNE3 mRNA or protein levels might 
have gone undetected in this study because they were below the detection limit of the 
techniques we employed. Low amounts of KCNE3 protein in a specific cell population 
might be indeed sufficient to achieve a specific function (e.g. in cardiac tissue). There 
might also be that in some organs KCNE3 is expressed only under very specific 
physiological or pathological circumstances (e.g. bacterial renal infections (Duranton et 
al. 2010)). 
 
Altogether, our analysis on the expression pattern of KCNE3, which has been validated 
by the use of kcne3-/- animals as controls, allowed us to draw a reliable picture of 




tract and in trachea, our data point to a general function of KCNE3 in supporting 
epithelial secretory functions together with its cognate subunit KCNQ1 (Figure 5.14). In 
all other tissues, we failed to detect KCNE3 expression (Figure 5.3 and 5.5). This is a 
valuable piece of evidence that contradicts previous reports and provides to date the 
most extensive and well validated analysis on the expression pattern of KCNE3 in 
mouse tissues.  
 
6.1.2 KCNE3 Expression in Gastric Epithelia 
Our data clearly demonstrate KCNE3 expression in stomach (Figure 5.3, 5.5 and 5.7), 
where it localizes to the basolateral membranes of epithelial cells found in basal gastric 
gland (Figure 5.7). These are the first data showing KCNE3 expression in gastric 
epithelia, which would suggest an involvement of this subunit in the secretory function 
of this organ. 
It is known that KCNQ1 is expressed together with KCNE2 in tubulovesicular and 
apical membranes of acid secreting parietal cells in the stomach (Grahammer et al. 
2001a; Heitzmann et al. 2004). The complex formed by KCNQ1/KCNE2 is 
constitutively open, and it is found in mid-apical parts of gastric glands. 
KCNQ1/KCNE2 currents are increased upon cAMP, PIP2 or acidic pH (Tinel et al. 
2000; Heitzmann et al. 2007). The channel complex has a major role in acid secretion, 
as it recycles the K+ ions necessary for the H+/K+ ATPase to secrete protons. Indeed 
animal models lacking one or other of the above mentioned components develop 
achlorhydria, gastric hyperplasia, and vitamin B12 deficit, and as a consequence 
macrocytic anemia (Lee et al. 2000, Roepke et al. 2006). 
It had never been shown before that KCNQ1 is also located in basolateral membranes of 
the epithelial cells at the bottom of gastric glands (Figure 5.7G-I). This localization 
pattern is consistent with a possible interaction of KCNQ1 with KCNE3 in basal glands, 
since we have shown that KCNE3 is also present in these membranes (Figure 5.7A, C 
and D). Interestingly, the staining in the parietal cells was found to be more 
cytoplasmatic, probably due to their high plasma membrane invaginations and abundant 
number of intracellular vesicular/tubular structures which were positive for 
KCNQ1/KCNE2 complex (Heitzmann and Warth 2008). On the other hand, cells 
located at the basal part of the gland displayed a KCNQ1 staining lining the plasma 




Kcne3-/- mice did not show any aberrant gastric morphology (Figure 5.6), that differs 
from kcne2-/- and kcnq1-/- mouse models, where striking morphological alterations were 
evident (Lee et al. 2000, Roepke et al. 2006). Most probably the impaired acid secretion 
from parietal cells, where KCNQ1 (Figure 5.7H-I) and KCNE2 (Roepke et al. 2006) are 
co-expressed is the cause of these morphological alterations. The discrepancy between 
the phenotypes of the kcnq1-/- and kcne2-/- mice on one hand, and the kcne3-/- on the 
other seems also to correlate with the expression pattern of the respective proteins. The 
absence of morphological alterations in kcne3-/- stomach, together with the preserved 
gastric gland morphology and acid-secreting parietal cells morphology, indirectly 
suggest that acid production was not altered.  
We speculate that in analogy to its intestinal function, gastric KCNQ1/KCNE3 
localization at the bottom of the gastric glands is involved in salt- and fluid secretion. 
Such fluid secretion would flush and dilute the contents of the gastric gland up to the 
gastric pit and lumen.  
There is a possibility that the presence of electroneutral K+-Cl- cotransporter (known as 
KCCs) type 3 in the basolateral membranes of gastric gland cells (Fujii et al. 2008), 
together with the residual activity of KCNQ1 homooligomers, might suffice to carry out 
K+ efflux and possibly compensate for the lack of the KCNE3 subunit in kcne3 -/- mice. 
 
6.2 KCNQ1 in the Absence of KCNE3 
KCNQ1 expression and localization was not altered in the absence of its beta subunit 
KCNE3 (Figure 5.9, 5.11 and 5.14). This finding shows that the beta subunit KCNE3 is 
not required for correct targeting of its alpha subunit KCNQ1 to the plasma membrane. 
Our results show that KCNQ1 protein stability is not depending on KCNE3 interaction. 
However in some cases the beta subunit is required for the proper function of the 
channel. That is the case of ClC7, which interaction with Ostm1 is important for protein 
stability and essential for bone resorption and lysosomal function. In fact, loss of 
function of the ClC7 or Ostm1 gene cause osteopetrosis. 
On the same way, Barttin is an essential beta subunit for CLC-Ka and CLC-Kb which 
are coexpressed in K+ secreting epithelia of the inner ear and renal tubules (Estevez et 
al. 2001). Mutations on CLC-Kb or Barttin gene cause Bartter syndrome type III or IV 
respectively, the latter characterized not only by renal failure but also by sensorineural 




biophysical properties and enhancing its membrane insertion (Waldegger et al. 2002). 
Unlike KCNQ1, CLC-Kb is retained in the Golgi apparatus in the absence of its beta 
subunit. Instead, CLC-Ka is able to travel to the plasma membrane but shows a reduced 
unitary conductance and altered voltage dependence of activation without Barttin 
(Scholl et al. 2006). 
In conclusion, KCNQ1 alone can reach the plasma membrane, probably via the default 
secretory pathway without requiring pre-assembly with a beta subunit. This is supported 
by the fact that KCNQ1 homomers are functionally expressed in the plasma membrane 
in hetereologous systems (Barhanin et al. 1996; Sanguinetti et al. 1996). 
 
The KCNE localization in the absence of KCNQ1 is source of controversy. Schroeder et 
al. (2000) reported that in the absence of its alpha subunit KCNQ1, KCNE3 was not 
targeted to the plasma membrane but accumulated in the ER compartment. A recent 
publication however showed that KCNE3 targeted to membrane lipid rafts when 
expressed alone in mammalian cells (Roura-Ferrer et al. 2010). Both are in vitro studies 
that use similar overexpression systems but show contradictory data. To resolve this 
issue, it would be interesting to analyze KCNE3 protein localization in kcnq1-/- 
epithelial cells.  
In vivo, the heteromers formed by KCNQ1/KCNE1 (Chouabe et al. 1997) and 
KCNQ1/KCNE2 (Heitzmann et al. 2004) reside in apical surfaces of marginal cells in 
the stria vascularis and in intracellular canalicular membranes of parietal cells in the 
gastric epithelia respectively. However, the abilility of KCNE subunits to target 
KCNQ1 channels to specific subcellular compartments is still a matter of debate. It had 
been reported that in MDCK (Madin-Darby Canine Kidney) cells, KCNQ1 was able to 
travel alone to basolateral membranes and that KCNQ1 targeting was not affected by 
KCNE co-expression (Jespersen et al. 2004). However, other groups showed by 
colocalization studies in hetereologous systems (Roura-Ferrer et al. 2010) and by 
analysis of KCNE1 mutants that impair KCNQ1 surface expression (Krumerman et al. 
2004) that KCNE subunits provide additional signals for intracellular targeting of the 
KCNE/KCNQ1 complex. More invetigations are however needed to elucidate the 
dependence of KCNQ1/KCNE complex targeting on the KCNE subunit and its cell type 





6.3 KCNQ1/KCNE3 Channels in Transepithelial Ionic Transport 
6.3.1 KCNE3 in Colonic Epithelial Ionic Transport 
Pharmacological experiments using chromanol 293B suggested KCNQ1 as an important 
player in epithelial transport (Lohrmann et al. 1995). Because KCNE3 had not yet been 
identified as a β-subunit for KCNQ1, it was first hypothesized that KCNQ1/KCNE1 
complexes were involved in transepithelial ion transport (Suessbrich et al. 1996; Busch 
et al. 1997). However, in contrast to KCNE3, KCNE1 could be detected neither in 
colonic nor in tracheal tissues (Grahammer et al. 2001b), and the kcne1-/- mice did not 
show any impairment in forskolin-stimulated intestinal Cl- secretion (Arrighi et al. 
2001; Warth et al. 2002). Moreover, KCNQ1/KCNE1 channels activate at membrane 
potential of -20 mV, and the negative membrane potential of intestinal epithelial cells 
would prevent the channel complex from being open. 
Assembly of KCNQ1 with KCNE1 renders the complex voltage dependent (Barhanin et 
al. 1996; Sanguinetti et al. 1996). KCNE1 slows KCNQ1 activation kinetics, and 
dramatically increase KCNQ1 current amplitude without altering the deactivation tail 
currents. KCNE1 shifts the activation threshold potential -40 mV (for KCNQ1) to -20 
mV (for KCNQ1+KCNE1) allowing the channel to be fully open in apical membranes 
of the marginal cells of the stria vascularis where the membrane voltage reaches +5 mV 
(Vetter et al. 1996). This voltage dependency however predicts that the channel will be 
closed at the membrane potential of epithelial cells in colon (-60 mV) (Greger et al. 
1997) or in upper airways (-35 mV) (Rickheit et al. 2008), thereby rendering a 
functional involvement of KCNQ1/KCNE1 complexes in these tissues unlikely. 
On the other hand, KCNQ1/KCNE3 heteromers are constitutively open (Schroeder et al. 
2000): their voltage independence is compatible with the expression in non-excitable 
tissues, like gut or airway epithelia. In addition, several studies have speculated a 
possible role of KCNQ1/KCNE3 complexes in basolateral K+ recycling. Our work 
represents the first genetic study that addresses the function of the KCNE3 subunit, and 
provides strong evidence supporting the involvement of basolateral KCNQ1/KCNE3 
heteromers in colonic Cl- secretion. Our Ussing chamber experiments showed that 
current response to forskolin stimulation was almost completely abolished in kcne3-/- 
colonic tissues, with ~80% reduction in the elicited averaged currents compared to 






Additional lines of evidence come from the colocalization of KCNQ1 and KCNE3 in 
basolateral membranes of colonic epithelia (Figure 5.11), and the nearly complete loss 
of chromanol 293B-inhibitable currents in kcne3-/- mice (Figure 5.15). 
The fact that kcne3-/- mice exhibit strongly reduced transepithelial transport in colonic 
tissue, although neither KCNQ1 expression nor localization were altered indicates that 
KCNQ1 homomers are not able to support K+ recycling in the absence of KCNE3. As 
predicted by their outward-rectification properties, KCNQ1 homomers are in fact 
incompatible with a role in transepithelial transport in both colonic and tracheal 
epithelia, since in these tissues they are predicted to be largely closed at resting 
membrane potential (Greger et al. 1997; Barhanin et al. 1996; Sanguinetti et al. 1996). 
Moreover, KCNQ1/KCNE3 channels mediate currents that are 3 times larger than 
homomeric KCNQ1 channels in overexpressing COS (Bendahhou et al. 2005) or CHO 
(Ohno et al. 2009) cells. 
Altogether, our functional analysis of transepithelial transport in kcne3-/-colonic tissue 
enabled us to clearly assign a functional role to KCNQ1/KCNE3 complexes in 
basolateral K+ extrusion, a recycling pathway that is necessary to provide 
electrochemical driving force for Cl- secretion. 
 
6.3.2 Calcium Stimulated Chloride Secretion in Colonic Mucosa 
Our Ussing chamber experiments on ex vivo tissue preparations show that carbachol 
application induced a similar increase in Cl- efflux in both wild type (after C293B 
addition) and kcne3-/- epithelia (Figure 5.15). These results indicate that, while cAMP-
stimulated Cl- secretion is strongly impaired in kcne3-/- colon, Ca++ stimulated secretion 
is largely unaffected. It seems therefore plausible that Ca++ is able to activate basolateral 
K+ conductances, which can compensate for the loss of functional KCNQ1/KCNE3 
complexes in KO tissues. Recent reports suggest that intermediate conductance, Ca++-
sensitive KCNN4 K+ channels are activated in intestinal cells by stimulation of 
muscarinic receptors (Warth et al. 1999; Flores et al. 2007). Therefore, activation of 
KCNN4 by carbachol would facilitate an alternative K+ recycling pathway and allow Cl- 
secretion in cAMP stimulated kcne3-/- epithelia. Note that Ca++ stimulated Cl- secretion 
requires coactivation of CFTR by cAMP.  
In conclusion, our ex vivo (Figure 5.15) and in vivo data (Figure 5.18) provide a strong 




the second messenger cAMP and Ca++ in intestinal epithelia promote a massive Cl- 
secretion that is reduced by 50% in kcne3-/- animals. In particular, given that KCNE3 
deletion mutant mice did not show any obvious deficit in intestinal physiology in vivo, 
and that cholera toxin stimulated fluid loss occurred normally in KO animals (Figure 
5.18), we believe that this remaining Ca++ stimulated Cl- secretion is able to compensate 
for impaired cAMP cascade under basal and pathophysiological conditions.  
Along this line kcnn4-/- mice, though suffering from impaired Ca++-stimulated intestinal 
Cl- secretion, do not display any major intestinal complication in vivo (Flores et al. 
2007). The lack of major in vivo effects of the KCNE3 and KCNN4 deletions indicates 
that in the gastrointestinal tract Ca++ and cAMP work synergistically, thereby masking 
individual signaling cascade defects in the single mutants.  
 
6.3.3 KCNE3 and Cholera Toxin-Stimulated Cl- Secretion 
Cholera toxin (CT) directly stimulates cAMP-stimulated Cl- secretion in enterocytes, 
which ultimately results in water loss and diarrhea, by activating adenylate cyclase 
(Cassel and Pfeuffer 1978; Gill and Meren 1978). Intracellular cAMP levels increase 
CFTR open probability by PKA induced phosphorylation (Clarke et al. 1992). cAMP 
also stimulates NKCC1, the basolateral Na+/2Cl-/K+ cotransporter (Lytle and Forbush 
1992), by enhancing its insertion into the membrane from intracellular storage sites 
(Reynolds et al. 2007). Increased cAMP, via PKA-induced phosphorylation, activates 
KCNQ1/KCNE3 complex (Schroeder et al. 2000) that will repolarize the cell membrane 
counteracting the depolarizing effect of opening an apical Cl- channel.  
Selective and specific molecular therapies have been designed to block CFTR 
activation, thus effects of cholera toxin (Ma et al. 2002; Li and Naren 2005; Li et al. 
2007). An alternative approach could target instead basolateral K+ channels, whose 
activity is necessary to provide the electrochemical driving force for Cl- extrusion. Our 
experiments indicate that one potential target might be the KCNQ1/KCNE3 complex 
(Figure 5.15 and 4.17). To directly test if the functional lack of this complex has an 
impact on the cholera toxin-induced water-loss phenotype, we performed in vivo 
experiments in kcne3-/- intestine. Our experiments however showed that kcne3-/- and 
wild type colon responded very similarly to cholera toxin injections (Figure 5.18), 
indicating that in vivo KCNE3/KCNQ1 activity does not play a major role on cholera 




Plausibly, in vivo cholera toxin effects are complex and do not simply rely on 
stimulation of adenylate cyclase in epithelial cells. Cholera toxin might act on multiple 
signaling pathways (Pothoulakis et al. 1998; Farthing et al. 2004) and its effect could be 
possibly mediated by multiple cell types. Cholera toxin might not only act on adenylate 
cyclase in epithelial cells, but also in enterochromaffin cells. These cells would 
consequently secrete serotonin, which leads to enteric nervous system stimulation and 
local acetylcholine and vasoactive intestinal peptide (VIP) secretion that cause smooth 
muscle contractions and promote intracellular cAMP and Ca++ cascades also in 
epithelial cells. Besides, activation of mast cells that secrete histamine would lead to 
general epithelium inflammation and prostaglandins release, also increasing cAMP and 
Ca++ intracellular levels. Under these circumstances, Na+ and Cl- absorption will be 
prevented in the surface epithelia, whilst the crypts will be flushed with Cl- and water 
secretion. In addition, it had been suggested that cholera toxin might directly promote 
Ca++ stimulated Cl- secretion cascade, thereby producing a synergistic cascade and 
massive fluid loss (Nocerino et al. 1995; Field 2003). 
In agreement with our conclusions other ligated-loop experiments, where fluid secretion 
could be blocked only by coinjection of cholera toxin with either CFTR inhibitors (Ma 
et al. 2002) or clotrimazole, an inhibitor for both KCNQ1/KCNE3 and KCNN4 
channels (Rufo et al. 1997). This evidence further supports the cooperativity of cAMP 
and Ca++ signaling to produce a synergistic action in vivo, since blocking both recycling 
pathways was shown to be necessary to prevent the effects of cholera toxin injection in 
intestinal fluid secretion. 
 
6.3.4 KCNE3 Function at the Single Cell Level: Whole Cell 
Recordings of Colonic Crypts 
Whole-cell recording from intact colonic crypt cells is a challenging technique used to 
study ion channel activity at the single cell level (Schroeder et al. 2000; O'Mahony et al. 
2007). The recorded current is the resultant of many different ionic conductances across 
the plasma membrane. In this configuration, it is therefore complex to resolve the 
contribution of individual ionic conductances to the total measured current. Selective 
removal of specific ions from bath and/or internal solution has been a useful way to 
circumvent this problem. Unfortunately, in our preparation of mouse colonic crypts, we 




colonic by substituting Cl- for gluconate from the bath solution (Schroeder et al. 2000), 
since this had deleterious effects on the quality of the preparation and on the stability of 
the recordings. Murine colonic crypts seem therefore to be more sensitive than their 
equivalent preparations in rabbit or rat, to Cl- removal. Our experiments were therefore 
performed in the presence of physiological Cl- concentrations, both intracellular and 
extracellular (see material and methods for further details).  
Forskolin application promoted a general membrane depolarization in both genotypes 
compatible with prominent Cl- secretion through CFTR activation (Figure 5.17C). 
Surprisingly, total whole-cell current was not increased by forskolin, though cAMP 
should increase currents through both CFTR and KCNQ1/KCNE3. Another group 
obtained similar results described previously in comparable preparations (Diener et al. 
1996). 
This paradoxical whole cell effects of forskolin can be explained by assuming that in 
addition to promote Cl- secretion, raising intracellular cAMP concentration might as 
well lead to inactivation of other conductances in the cell, which are active before 
forskolin addition (e.g. KCNN4 and ENaC). On one hand, inactivation of Ca++ activated 
K+ channels KCNN4, which opened because of increases in intracellular Ca++ (because 
of cell swelling, or through stretch-activated channels (Hoyer et al. 1994), possibly due 
to mechanical pressure exerted by the patch pipette onto the plasma membrane), could 
lead to decreased total currents. On the other hand, inhibition of Na+ conductances 
through ENaC, as an indirect effect of cAMP-stimulated Cl- efflux, could also 
negatively affect whole cell conductances. Although, the epithelial sodium channel 
ENAC is reported to be expressed mostly in surface epithelial cells (Amasheh et al. 
2009). 
As expected, while in wild type the C293B-sensitive K+ current displayed a reversal 
potential of about -75 mV, which is close to the K+ reversal potential (-86 mV), in 
kcne3-/- cells this current was completely abolished (Figure 5.17E). 
Altogether, our data from whole-cell recording of intestinal crypt cells clearly showed 
the lack of chromanol 293B sensitive K+ channel activity in the kcne3-/- mouse. This is 





6.3.5 KCNE3 and Small Intestine Function 
Small intestine and colon are specialized segments of the intestinal tract, which have 
distinct biophysical properties and serve different functions. While the first is mainly 
responsible for nutrient absorption, the last is involved in fluid and electrolyte 
absorption (Heitzmann et al 2004). 
For these reasons, the contribution of specific basolateral K+ channels to the secretory 
response may differ between colon and small intestine. Whereas the cAMP-stimulated 
current component is almost totally dependent on KCNQ1/KCNE3 channels in colon, 
we believe that in small intestine the contribution of KCNQ1/KCNE3 is much lower. 
Recent work on bioelectrical properties of small intestine have shown that  forskolin 
stimulated currents were reduced by only about ~50% in kcnq1-/- animals (Grubb et al. 
2000; Vallon et al. 2005) instead of being completely abolished as it would be expected 
if KCNQ1-containing channels were the only conductance supporting basolateral K+ 
recycling. In addition, also nkcc1-/- small intestine displayed a similar phenotype, with 
only a partial impairment in cAMP stimulated Cl- secretion (Grubb et al. 2000) though 
in this case nkcc1-/- suffer of mild intestinal obstruction (Flagella et al. 1999).  
These experiments clearly indicate that in small intestine alternative basolateral K+ and 
Cl- conductances are activated under cAMP stimulation, as was also suggested by 
electrophysiological and pharmacological experiments in isolated crypt cells 
(McNicholas et al. 1994; Heitzmann et al. 2004).  
In particular, cAMP stimulated Cl- secretion is not fully dependent on KCNQ1/KCNE3 
channels, but there seems to be extensive functional redundancy between alternative 
cotransporters in this epithelium. Although we did not directly test this hypothesis, we 
believe that, the overall impact of the KCNE3 deletion in cAMP-stimulated Cl- 
secretion in the small intestine would be minor than in colon. 
Given absorptive function of the small intestine, a functional impairment is expected to 
have major consequences on growth and ionic homeostasis. However, kcne3-/- animals 
did not suffer from any malnutrition, growth retardation, abnormal intestinal 
morphology and all the analyzed parameters in serum, feces and urine samples were 
within the normal range. In comparison, kcnq1-/- mice suffered from fecal loss of Na+ 
and K+ (Vallon et al. 2005) and kcnn4-/- present decreased Na+ and water contents in the 




show any intestinal impairment (besides the reduced Cl- secretion), and its overall 
intestinal morphology was preserved. 
In small intestine there should exist some yet unknown alternative pathways for 
basolateral K+ transport that partially compensate for the loss of KCNQ1 and KCNE3 in 
the respective KO mouse models. Although this hypothesis has not yet been tested, this 
compensatory role might be played by other cAMP stimulated basolateral K+ 
conductances and/or for instance by the electroneutral KCC cotransporter. 
 
6.3.6 Genetic Evidences for the Biophysical Cell Model of Epithelial 
Chloride Secretion 
In a simplified biophysical model of transepithelial transport, only KCNQ1/KCNE3 
would provide the basolateral K+ conductance and CFTR would be the sole apical Cl- 
channel (Figure 6.1). This basic model can be extended by taking into account the 
contribution of KCNN4, a Ca++ activated basolateral K+ channel, which sustains Ca++ 
stimulated Cl- secretion. This model for K+ recycling has been supported by several 
genetic evidences.  
 
Figure 6.1. Cell model for Cl- secretion 
by a colonic/tracheal epithelial cell. 
Driven by the Na+ gradient established 
by the basolateral Na+/K+-ATPase,  Na+ 
powers the basolateral NKCC1 
cotransporter, raising intracellular Cl- 
above its electrochemical equilibrium. 
Hence, Cl- can exit the cell passively 
through apical, cAMP-stimulated CFTR 
Cl- channels (and/or Ca++-activated Cl- 
channels in airway), resulting in Cl- 
secretion. Basolateral K+ channels are 
needed to recycle K+. These channels 
additionally render the cell interior more 
negative, increasing the driving force for 
apical Cl- exit. Epithelial cells express 
both cAMP activated KCNQ1/KCNE3 
K+ channels and Ca++-activated KCNN4 
(SK4, KCa3.1) K+ channels. The 
epithelial sodium channel Note that, 
ENaC, is expressed at low level in 
colonic crypt cells. 
 
 
In kidney, KCNQ1 is expressed in mid and late proximal tubules, together with KCNE1 




animal models for each protein showed dissimilar kidney phenotypes. While kcnq1-/- 
mice suffered from impaired kidney function only under pathological substrate overload 
conditions (Vallon et al. 2005), kcne1-/- mice not only displayed high aldosterone levels 
under basal conditions, but also hypokalemia, Na+ and glucose renal excretion, and 
fecal loss of Na+ and K+ loss (Arrighi et al. 2001). The reasons for these discrepancies 
are currently unknown. 
On the other hand, the fact that we could not detect KCNE3 in murine kidney (Figure 
5.3 and 5.5) is consistent with the balanced ionic homeostasis and body fluids 
composition observed in kcne3-/- mice (table 5.1). In particular, unlike the KCNQ1 
deletion, K+ and Na+ excretion and homeostasis were unaffected by the KCNE3 
deletion. The fact that in colon ENaC is expressed in surface epithelial cells (Greig et al. 
2004) and not in colonic crypts, the predominant site of KCNQ1/KCNE3 expression, 
would already argue against a major impact of the KCNE3 deletion on aldosterone-
induced colonic Na+ absorption. 
In addition, the analysis of kcnn4-/- mice has provided insights into the molecular 
mechanisms of Cl- secretion, revealing that under KCNQ1/KCNE3 inhibition, Ca++ 
stimulated Cl- secretion was completely abolished in absence functional KCNN4 
channels (Flores et al. 2007). However, the fact that KCNQ1/KCNE3 conductances 
were inhibited by C293B throughout the experiment makes the contribution of 
individual channel difficult to assess.  
CFTR is believed to be the major player in both cAMP and Ca++ stimulated Cl- 
secretion in the intestine. As expected, CFTR deletion leads to major defects in 
transepithelial transport, and to massive degeneration of the tissue (Clarke et al. 1992). 
These degenerative effects of the mutation have not been described neither for KCNE3 
(Figure 5.8 and 5.10) nor for KCNN4 deletions. In particular, in kcne3-/- we did not 
observe any atypical immune cell infiltration or mucus accumulation (Figure 5.10), as it 
would be expected in intestinal obstructive or irritative pathologies, as seen in the cftr1-/- 
or nkcc1-/-mice. 
Altogether, our data corroborate the biophysical model for Cl- secretion from intestinal 
epithelial cells, and provide additional evidence concerning the molecular nature of the 
ion channels involved in basolateral K+ recycling. This is an important contribution that 






6.4 KCNE3 and Airways Physiology 
The present study shows that in mouse trachea KCNQ1/KCNE3 channels contribute 
significantly to the driving force for apical Cl- exit through either CFTR or Ca++-
activated Cl- channels. 
For the first time KCNQ1/KCNE3 complex was immunolocalized to the basolateral 
membrane of the lining epithelia of the trachea. Other groups detected KCNE3 
expression in trachea by PCR some years ago (Grahammer et al. 2001b; Cowley and 
Linsdell 2002). In addition, KCNQ1/KCNE3 mediated hyperpolarization should 
increase Na+ absorption, but in our Ussing chambers experiment  (Figure 5.19C) 
differences between the amiloride sensitive currents of WT and KO tracheas were not 
statistically significant. However, there is a borderline effect on kcne3-/- amiloride-
sensitive currents, indicating that KCNQ1/KCNE3 complex might contribute in Na+ 
absorption.  
In trachea there is not only cAMP stimulated Cl- secretion via CFTR, but also there is 
an important contribution from Ca++-activated Cl- channels ( probably TMEM16A 
(Rock et al. 2009)). This secretion is supported by K+ extrusion by either cAMP 
stimulated KCNQ1/KCNE3 complex or Ca++ activated K+ channel, probably KCNN4 
(Thompson-Vest et al. 2006). Therefore, in trachea, unlike in colonic epithelia, cAMP 
and Ca++ signaling can independently stimulate Cl- secretion through different Cl- 
channels. In this tissue, in fact carbachol is able to induce Cl- secretion also in absence 
of forskolin.  
Stimulation of Cl- secretion by either forskolin or carbachol application was drastically 
reduced in kcne3-/- tracheal tissues compared to controls (Figure 5.20 and 5.21), 
indicating that, in contrast to what we observed in colon (Figure 5.15), in tracheal tissue 
KCNQ1/KCNE3 complexes are also needed to sustain Ca++ stimulated Cl- secretion. 
This functional difference between these two epithelia might be explain in part by the 
presence in trachea of the Ca++ stimulated Cl- channel which operates in parallel to 
CFTR. Moreover, KCNN4 would not fully compensate the loss of functional 
KCNQ1/KCNE3 as seen in kcne3-/- colonic epithelia. Therefore, in trachea it seems that 
the basal activity of KCNQ1/KCNE3 (without cAMP-stimulation) would contribute to 
the driving force for Cl- secretion through Ca++ stimulated Cl- secretion. 
To closely mimic the in vivo situation, we also monitored Cl- secretion under ATP 




cAMP  (Kottgen et al. 2003; Mounkaila et al. 2005) promoted a massive Cl- secretion 
through both CFTR and CaCC that was reduced by 50% in kcne3-/- tissues compared to 
controls (Figure 5.20B and D). The response to ATP does not only involve apical Cl- 
secretion via CFTR or CaCC, but also basolateral K+ recycling, activating both K+ 
channels.  
Interestingly, ATP and carbachol induced currents three times larger than currents 
obtained under forskolin stimulation, indicating that first, Ca++ mediated response 
promotes larger Cl- secretion than cAMP; second, Ca++ and cAMP have a synergistic 
effect on Cl- secretion. In agreement with these conclusions, ATP and carbachol 
stimulated secretion were decreased to a lesser (50%) extent by the KCNE3 deletion 
compared to forskolin stimulated currents (80%).  
In summary, seeing that current responses to forskolin, carbachol and ATP applications 
in our Ussing chamber experiments were strongly reduced in kcne3-/- animals, we 
conclude that KCNE3 deletion has a strong impact on tracheal Cl- secretion.  
 
6.5 Mucociliary Clearance Experiments 
In order to functionally characterize the impaired Cl- secretion we observed in ex vivo 
tracheal tissue preparations from kcne3-/- animals, we performed mucociliary clearance 
(MCC) experiments. These experiments consist in quantifying the transport of small 
microspheres on the tracheal epithelial surface, to assess defects in the self-clearing 
mechanism of airways tissues.  
These experiments did not reveal any functional impairment in kcne3-/- tissues compared 
to controls (Figure 5.22). Both carbachol and ATP applications, which in Ussing 
chambers promoted massive Cl- secretion that was reduced to 50% in the kcne3-/- 
trachea, stimulated MCC with similar efficiencies in both genotypes (Figure 5.22). It is 
interesting to mention however that the MCC observed in kcne3-/- tissues by ATP 
appeared to be much less pronounced than the effect observed in control tissues, 
although this difference did not reach statistical significance. This trend in our data set 
might indicate that minor effects of the mutation could have gone undetected, possibly 
due to the scarse sensitivity of the MCC assay.   
The discrepancy between Ussing chamber and MCC experiments might however be due 
to different tissue preparations. In the Ussing chamber experiments the net ion transport 




innervations. Instead, MCC experiments were performed on intact tissue, where ATP 
not only promotes epithelial Cl- secretion but also stimulates neuromuscular activity, 
which might in turn boost mucociliary transport and render it quite insensitive to minor 
ion transport impairments in epithelial cells.  
In addition, the lack of a functional impairment in kcne3-/- tracheas, assessed by MCC 
experiments, might be due to the remaining activity of Ca++ stimulated Cl- secretion in 
this tissue (Figure 5.21). We speculate that in murine trachea in vivo, Ca++ activated Cl- 
channel would take over loss of CFTR function (Clarke et al. 1994; Grubb et al. 1994), 
hereby avoiding the dramatic phenotype seen in the human CF patients. 
In addition to the absence of an obvious impairment in respiratory phenotype, kcne3-/- 
mice also did not show any sign of diseased upper airway morphology, nor mucus 
accumulation or immune cells infiltration in this tissue (Figure 5.12).  
Altogether, these evidences suggest that the remaining Cl- secretion that we observe in 
ex vivo tissue preparations from kcne3-/- animals seems to be sufficient to support 
normal trachea physiology in vivo. We cannot exclude however that this impairment in 
Cl- secretion becomes crucial under altered physiopathological conditions, or in 
combination with other genetic manipulations (e.g. KCCN4 deletion). 
 
6.6 KCNE3 and Skeletal Muscle 
The present study contradicts the hypothesis of Kv3.4/KCNE3 K+ channel complex 
being involved in setting the resting membrane potential of skeletal muscle and being a 
cause of a genetically heterogeneous human disease called periodic paralysis (Abbott et 
al 2001 and 2006). 
First of all, neither KCNE3 mRNA nor protein was detected in murine skeletal muscle 
(Figure 5.3 and 5.5). Second, kcne3-/- animals did not show any uncoordinated 
movement, myotonia or periodic paralysis before, during or after exercise as seen in 
rotarod experiments performed also under hypokalemic diet conditions (Figure 5.23). 
Third, histological analysis of skeletal muscle from kcne3-/- mice did not reveal any 
morphological abnormalities. In particular, we did not observe any vacuoles or tubular 
aggregates similar to the ones reported in muscle biopsies from human patients affected 
by periodic paralysis (Abbott et al. 2001). 
In addition to our study, other groups have provided evidence against a functional 




R83H substitution in the KCNE3 gene was shown to be a benign polymorphism, rather 
than a mutation linked to periodic paralysis, since it had been found in healthy 
individuals (Sternberg et al. 2003; Jurkat-Rott and Lehmann-Horn 2004). Indeed, it had 
been reported at frequency of 1% in healthy controls. Also the expression of KCNE3 in 
human skeletal muscle has been recently questioned by the work of Lundquist and 
collaborators, which failed to detect KCNE3 expression in this tissue (Lundquist et al. 
2006). 
 
6.7 KCNE3 and the Central Nervous System  
Several groups had reported KCNE3 to be highly expressed in the mammalian brain, 
and proposed its functional interaction with Kv2.1 and Kv3.1 (McCrossan et al. 2003), 
Kv3.1 and Kv3.2 (Lewis et al. 2004) or Kv3.4 K+ channels (Pannaccione et al. 2007). 
The latter complex had been also implicated in Alzheimer disease, since it had been 
shown to be upregulated by direct action of the beta amyloid peptide (Pannaccione et al. 
2007). Furthermore, single nucleotide polymorphisms (SNPs) in KCNE3 gene had been 
related to Ménière’s disease (MD) (Doi et al. 2005), a disorder of the inner ear 
characterized by tinnitus, vertigo, and sensorineural hearing loss. However, it has been 
recently reported that SNPs in KCNE3 are not associated with MD (Campbell et al. 
2010). 
These studies however suffer from major technical limitations. Most of the conclusions 
were in fact based on in vitro experimental evidences from heterologous expression 
systems and electrophysiological analysis from transfected cells. Systems that rely on 
overexpression of the protein(s) of interest are often prone to artifacts and, although 
very valuable for collection of preliminary data, these approaches should be routinely 
supported by evidences from in vivo or intact tissues. 
Our study on the other hand provides well validated in vivo evidences for the absence of 
KCNE3 expression and function in the mouse brain. Not only KCNE3 mRNA and 
protein were not detected in murine brain (Figure 5.3 and 5.5), but also we did not 
detected any obvious neurological defects in rotarod performances, which requires good 
sensorimotor coordination and is sensitive to cerebellar and basal ganglia dysfunction 
(Crawley 1999). We observed neither impaired neurological reflexes nor morphological 




these evidences suggest that KCNE3 protein does not play a major role in murine CNS 
physiology. 
 
6.8 KCNE3 and Cardiac Function  
Unlike the present study, experimental evidences on KCNE3 expression in heart are 
weakened by the lack of optimal controls (e.g. kcne3-/- tissues) or by the use of 
questionable approaches for mRNA detection (e.g. RT-PCR to amplify internal exonic 
sequences) (Franco et al. 2001; Bendahhou et al. 2005; Lundquist et al. 2005; de Castro 
et al. 2006; Radicke et al. 2006). In addition, some conclusions have been solely based 
on experimental evidences from heterologous expression systems, and non conclusive 
genetic studies of single patients or families carrying putative mutations in the KCNE3 
gene missing statistical linkage analysis (Delpon et al. 2008; Lundby et al. 2008; Ohno 
et al. 2009). 
In conclusion, we believe that further investigations are necessary to clearly elucidate 
the putative functional involvement of KCNE3 in cardiac physiology.  
We did not observe KCNE3 expression in murine heart, neither at mRNA nor at the 
protein level, and kcne3-/- mice reached about 2 years of age without any major 
pathological consequences, and did not display any obvious phenotype. Our findings 
therefore arise some doubts concerning the implication of KCNE3 in cardiac muscle 









The present analysis of kcne3-/- mice strongly supports a crucial role of 
KCNQ1/KCNE3 channels in salt- and fluid secretion across intestinal and airway 
epithelia. In particular, we found that KCNQ1/KCNE3 heteromers are present in 
basolateral membranes of intestinal and tracheal epithelial cells where they facilitate 
transepithelial Cl- secretion through basolateral recycling of K+ ions and by increasing 
the electrochemical driving force for apical Cl- exit. Because the abundance and 
subcellular localization of KCNQ1 was unchanged in kcne3-/- mice, the modification of 
biophysical properties of KCNQ1 by KCNE3 is essential for its role in intestinal and 
tracheal transport. Whereas inhibition of KCNQ1/KCNE3 channels is unlikely to be 
useful in treating cholera or other severe forms of diarrhea, specific activators of these 
channels in combination with other therapies, might hold promise in alleviating the 
pulmonary symptoms of cystic fibrosis.  
In addition, our work does not support the postulated role of KCNE3 heteromers in 
skeletal muscle, heart and CNS physiology, and raises considerable doubts concerning 
its implication in human pathologies which affect these tissues (Abbott et al. 2001; 
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Amino acid code 
 
A Alanine M Methionine 
C Cysteine N Asparagine 
D Aspartic acid P Proline 
E Glutamic acid Q Glutamine 
F Phenyl alanine R Arginine 
G Glycine S Serine 
H Histidine T Threonine 
I Isoleucine V Valine 
K Lysine W Tryptophan 




A Ampere (current) kDa Kilodalton 
bp Base pair L Liter  
°C Grad Celsius (temperature) M Meter  
Ci Curie M mol/l (molarity) 
cpm Counts per min Min Minute  
F Farad (capacitance) Ω Ohm (resistance) 
G Gram  Rpm Revolutions per min  
H Hour S Seconds 
Hz Hertz (frequency) U Enzymatic activity 





ATP Adenosine triphosphate  
BCA Bicinchoninic acid 
BSA Bovine serum albumin 
cAMP Cyclic adenosine triphosphate 
CCHO Carbachol (2-carbamoyloxyethyl- trimethyl- azanium) 
cDNA Deoxyribonucleic acid 
CFTR Cystic Fibrosis Transmembrane Conductance Regulator 






C-Terminus Carboxy terminus 
dCTP Deoxycytidine triphosphate 
DEPC Diethylpyrocarbonat 
DMEM Dulbecco’s modified Eagle Medium 
DMSO Dimethylsulfoxid 
DNA Deoxyribonucleic acid 
dNTP Deoxynucleotide triphosphate 
DTT Dithiothreitol 
EDTA Ethylenediaminetetraacetic 
ENac Epithelial sodium channel 
ES Embryonic stem cells 
EST Expressed sequence tag 
FSK Forskolin 
HA Influenza hemagglutinin-epitope 
HE Hematoxilyn-Eosin 
HEPES N-(2-Hydroxyethyl)piperazin-N’-2-ethansulfonic acid 
HRP Horse radish peroxidase 
IBMX 3-isobutyl-1-methylxanthine 
Isc  Short-circuit current 
KO Knock-Out 
LB Luria Broth 
Lox Locus of crossover in P1 
µ Micro 
MCC Mucociliary clearance 
MEF Murine embryonic fibroblast 
mRNA Messenger RNA 
N Nano 
Neo Neomycin-resistance gene 
NGS Normal goat serum 
NP-40 Nonidet P40 
N-Terminus Aminoterminus 
P Pico  
PBS Phosphate buffer saline 
PCR Polymerase chain reaction  
PFA Paraformaldehyde 
pH Negative decimal logarithm of the hydrogen ion activity in a 
solution 
PNGase peptide N-glycosidase F 
qRT-PCR Quantitative real-time polymerase chain reaction 
RNA Ribonucleic acid 
RNase Ribonuclease 
RT Room temperature  
RT-PCR Reverse transcriptase polymerase chain reaction 
SDS Sodiumdodecylsulfate 




SEM Standard error of mean 
TAE Tris-Acetat-EDTA-buffer 
Taq Thermus aquaticus 
TE Tris-EDTA-buffer 
TEVC Two electrode voltage clamp 
UV Ultraviolet 
v/v Volume per volume 
WB Western Blot 
WT Wild type  
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